data_1e10_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e10 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.99 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 99.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 99.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 99.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 99.0 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CE2' HD11 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 99.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 99.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 99.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 99.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 99.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 99.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 99.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 99.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 99.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 99.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 99.0 110.848 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 99.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 99.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 99.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 99.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 99.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 99.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 99.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 99.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 99.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 99.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 99.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 99.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 99.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 99.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 99.0 110.227 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 99.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 99.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 99.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 99.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 99.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 99.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 99.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 99.0 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 99.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 99.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 99.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 99.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 99.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 99.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 48' ' ' ILE . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 99.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 101' ' ' THR . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 99.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 99.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 99.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 99.0 110.084 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 99.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 99.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 99.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 99.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 99.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 99.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 99.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.314 0.578 . . . . 99.0 110.423 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 99.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 99.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 99.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 99.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 99.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 99.0 109.452 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 99.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 81' ' ' ASP . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 99.0 110.242 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 99.0 110.216 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 99.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 99.0 110.043 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 99.0 110.074 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 99.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 99.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 99.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 99.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 99.0 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 99.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 99.0 110.376 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.524 ' CB ' HG21 ' A' ' 74' ' ' ILE . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 99.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 99.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 99.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 99.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 99.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 99.0 110.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 99.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 99.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 99.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 99.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 99.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 99.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 99.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 99.0 110.507 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 99.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 99.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 99.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 99.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.4 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 99.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 99.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 99.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.481 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 99.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.574 HD11 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 99.0 110.442 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.99 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' MET . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 99.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 99.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 99.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 99.0 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 99.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 99.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 99.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 99.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 99.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 99.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 99.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 99.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 99.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 99.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 99.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 99.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 99.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 99.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 99.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.521 ' CD1' HD12 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 99.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 99.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 99.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 99.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 23' ' ' LEU . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 99.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 99.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 99.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 99.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 99.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 99.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 99.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 99.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 99.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 99.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 99.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 99.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 99.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.482 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 99.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 99.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CB ' ' HG3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 99.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 99.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 99.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 99.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 99.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.46 ' CD1' ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 99.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 99.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 99.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 99.0 110.146 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 99.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 99.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 99.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 99.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 99.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 99.0 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 99.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.587 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 99.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' CA ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 99.0 110.535 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.486 ' OG ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 99.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 99.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 99.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 99.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 99.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 99.0 110.113 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 81' ' ' ASP . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 99.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.508 ' N ' HG21 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 99.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 99.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 99.0 110.141 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.185 0.517 . . . . 99.0 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 99.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 99.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 99.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' CD ' ' A' ' 99' ' ' ARG . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 99.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 99.0 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 99.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' O ' HD11 ' A' ' 74' ' ' ILE . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 99.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 99.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' SER . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 99.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.514 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 99.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 59' ' ' TRP . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 99.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' CD1' ' A' ' 48' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 99.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 99.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 99.0 110.161 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 99.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 99.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG3' ' CB ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 99.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.508 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 99.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 99.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 99.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 99.0 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 99.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 99.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.587 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 99.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 99.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB2' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 99.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 99.0 110.114 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 99.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 99.0 110.31 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.428 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.99 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 99.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 99.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 99.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 99.0 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 120' ' ' LEU . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 99.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 99.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 99.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 99.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 99.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 99.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 99.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 99.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 99.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 99.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 99.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 99.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 99.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 99.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 99.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 99.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 99.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 99.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 99.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 99.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 99.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 99.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 99.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 99.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 99.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 99.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 99.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 99.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 99.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 99.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 99.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 99.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 99.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 99.0 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 99.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 99.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 99.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 99.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 99.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 99.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 99.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 99.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 99.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 99.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 99.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 99.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 99.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 99.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 99.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 99.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 99.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' HG23 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 99.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HG3' ' CB ' ' A' ' 72' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' CB ' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.278 0.561 . . . . 99.0 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 99.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 99.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 99.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 99.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 99.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 99.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 99.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 80' ' ' ILE . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 99.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 99.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 99.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 99.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.277 0.561 . . . . 99.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.47 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 99.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 99.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 99.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 99.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' N ' HG11 ' A' ' 93' ' ' VAL . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 99.0 110.192 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 99.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 99.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 99.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 99.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 99.0 109.876 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 99.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.539 HG23 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 99.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 99.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 99.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 99.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 99.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HB3' HG22 ' A' ' 3' ' ' VAL . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 99.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 99.0 110.363 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 99.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 99.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 3' ' ' VAL . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 99.0 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 99.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 99.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 99.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.521 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 99.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 99.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 99.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 99.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 99.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 99.0 110.264 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.99 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' OE1' ' CG2' ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 99.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 99.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 99.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 99.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 99.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 99.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.46 HG21 ' HG3' ' A' ' 14' ' ' GLN . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 99.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 99.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 99.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 99.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.569 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 99.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 99.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 99.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 99.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 99.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 99.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 99.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 99.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 99.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' HD23 ' A' ' 11' ' ' LEU . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 99.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 99.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 99.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 99.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 99.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 99.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 99.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 99.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 99.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 99.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 99.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 99.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 99.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 99.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 99.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 99.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' CG2' ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 99.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 99.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 99.0 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 99.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 99.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 99.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 99.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 99.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 49' ' ' LEU . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 99.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 99.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 99.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 99.0 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 99.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 99.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 51' ' ' ALA . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 99.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 99.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 99.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.428 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 99.0 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 99.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 99.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.382 0.61 . . . . 99.0 110.505 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 99.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 99.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 99.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 112' ' ' LYS . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 99.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 99.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 99.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 99.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' CD1' ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 99.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 99.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.502 ' HE1' ' CG2' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 99.0 110.143 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 99.0 110.233 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 99.0 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 99.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 99.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 99.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 99.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 99.0 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 99.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 99.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 99.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 99.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 99.0 110.259 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 99.0 110.312 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 99.0 110.134 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 99.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.574 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 99.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 99.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 99.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 99.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 99.0 110.04 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 99.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' O ' ' OE2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 99.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 77' ' ' GLU . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 99.0 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 99.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 113' ' ' ILE . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 99.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 99.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 99.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.548 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 99.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 99.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 99.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 99.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.99 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' MET . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 99.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 99.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 99.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.524 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 99.0 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 99.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 99.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 99.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 99.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 99.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 99.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 99.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 99.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 99.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.425 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 99.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 99.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 99.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 99.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 99.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' CD2' ' CD1' ' A' ' 16' ' ' TRP . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 99.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 99.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 99.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 99.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 99.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 99.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 99.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 99.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 99.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 99.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 99.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 99.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 99.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.54 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 99.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 99.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 99.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 99.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.471 ' HE2' ' O ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 99.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 99.0 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 99.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 99.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 99.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 99.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 99.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 99.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.471 ' O ' ' HE2' ' A' ' 40' ' ' MET . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 99.0 110.087 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 99.0 110.342 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 99.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 99.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 99.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 99.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 99.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 99.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 99.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 99.0 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 99.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 99.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.227 0.537 . . . . 99.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 99.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 99.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 99.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 99.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.485 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 99.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 99.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 99.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 99.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 99.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 99.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 99.0 110.359 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.211 0.529 . . . . 99.0 110.379 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 99.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 99.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 99.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 99.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 99.0 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 99.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 99.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.486 ' HB3' HG21 ' A' ' 74' ' ' ILE . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 99.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 99.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 99.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 99.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.47 ' HB ' HG23 ' A' ' 48' ' ' ILE . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 99.0 110.275 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 99.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 99.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 99.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 99.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 99.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 99.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 99.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 99.0 109.899 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 99.0 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 99.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 99.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 99.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 99.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 99.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 99.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 99.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 99.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 99.0 110.359 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.99 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 113' ' ' ILE . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 99.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 99.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 99.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 99.0 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 99.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 99.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 99.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD12 ' CA ' ' A' ' 17' ' ' ASP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 99.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 99.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 99.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 99.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 99.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 99.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' CA ' HD12 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 99.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.429 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 99.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 99.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 99.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 99.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 99.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 99.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 99.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 99.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 99.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 99.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 99.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 99.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 99.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 99.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 99.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 99.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 99.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 99.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 99.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 99.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 99.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 99.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 99.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 99.0 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 99.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 99.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 99.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 99.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 99.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 99.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 99.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 99.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' HG2' ' A' ' 46' ' ' GLU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 99.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 99.0 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 99.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 99.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 99.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 99.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 99.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 99.0 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 99.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 99.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.46 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.119 0.485 . . . . 99.0 110.035 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.459 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 99.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 99.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 99.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 99.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 99.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 99.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 99.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 99.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 99.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 99.0 109.973 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.231 0.539 . . . . 99.0 110.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 99.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 99.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 99.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 99.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.514 ' N ' HG11 ' A' ' 93' ' ' VAL . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 99.0 109.537 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 99.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 99.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 99.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 99.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 99.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 99.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 99.0 110.152 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' HA ' HD22 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 99.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 99.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 99.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 99.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 99.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.463 ' CB ' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 99.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 99.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 99.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 99.0 110.315 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 99.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 3' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 99.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 99.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 99.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 99.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 99.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 99.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 99.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 99.0 110.408 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.99 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 40' ' ' MET . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' HG13 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 99.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 99.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 99.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' OD1' ' CE1' ' A' ' 115' ' ' TYR . 66.8 t30 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 99.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 99.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 99.0 109.824 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 99.0 109.429 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 99.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 99.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 99.0 109.858 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 32' ' ' LEU . 4.2 mm-40 -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 99.0 109.975 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 99.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.521 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 99.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 99.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.413 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 99.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 99.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 99.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 99.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 99.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 23' ' ' LEU . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 99.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 76' ' ' LYS . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 99.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 99.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 99.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 99.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 99.0 109.91 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 99.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 99.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 99.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD23 ' NE2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 99.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 99.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 99.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 99.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 99.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 99.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 99.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 99.0 110.136 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 99.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 99.0 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 99.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 99.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 99.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 99.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 99.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 99.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.516 HG22 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 99.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 99.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 99.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 99.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 99.0 110.319 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 99.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 99.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 99.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 99.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 99.0 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 99.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 99.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 43.8 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.136 0.494 . . . . 99.0 110.556 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 99.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 99.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 99.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 99.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 99.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 99.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 99.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 99.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.511 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 99.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 99.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 99.0 110.542 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.31 0.576 . . . . 99.0 110.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 99.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 99.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 99.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 99.0 109.786 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 99.0 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 99.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 99.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 99.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 99.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 99.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 99.0 110.348 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.423 HG23 ' OG ' ' A' ' 73' ' ' SER . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 99.0 110.153 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 99.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.411 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 99.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 99.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 99.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 99.0 110.188 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 99.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 99.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 99.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 112' ' ' LYS . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 99.0 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 99.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 99.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 99.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.568 ' CE1' ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 99.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 99.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 99.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 99.0 110.12 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 99.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.502 HD13 ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 99.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.99 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 99.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 99.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 99.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.58 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 99.0 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 99.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.425 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 99.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 99.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 99.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 99.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 99.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 99.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 99.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 99.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 99.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 99.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 99.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 99.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 99.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 99.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 99.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 99.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 99.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 99.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 99.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 99.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 99.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 99.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 99.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 99.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 99.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 99.0 109.394 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 99.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 99.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 99.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 99.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 99.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 99.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 48' ' ' ILE . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 99.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 99.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 99.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 99.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 99.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 99.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG21 ' CE ' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 99.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 99.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 99.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 99.0 109.742 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 99.0 109.856 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 99.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 99.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 99.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 99.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 99.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 99.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.604 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 99.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.298 0.57 . . . . 99.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 99.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 99.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 99.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 99.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 99.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 99.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 99.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 99.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 99.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 99.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 99.0 110.274 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.207 0.527 . . . . 99.0 110.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 99.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 99.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 99.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 99.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 99.0 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 99.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 99.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 99.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 73' ' ' SER . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 99.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' HG22 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 99.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 99.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 99.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.424 ' SG ' HD12 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 99.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 99.0 110.222 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 99.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 99.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 3' ' ' VAL . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 99.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 99.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 99.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 99.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 99.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 99.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 99.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 99.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 99.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 99.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 99.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 99.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 99.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 99.0 110.431 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.99 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 99.0 110.302 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 99.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 99.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.581 ' HA ' ' CD2' ' A' ' 115' ' ' TYR . 39.0 t30 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 99.0 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 99.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 99.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 99.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 99.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 99.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 99.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 99.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 99.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 99.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 99.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 99.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 99.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 99.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.58 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 99.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 99.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 16' ' ' TRP . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 99.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.459 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 99.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 99.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 99.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 99.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 25' ' ' GLU . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 99.0 110.192 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 99.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 99.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 99.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 99.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 99.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 99.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 99.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.475 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 99.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 99.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 99.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.525 ' HG3' ' CE2' ' A' ' 57' ' ' TYR . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 99.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 99.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 99.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 99.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 99.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 99.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 99.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 99.0 110.194 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 40' ' ' MET . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 99.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ILE . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 99.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 99.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 99.0 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 99.0 110.011 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 99.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 99.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 99.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 99.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 99.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 99.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 99.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 99.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 99.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 99.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 99.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 99.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 99.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 99.0 109.36 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 99.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 48' ' ' ILE . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 99.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 99.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 99.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 99.0 110.174 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.199 0.523 . . . . 99.0 109.817 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 99.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 99.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 99.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 99.0 109.863 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 99.0 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 99.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 99.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 74' ' ' ILE . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 99.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 99.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 99.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.468 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 99.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 99.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 99.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 99.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 99.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 99.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 99.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 99.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 99.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 99.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 99.0 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 99.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 99.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 99.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CD2' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 99.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 99.0 109.916 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 99.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 99.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.521 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 99.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 55.9 tp . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 99.0 110.276 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.99 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 99.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 99.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 99.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 99.0 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 99.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 99.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.418 HG21 ' HG3' ' A' ' 14' ' ' GLN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 99.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 17' ' ' ASP . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 99.0 109.765 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 99.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 99.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.418 ' HG3' HG21 ' A' ' 10' ' ' THR . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 99.0 110.116 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 99.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 99.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 11' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 99.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 99.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 99.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 99.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 99.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 99.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 99.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 99.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 99.0 110.231 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 99.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 99.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 99.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 99.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 99.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 99.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 99.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 99.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 99.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 99.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 99.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 99.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 99.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 99.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 99.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 99.0 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 99.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 99.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 99.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 99.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 99.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 103' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 99.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 99.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 99.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 99.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 99.0 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' HE2' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 99.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 99.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 99.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 99.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 99.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 99.0 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 99.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 99.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.245 0.545 . . . . 99.0 110.424 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 99.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 74' ' ' ILE . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 99.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 99.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 99.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 99.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 99.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 99.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 99.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 105' ' ' SER . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 99.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 99.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 99.0 110.24 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.203 0.525 . . . . 99.0 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 99.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 99.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 99.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 99.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 99.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 99.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 99.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 99.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 99.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 99.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 99.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 99.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 99.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 47' ' ' TYR . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 99.0 110.063 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 99.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 99.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 99.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 99.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 99.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 99.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 99.0 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 99.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 99.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 99.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 99.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 99.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 99.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 99.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 99.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 99.0 110.088 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.99 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 4' ' ' GLU . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 99.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 99.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 99.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 99.0 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 99.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 99.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 99.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 99.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 99.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 99.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 99.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 99.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.543 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 99.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 99.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 99.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 99.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 99.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 99.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 99.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 99.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 99.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 99.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 99.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 99.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 99.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 99.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 99.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 99.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 99.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 99.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 99.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 99.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 99.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 99.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.502 ' CG2' HG22 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 99.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.507 ' CE ' HG21 ' A' ' 48' ' ' ILE . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 99.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 99.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 1' ' ' PRO . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 99.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 99.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 99.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 99.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 99.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 99.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.507 HG21 ' CE ' ' A' ' 40' ' ' MET . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 99.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 103' ' ' ILE . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 99.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 99.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 99.0 110.479 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 99.0 110.382 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 99.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 99.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 99.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 99.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 99.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 99.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.612 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 99.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 72' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 99.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 99.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 99.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 99.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 99.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 99.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 99.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.488 ' CB ' ' HB1' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 99.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 99.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 99.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 99.0 110.217 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 99.0 109.933 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.257 0.551 . . . . 99.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 99.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 99.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 99.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 99.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 99.0 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 99.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 99.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 92' ' ' GLU . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 99.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 99.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 99.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 99.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 102' ' ' CYS . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 99.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.494 ' N ' HG21 ' A' ' 101' ' ' THR . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 99.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' N ' HD22 ' A' ' 49' ' ' LEU . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 99.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 99.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 99.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.488 ' HB1' ' CB ' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 99.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 99.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 99.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 99.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 99.0 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 99.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 99.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 99.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 99.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 99.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 99.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 99.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 99.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 99.0 110.345 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.99 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' MET . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 99.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 99.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 99.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 115' ' ' TYR . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 99.0 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 99.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 99.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 99.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 99.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 99.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 99.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 99.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 99.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 99.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 99.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.461 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 99.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 99.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 99.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 99.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 99.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 99.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 99.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 99.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 99.0 110.083 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 99.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 99.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 99.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 99.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.446 HD11 ' HB1' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 99.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 99.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 99.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 99.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 99.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 99.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 99.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 99.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.497 ' HE3' ' CG2' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 99.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 99.0 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 99.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 99.0 110.391 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 99.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 99.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 99.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 99.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.497 ' CG2' ' HE3' ' A' ' 40' ' ' MET . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 99.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 99.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 99.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB1' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 99.0 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 99.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 99.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 99.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 99.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 99.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 99.0 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 99.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 99.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 44.0 Cg_endo . . . . . 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.347 0.594 . . . . 99.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.538 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 99.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 99.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 99.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 99.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 99.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 99.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 81' ' ' ASP . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 99.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 99.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 99.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 99.0 110.165 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.302 0.572 . . . . 99.0 110.395 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 99.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 99.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HG2' ' CG1' ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 99.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 99.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 99.0 110.03 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 99.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 99.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 99.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG1' ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 99.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 99.0 110.463 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 99.0 110.059 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 99.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.403 ' HB2' HD22 ' A' ' 100' ' ' LEU . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 99.0 110.123 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 99.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 99.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 99.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 99.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 99.0 110.218 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 99.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 99.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 99.0 110.375 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 99.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 99.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 99.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 99.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 99.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB1' ' CA ' ' A' ' 73' ' ' SER . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 99.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.496 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 99.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 99.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 99.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.99 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 ' CG2' ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' MET . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 99.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 99.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 99.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 99.0 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.462 ' CA ' HG23 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 99.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 99.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 99.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 99.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 99.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 99.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 99.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 99.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.558 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 99.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 99.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 99.0 110.323 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 99.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 99.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.558 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 99.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 99.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 99.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 99.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 99.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 99.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 99.0 110.043 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 99.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 99.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 99.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 99.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 99.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 99.0 109.685 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 99.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 99.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 99.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 99.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.527 ' CG2' HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 99.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.559 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 99.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 2' ' ' THR . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 99.0 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 99.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 99.0 110.273 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 99.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 99.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 99.0 110.17 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 102' ' ' CYS . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 99.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 99.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 99.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 99.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 99.0 109.969 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 99.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 99.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 99.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 99.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 99.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 99.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 99.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 99.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.228 0.537 . . . . 99.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 99.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 99.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 99.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 99.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 99.0 110.308 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 99.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 111' ' ' VAL . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 99.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 99.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.474 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 99.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 99.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 99.0 110.139 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.201 0.524 . . . . 99.0 110.225 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 99.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 99.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 99.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 99.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 99.0 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 99.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 99.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.545 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 99.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 99.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 99.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 99.0 109.971 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 99.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 99.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 99.0 109.911 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 99.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 99.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.528 ' HD3' ' CG1' ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.414 ' CB ' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 99.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 99.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 99.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 99.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 79' ' ' GLU . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 99.0 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 99.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 99.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 99.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.607 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 99.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.607 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 99.0 110.074 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 99.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 99.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 50.5 m-70 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 99.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 99.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.99 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 40' ' ' MET . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 99.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 99.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 99.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.502 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 99.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 99.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 99.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 99.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 99.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 99.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 99.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 99.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 99.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.557 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 99.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 99.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 99.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 99.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 99.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 99.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 99.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 6' ' ' LEU . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 99.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 99.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 99.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 99.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 99.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 99.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 99.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 99.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 99.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 99.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 99.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 99.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 99.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 99.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 99.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 99.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 99.0 110.262 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 99.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 99.0 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG21 ' CB ' ' A' ' 51' ' ' ALA . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 99.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 99.0 110.1 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 1' ' ' PRO . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 99.0 109.984 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 99.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 99.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 99.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 103' ' ' ILE . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 99.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.523 HD21 ' CA ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 99.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 99.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' CB ' HG21 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 99.0 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' CB ' ' HE3' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 99.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 99.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 99.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 99.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 99.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 99.0 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 99.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 99.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 99.0 110.76 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 99.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 99.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 99.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 99.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.454 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 99.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 99.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 99.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 99.0 110.223 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 99.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 83' ' ' ASP . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 99.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 99.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.145 0.497 . . . . 99.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 99.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 99.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 99.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 99.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 99.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 99.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 99.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 99.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 99.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 99.0 110.23 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 99.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.523 ' CA ' HD21 ' A' ' 49' ' ' LEU . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 99.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 99.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 99.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 99.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 99.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 99.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 99.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 99.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 99.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 77' ' ' GLU . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 99.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 99.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 99.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 99.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 99.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.566 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.4 t30 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 99.0 109.884 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 99.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 99.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 99.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 99.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.99 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 3' ' ' VAL . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' MET . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 99.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.521 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 99.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 99.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 99.0 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 99.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 99.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.479 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 99.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 99.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 99.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 99.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 99.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 99.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE3' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 99.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' HD22 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 99.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 99.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 99.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 99.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 99.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 99.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 ' CE3' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 99.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 99.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 99.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 99.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 99.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 99.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 99.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 99.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 99.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 99.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 99.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.47 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 99.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 99.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 99.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.508 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 99.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 3' ' ' VAL . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 99.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 99.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 99.0 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 99.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 99.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 99.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 99.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 99.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 99.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.527 HG21 ' CE ' ' A' ' 40' ' ' MET . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 99.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 99.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 99.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 99.0 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 99.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 99.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 99.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 99.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 99.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 99.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 99.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 99.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 47.3 Cg_endo . . . . . 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.208 0.528 . . . . 99.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.483 ' OG ' ' CZ3' ' A' ' 59' ' ' TRP . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 99.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 99.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 97' ' ' ASP . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 99.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 99.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 99.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 99.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 99.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG21 ' O ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 99.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 99.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 99.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 99.0 110.184 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.208 0.528 . . . . 99.0 110.014 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 99.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 99.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 99.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 99.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 99.0 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 99.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 99.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 75' ' ' VAL . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 99.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 73' ' ' SER . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 99.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' N ' HG11 ' A' ' 98' ' ' VAL . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 99.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 99.0 110.063 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.444 ' CG2' HG23 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 99.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 99.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 99.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 99.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 99.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 99.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 99.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 99.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 99.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 99.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 99.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 ' HB3' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 99.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 99.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 99.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 99.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.529 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 99.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 99.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 99.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 99.0 110.379 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.99 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 99.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 99.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 99.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.597 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 99.0 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 99.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 99.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 HG22 HD13 ' A' ' 32' ' ' LEU . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 99.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 99.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 99.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 99.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 99.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 99.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.519 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 99.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 99.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 99.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 99.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 99.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 99.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 99.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 99.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 99.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 99.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 99.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 99.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 99.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 99.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 99.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 99.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 10' ' ' THR . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 99.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 99.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 99.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 99.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 99.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 99.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 99.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 99.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.476 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 99.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 99.0 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 99.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 99.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 99.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 99.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 99.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 99.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.461 HG21 ' HE3' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 99.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 99.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 99.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' HG21 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 99.0 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 99.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 99.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 99.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 99.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 99.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 99.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 99.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 99.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.314 0.578 . . . . 99.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 99.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 99.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 99.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 99.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 99.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 99.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 99.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 99.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 99.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 99.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 99.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.201 0.524 . . . . 99.0 110.264 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 99.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 99.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 99.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 99.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 99.0 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 99.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 99.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.551 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 99.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 99.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 99.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 99.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 99.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 99.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.577 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 99.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 99.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 99.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 99.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.419 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 99.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 99.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 99.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 99.0 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 99.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 99.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 99.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 99.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 99.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.554 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 99.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 99.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 99.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 99.0 110.629 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.99 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 99.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 99.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 99.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 99.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 99.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 99.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 99.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' CD1' ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 99.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 99.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 99.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 99.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 99.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.547 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 99.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 99.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.464 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 99.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 99.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 99.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 99.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 99.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.514 ' CD1' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 99.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 99.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 99.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 99.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 99.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 99.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 99.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 99.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 99.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 99.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 99.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 99.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 99.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.519 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 99.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 99.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 99.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 99.0 110.345 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.529 ' CE ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 99.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 99.0 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 40' ' ' MET . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 99.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' VAL . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 99.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 99.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 99.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 99.0 110.133 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 99.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.513 HG21 ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 99.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 99.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 99.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 99.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 99.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 99.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 99.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 99.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 99.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 99.0 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 99.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 99.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.334 0.588 . . . . 99.0 110.699 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 99.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 99.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 99.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 99.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 99.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 99.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 99' ' ' ARG . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 99.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 99.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.495 ' HE3' ' CD2' ' A' ' 100' ' ' LEU . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 99.0 110.015 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 99.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.18 0.514 . . . . 99.0 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.477 ' O ' HG11 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 99.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 99.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 99.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 99.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 99.0 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 99.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 99.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 99.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 99.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 99.0 110.157 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' CD2' ' HE3' ' A' ' 82' ' ' MET . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 99.0 110.752 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 99.0 109.879 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 99.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 99.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 99.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 99.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 99.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 99.0 110.231 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 99.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 99.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 99.0 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 99.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 99.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 99.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 99.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 99.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.534 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 99.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 99.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 99.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 99.0 110.072 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.99 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 99.0 110.242 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 99.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 99.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.59 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 99.0 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 99.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 99.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 99.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 99.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 99.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 99.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 99.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 99.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD2' ' HB2' ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 99.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 99.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 99.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 99.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 99.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 99.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 99.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' ' CD2' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 99.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 37' ' ' TYR . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 99.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 99.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 99.0 110.443 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB3' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 99.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 99.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 99.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 99.0 110.313 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 99.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 99.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 99.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 99.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 99.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 99.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 99.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 99.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 3' ' ' VAL . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 99.0 110.01 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 99.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 99.0 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 99.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 99.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 99.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 99.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 99.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CD1' HG22 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 99.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 99.0 110.06 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 99.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 99.0 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 99.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 99.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 99.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 99.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 99.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 99.0 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 99.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 99.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo . . . . . 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.29 0.567 . . . . 99.0 110.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.463 ' O ' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 99.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 99.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 99.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 99.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 99.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 99.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 99.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 99.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 99.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.441 ' HE1' HG13 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 99.0 110.278 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 99.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 99.0 110.239 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.469 ' O ' HG11 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 99.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 99.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 99.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 99.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 99.0 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 99.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 99.0 110.664 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 99.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 99.0 110.329 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 99.0 110.285 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 99.0 110.18 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 99.0 110.267 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 99.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 99.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 99.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 99.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 99.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 99.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 99.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 99.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 77' ' ' GLU . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 99.0 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 99.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 99.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 99.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 99.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 99.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 99.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD2' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 99.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 62.7 m-70 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 99.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 99.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.99 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.446 ' HB ' ' OE2' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' MET . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 99.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 99.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 99.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.527 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 99.0 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 99.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 99.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.437 HG22 HD23 ' A' ' 32' ' ' LEU . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 99.0 110.09 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 17' ' ' ASP . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 99.0 109.653 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 99.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 99.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 99.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 99.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 99.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 11' ' ' LEU . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 99.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 99.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 99.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 99.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 99.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 99.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 99.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 99.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 99.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 99.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 99.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 99.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 99.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 99.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 99.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 10' ' ' THR . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 99.0 110.377 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 99.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 99.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 99.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 99.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 99.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 99.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 99.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.518 ' CE ' HG21 ' A' ' 48' ' ' ILE . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 99.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 99.0 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 99.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 99.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 99.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 99.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 99.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 99.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 40' ' ' MET . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 99.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 101' ' ' THR . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 99.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 99.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 99.0 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 99.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 99.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 99.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 99.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 99.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 99.0 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 99.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 99.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.979 0.419 . . . . 99.0 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 99.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 99.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' CA ' HD11 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 99.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 99.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 99.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 99.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 99.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 99.0 109.903 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 99.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 99.0 110.116 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 99.0 110.356 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.181 0.515 . . . . 99.0 110.14 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 99.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 99.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 99.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 99.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 99.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 99.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 99.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 99.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' SER . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 99.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 98' ' ' VAL . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 99.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 99.0 110.26 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 99.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.456 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 99.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 99.0 110.273 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 99.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 99.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 99.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 99.0 110.382 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 99.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.446 ' OE2' ' HB ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 99.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 99.0 110.181 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 99.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 99.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 99.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.573 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 99.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 99.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 99.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 99.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 99.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 99.0 110.279 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.99 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 40' ' ' MET . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 99.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 99.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 99.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 99.0 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.431 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 99.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 99.0 109.805 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 99.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 99.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 99.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 99.0 109.917 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 99.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 99.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 99.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 99.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 99.0 110.148 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 99.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 99.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 99.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 99.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 99.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 99.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 99.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 99.0 110.231 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 99.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 99.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 99.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 99.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 99.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 99.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 99.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 99.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 99.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 99.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 99.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.561 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 99.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.447 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 99.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 99.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 99.0 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 99.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 99.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 99.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 99.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 99.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 99.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 99.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 99.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 99.0 110.26 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 99.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 99.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 99.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 99.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 99.0 109.755 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 99.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 99.0 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 99.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 99.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.356 0.598 . . . . 99.0 110.33 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 99.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 99.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 99.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 99.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 99.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 99.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 99.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 99.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 99.0 109.866 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 99.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 99.0 110.213 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.306 0.574 . . . . 99.0 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 99.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 99.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 99.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 99.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 99.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 99.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 99.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CB ' HG21 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 99.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 99.0 110.633 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 99.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 99' ' ' ARG . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 99.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 99.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 99.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 99.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 99.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 99.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' HG12 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 99.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 99.0 110.179 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 99.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 99.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 99.0 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 99.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 99.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 99.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 99.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.478 ' OD1' ' CZ ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 99.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 99.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 99.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.452 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 56.3 m-70 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 99.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 99.0 110.277 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.99 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 99.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 99.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 99.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 99.0 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CE2' HD11 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 99.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 99.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 99.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 99.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 99.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 99.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 99.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 99.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 99.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 99.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 99.0 110.848 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 99.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 99.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 99.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 99.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 99.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 99.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 99.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 99.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 99.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 99.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 99.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 99.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 99.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 99.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 99.0 110.227 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 99.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 99.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 99.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 99.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 99.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 99.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 99.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 99.0 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 99.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 99.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 99.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 99.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 99.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 99.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 48' ' ' ILE . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 99.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.562 HD23 ' CZ ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 99.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 99.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 99.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 99.0 110.084 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 99.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 99.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 99.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 99.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 99.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 99.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 99.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' SER . 46.0 Cg_endo -72.4 77.78 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.562 ' CZ ' HD23 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -48.48 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 99.0 110.262 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.493 ' C ' ' S1 ' ' A' ' 130' ' ' FES . 15.2 t -85.12 43.61 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 99.0 110.229 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.1 OUTLIER -83.4 120.02 25.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.92 . . . . 99.0 110.113 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.51 172.48 8.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 99.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.86 117.33 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 99.0 110.136 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 99.66 93.16 2.08 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.449 -1.46 . . . . 99.0 109.449 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 66' ' ' GLY . . . 50.92 -179.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -1.164 . . . . 99.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 11.6 t -174.81 158.5 2.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 99.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' N ' ' SG ' ' A' ' 68' ' ' CYS . . . -171.04 33.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 99.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.8 m-20 -150.13 69.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 99.0 109.92 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.451 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 34.2 m -60.98 -120.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 99.0 109.979 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -173.28 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.843 -1.161 . . . . 99.0 110.423 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 99.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 99.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 99.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 99.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 99.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 99.0 109.452 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 99.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 81' ' ' ASP . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 99.0 110.242 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 99.0 110.216 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 99.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -57.5 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 99.0 110.043 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -49.37 -179.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 99.0 110.183 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 158.41 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.021 . . . . 99.0 110.464 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -178.4 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 99.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.3 mm -61.46 -50.12 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 99.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.12 168.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 99.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.77 138.98 36.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 99.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 99.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 99.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 99.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 99.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 99.0 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 99.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 99.0 110.376 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.524 ' CB ' HG21 ' A' ' 74' ' ' ILE . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 99.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 99.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 99.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 99.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 99.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 99.0 110.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 99.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 99.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 99.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 99.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 99.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 99.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 99.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 99.0 110.507 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 99.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 99.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 99.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 99.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.4 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 99.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 99.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 99.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.481 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 99.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.574 HD11 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -41.76 152.67 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 99.0 110.442 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.65 -19.38 41.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 99.0 110.01 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -7.81 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 99.0 110.178 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLN . 1.3 mt -129.7 -29.71 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 99.0 110.533 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.441 ' HA ' HG22 ' A' ' 127' ' ' VAL . 1.2 tt0 -42.41 -43.03 3.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 99.0 110.532 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -65.82 -37.07 85.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 99.0 110.493 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -89.53 24.65 2.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 99.0 110.347 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG13 HD12 ' A' ' 128' ' ' ILE . 25.4 t -73.45 -45.36 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 99.0 110.149 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 127' ' ' VAL . 23.6 mm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.932 -1.032 . . . . 99.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.745 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.493 ' S1 ' ' C ' ' A' ' 62' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.99 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' MET . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 99.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 99.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 99.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 99.0 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 99.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 99.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 99.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 HD12 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 99.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 99.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 99.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 99.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 99.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 99.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 99.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 99.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 99.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 99.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 99.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 99.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.521 ' CD1' HD12 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 99.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 99.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 99.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 99.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 23' ' ' LEU . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 99.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 99.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 99.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 99.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 99.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 99.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 99.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 99.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 99.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 99.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 99.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 99.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 99.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.482 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 99.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 99.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CB ' ' HG3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 99.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 99.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 99.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 99.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 99.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.46 ' CD1' ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 99.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 99.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 99.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 99.0 110.146 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 99.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 99.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 99.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 99.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 99.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 99.0 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 99.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.587 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 99.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 45.0 Cg_endo -72.69 74.21 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' CD2' HD13 ' A' ' 49' ' ' LEU . 7.7 p90 -100.98 156.84 17.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 99.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.39 82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 99.0 109.874 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 3.7 m -82.52 9.95 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.91 . . . . 99.0 110.204 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -53.39 -26.11 18.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 99.0 110.089 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 66' ' ' GLY . . . -72.83 137.04 45.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 99.0 110.043 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.81 123.36 4.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.519 -1.432 . . . . 99.0 109.519 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 52.72 94.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -1.117 . . . . 99.0 110.231 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 1.9 t -54.45 133.06 45.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 99.0 110.278 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.86 -64.86 1.02 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 99.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 38.3 p-10 -127.87 162.52 26.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 99.0 110.295 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 100' ' ' LEU . 61.3 m -104.9 -103.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 99.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' CA ' ' HB2' ' A' ' 117' ' ' ALA . . . -179.53 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.819 -1.176 . . . . 99.0 110.535 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.486 ' OG ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 99.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 99.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 99.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 99.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 99.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 99.0 110.113 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 81' ' ' ASP . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 99.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.508 ' N ' HG21 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 99.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 99.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.03 153.22 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 99.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 42.3 mtm -62.71 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 99.0 110.227 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -156.04 -174.6 5.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 99.0 110.09 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -139.06 85.65 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 99.0 110.308 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 68' ' ' CYS . 20.4 mm -95.57 -4.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 99.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.83 163.62 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 99.0 110.129 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -104.27 157.58 17.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 99.0 110.282 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 99.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 99.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 99.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' CD ' ' A' ' 99' ' ' ARG . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 99.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 99.0 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 99.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' O ' HD11 ' A' ' 74' ' ' ILE . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 99.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 99.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' SER . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 99.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.514 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 99.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 71' ' ' CYS . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 99.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' CD1' ' A' ' 48' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 99.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 99.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 99.0 110.161 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 99.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 99.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG3' ' CB ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 99.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.508 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 99.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 99.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 99.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 99.0 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 99.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 99.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.587 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 99.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 99.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB2' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 99.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 99.0 110.114 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 99.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -42.9 127.69 4.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 99.0 110.31 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.78 -28.16 54.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 99.0 110.347 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.46 -28.55 52.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 99.0 110.428 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER -87.37 -35.53 18.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 99.0 110.272 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' LEU . 3.0 mt-30 -44.29 -26.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 99.0 110.336 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.34 -47.2 72.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 99.0 110.281 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -49.27 -38.4 27.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 99.0 110.286 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.43 131.41 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 99.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.07 -0.967 . . . . 99.0 110.207 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.428 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.99 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 99.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 99.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 99.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 99.0 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 120' ' ' LEU . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 99.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 99.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 99.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 99.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 99.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 99.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 99.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 99.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 99.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 99.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 99.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 99.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 99.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 99.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 99.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 99.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 99.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 99.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 99.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 99.0 109.878 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 99.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 99.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 99.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 99.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 99.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 99.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 99.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 99.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 99.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 99.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 99.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 99.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 99.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 99.0 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 99.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 99.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 99.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 99.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 99.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 99.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 99.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 99.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 99.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 99.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 99.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 99.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 99.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 99.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 99.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 99.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 99.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' HG23 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 99.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HG3' ' CB ' ' A' ' 72' ' ' ALA . 46.8 Cg_endo -72.68 73.44 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.81 102.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.32 -0.863 . . . . 99.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 t -140.16 29.7 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 99.0 110.423 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -167.91 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 99.0 110.045 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' ALA . 3.2 tpp180 -164.15 39.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 99.0 110.377 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 64' ' ' ARG . . . 44.22 90.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 99.0 110.09 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.97 -100.63 0.62 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.176 -1.57 . . . . 99.0 109.176 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.61 168.86 12.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 99.0 109.996 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.5 t -155.9 -80.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 99.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 46.43 25.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 99.0 110.323 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.4 m-80 -127.69 1.66 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 99.0 110.229 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -58.29 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 99.0 110.195 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' CB ' ' HG3' ' A' ' 60' ' ' PRO . . . -161.55 86.15 0.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.117 -0.99 . . . . 99.0 110.625 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 99.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 99.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 99.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 99.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 99.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 99.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 99.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 80' ' ' ILE . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 99.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 99.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 99.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.24 164.71 2.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 99.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.58 119.92 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 99.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -172.12 -155.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 99.0 110.011 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -92.02 95.48 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 99.0 110.271 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pt -74.3 169.28 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 99.0 110.223 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.3 mt -84.69 -171.46 3.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 99.0 110.244 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m -110.5 144.22 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 99.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 99.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 99.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 99.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 99.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' N ' HG11 ' A' ' 93' ' ' VAL . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 99.0 110.192 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 99.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 99.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 99.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 99.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 99.0 109.876 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 99.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.539 HG23 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 99.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 99.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 99.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 99.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 99.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HB3' HG22 ' A' ' 3' ' ' VAL . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 99.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 99.0 110.363 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 99.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 99.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 3' ' ' VAL . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 99.0 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 99.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 99.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 99.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.521 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 99.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 99.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 99.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 99.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 99.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -44.15 138.77 2.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 99.0 110.264 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.43 -29.52 41.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 99.0 110.07 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -76.65 -12.79 60.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 99.0 110.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.09 -34.33 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 99.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.47 ' O ' ' CG2' ' A' ' 127' ' ' VAL . 7.4 tt0 -70.65 -25.32 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 99.0 110.34 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -63.68 -10.86 21.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 99.0 110.215 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -60.31 -30.93 69.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 99.0 110.228 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 124' ' ' GLN . 16.2 m -78.21 92.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 99.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.023 -0.989 . . . . 99.0 110.278 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.99 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' OE1' ' CG2' ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 99.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 99.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 99.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 99.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 99.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 99.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.46 HG21 ' HG3' ' A' ' 14' ' ' GLN . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 99.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 99.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 99.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 99.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.569 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 99.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 99.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 99.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 99.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 99.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 99.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 99.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 99.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 99.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' HD23 ' A' ' 11' ' ' LEU . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 99.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 99.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 99.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 99.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 99.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 99.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 99.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 99.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 99.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 99.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 99.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 99.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 99.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 99.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 99.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 99.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' CG2' ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 99.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 99.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 99.0 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 99.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 99.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 99.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 99.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 99.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 49' ' ' LEU . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 99.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 99.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 99.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 99.0 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 99.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 99.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 51' ' ' ALA . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 99.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 99.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 99.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.428 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 99.0 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 99.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 99.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -70.83 109.13 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 61' ' ' PHE . 12.5 p90 -137.5 121.99 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 99.0 110.682 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 64' ' ' ARG . 2.3 p -138.93 43.87 2.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 99.0 109.793 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -48.33 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 99.0 110.556 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 31.1 ttt180 -178.59 161.58 1.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 99.0 110.29 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 64' ' ' ARG . . . 69.24 -67.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.897 . . . . 99.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . 177.25 117.89 0.53 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 99.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' ' SG ' ' A' ' 68' ' ' CYS . . . 64.79 -165.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 99.0 110.188 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 71' ' ' CYS . 78.9 m -150.09 77.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 99.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.67 -58.67 4.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 99.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -39.07 57.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 99.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' PRO . 20.3 t -66.53 96.89 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.922 . . . . 99.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -153.01 145.15 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 99.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 99.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 99.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 99.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 112' ' ' LYS . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 99.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 99.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 99.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 99.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' CD1' ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 99.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 99.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.502 ' HE1' ' CG2' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 99.0 110.143 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.66 140.44 47.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 99.0 110.233 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.67 120.55 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 99.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.16 -56.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.895 . . . . 99.0 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.13 161.17 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 99.0 110.175 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 87' ' ' ILE . 16.6 tt -80.68 130.87 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 99.0 110.427 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.46 143.08 37.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 99.0 109.879 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.82 133.64 55.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 99.0 110.373 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 99.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 99.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 99.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 99.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 99.0 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 99.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 99.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 99.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 99.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 99.0 110.259 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.562 HD13 ' S1 ' ' A' ' 130' ' ' FES . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 99.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 99.0 110.134 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 99.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.574 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 99.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 99.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 99.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 99.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 99.0 110.04 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 99.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' O ' ' OE2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 99.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 77' ' ' GLU . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 99.0 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 99.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 113' ' ' ILE . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 99.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 99.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 99.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.548 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 99.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 99.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 99.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.548 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 99.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.67 132.1 3.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.146 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.04 -31.92 73.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 99.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -65.55 -15.4 62.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 99.0 110.045 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -108.58 -25.26 10.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 99.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.21 -25.31 66.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 99.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.0 -24.05 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 99.0 110.145 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -83.66 -33.79 25.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 99.0 110.231 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.77 109.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 99.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 pt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.047 -0.978 . . . . 99.0 110.138 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . 0.513 ' O ' ' ND2' ' A' ' 116' ' ' ASN . . . . . . . . 0 C--O 1.215 -0.712 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.562 ' S1 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.99 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' MET . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 99.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 99.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 99.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.524 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 99.0 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 99.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 99.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 99.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 99.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 99.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 99.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 99.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 99.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 99.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 99.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 99.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 99.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 99.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 99.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' CD2' ' CD1' ' A' ' 16' ' ' TRP . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 99.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 99.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 99.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 99.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 99.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 99.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 99.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 99.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 99.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 99.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 99.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 99.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 99.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 99.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 99.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 99.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 99.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.471 ' HE2' ' O ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 99.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 99.0 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 99.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 99.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 99.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 99.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 99.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 99.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.471 ' O ' ' HE2' ' A' ' 40' ' ' MET . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 99.0 110.087 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 99.0 110.342 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 99.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 99.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 99.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 99.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 99.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 99.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 99.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 99.0 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 99.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 99.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo -76.72 -179.72 5.64 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.73 172.5 7.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.355 -0.841 . . . . 99.0 109.972 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.8 -35.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 99.0 110.397 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 174.05 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -0.974 . . . . 99.0 110.122 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -127.88 20.1 6.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 99.0 110.316 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.06 132.5 54.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -0.871 . . . . 99.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.76 -177.9 49.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.362 -1.495 . . . . 99.0 109.362 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 79.39 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -1.19 . . . . 99.0 110.15 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.585 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 3.4 t -57.87 117.92 4.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 99.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.76 -58.46 1.67 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 99.0 110.288 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' TRP . 2.8 p30 -159.0 103.69 1.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 99.0 110.148 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.525 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER 175.41 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 99.0 110.188 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.37 108.42 2.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 99.0 109.937 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 99.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 99.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 99.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 99.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 99.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 99.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 99.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 99.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 99.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 99.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.21 176.93 4.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 99.0 110.359 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.454 ' O ' ' OE1' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -74.3 157.89 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 99.0 110.27 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -164.07 173.61 12.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 99.0 110.211 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 -4.51 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 99.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 tp -94.6 14.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 99.0 110.305 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.47 142.04 32.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 99.0 109.972 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -135.89 123.36 22.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 99.0 110.379 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 99.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 99.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 99.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 99.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 99.0 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 99.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 99.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.486 ' HB3' HG21 ' A' ' 74' ' ' ILE . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 99.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 99.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 99.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 99.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.47 ' HB ' HG23 ' A' ' 48' ' ' ILE . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 99.0 110.275 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 99.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 99.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 99.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 99.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 99.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 99.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 99.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 99.0 109.899 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 99.0 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 99.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 99.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 99.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 99.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 99.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 99.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 99.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 99.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -41.69 113.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 99.0 110.359 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 0.9 OUTLIER -61.83 -30.2 70.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 99.0 110.015 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.404 ' C ' HD11 ' A' ' 123' ' ' LEU . 29.3 t80 -56.99 -21.2 28.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 99.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 123' ' ' LEU . 3.2 mp -111.38 -20.68 12.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -0.819 . . . . 99.0 110.158 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -57.78 -33.18 68.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 99.0 110.305 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.0 -18.49 65.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 99.0 110.104 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -85.4 -14.68 45.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 99.0 110.324 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.495 HG11 ' N ' ' A' ' 128' ' ' ILE . 8.5 p -54.53 -23.0 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 99.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.495 ' N ' HG11 ' A' ' 127' ' ' VAL . 9.7 pt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.064 -0.969 . . . . 99.0 110.278 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.585 ' S2 ' ' HA ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.99 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 113' ' ' ILE . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 99.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 99.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 99.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 99.0 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 99.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 99.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 99.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD12 ' CA ' ' A' ' 17' ' ' ASP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 99.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 99.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 99.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 99.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 99.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 99.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' CA ' HD12 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 99.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.429 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 99.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 99.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 99.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 99.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 99.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 99.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 99.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 99.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 99.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 99.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 99.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 99.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 99.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 99.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 99.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 99.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 99.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 99.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 99.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 99.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 99.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 99.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 99.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 99.0 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 99.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 99.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 99.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 99.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 99.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 99.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 99.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 99.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' CD ' ' HG2' ' A' ' 46' ' ' GLU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 99.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 99.0 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 99.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 99.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 99.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 99.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 99.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 99.0 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 99.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 99.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 45.5 Cg_endo -72.1 -172.54 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 5.2 t80 67.97 147.43 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 99.0 110.383 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -178.44 122.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 99.0 110.043 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.6 65.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 99.0 110.415 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' SER . 31.2 ttm-85 62.32 14.75 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 99.0 110.364 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.63 -162.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 99.0 110.063 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -89.33 1.0 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.586 -1.406 . . . . 99.0 109.586 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.93 8.62 18.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 99.0 110.396 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 148.03 38.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 99.0 110.174 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.73 -89.7 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 99.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.526 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 0.4 OUTLIER 179.53 156.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 99.0 110.218 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.458 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 2.5 p -167.38 131.5 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.97 . . . . 99.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . 176.68 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 99.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 99.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 99.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 99.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 99.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 99.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 99.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 99.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 99.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 99.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -46.08 162.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 99.0 109.973 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 1.3 mmt -64.09 145.14 56.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 99.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.7 mt-30 -178.19 -36.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 99.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.1 129.65 34.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 99.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -46.58 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 99.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.62 178.87 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 99.0 110.026 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t -155.45 163.17 40.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 99.0 110.324 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 99.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 99.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 99.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 99.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.514 ' N ' HG11 ' A' ' 93' ' ' VAL . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 99.0 109.537 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 99.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 99.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 99.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 99.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 99.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 99.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 99.0 110.152 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' HA ' HD22 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 99.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 99.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 99.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 99.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB1' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 99.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.463 ' CB ' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 99.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 99.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 99.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 99.0 110.315 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 99.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 3' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 99.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 99.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 99.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 99.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 99.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 99.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 99.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -46.48 143.11 2.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 99.0 110.408 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -45.53 71.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 99.0 110.289 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.6 -25.68 18.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 99.0 109.582 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.61 -35.81 13.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 99.0 109.921 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -43.74 97.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 99.0 110.142 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.18 -9.86 44.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.493 -0.755 . . . . 99.0 110.09 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.14 8.01 38.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 99.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.04 136.51 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.234 -0.916 . . . . 99.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.963 -1.018 . . . . 99.0 110.152 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.526 ' S2 ' ' HA ' ' A' ' 70' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.99 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 40' ' ' MET . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' N ' HG13 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 99.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 99.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 99.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' OD1' ' CE1' ' A' ' 115' ' ' TYR . 66.8 t30 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 99.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 99.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 99.0 109.824 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 99.0 109.429 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 99.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 99.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 99.0 109.858 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 32' ' ' LEU . 4.2 mm-40 -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 99.0 109.975 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 99.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.521 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 99.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 99.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.413 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 99.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 99.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 99.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 99.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 99.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 23' ' ' LEU . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 99.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 76' ' ' LYS . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 99.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 99.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 99.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 99.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 99.0 109.91 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 99.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 99.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 99.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD23 ' NE2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 99.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 99.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 99.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 99.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 99.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 99.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 99.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 99.0 110.136 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 99.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 99.0 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 99.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 99.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 99.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 99.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 99.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 99.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.516 HG22 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 99.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 99.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 99.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 99.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 99.0 110.319 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 99.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 99.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 99.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 99.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 99.0 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 99.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 99.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 43.8 Cg_endo -70.61 101.22 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -69.09 72.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.88 . . . . 99.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 p -85.98 5.56 32.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 99.0 110.118 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.92 104.74 16.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 99.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 77.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 99.0 110.252 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.77 -40.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 99.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.12 -14.12 6.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.321 -1.512 . . . . 99.0 109.321 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.6 109.08 4.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -1.106 . . . . 99.0 109.915 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.4 t -142.98 148.7 37.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 99.0 110.217 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.75 10.99 1.61 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 99.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -145.76 141.19 27.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 99.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 100' ' ' LEU . 15.3 m -116.2 -136.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 99.0 110.106 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -144.25 58.58 1.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 99.0 110.556 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 99.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 99.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 99.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 99.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 99.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 99.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 99.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 99.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.511 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 99.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 99.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.43 175.58 0.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 99.0 110.542 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ttp -79.98 85.25 5.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 99.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -173.13 -153.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.957 . . . . 99.0 110.42 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -148.26 -87.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 99.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 19.5 mt 56.54 170.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 99.0 110.662 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 13.5 mt 61.16 177.68 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 99.0 110.423 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -133.19 156.74 46.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.361 -0.837 . . . . 99.0 110.0 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 99.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 99.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 99.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 99.0 109.786 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 99.0 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 99.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 99.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 99.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 99.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 99.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.465 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 99.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.423 HG23 ' OG ' ' A' ' 73' ' ' SER . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 99.0 110.153 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 99.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.411 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 99.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 99.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 99.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 99.0 110.188 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 99.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 99.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 99.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 112' ' ' LYS . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 99.0 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 99.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 99.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 99.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' CE1' ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 99.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 99.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 99.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 99.0 110.12 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 99.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.502 HD13 ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -43.56 141.1 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 99.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.75 -28.95 52.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 99.0 110.29 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -72.29 -10.93 60.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 99.0 110.004 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.43 -37.94 4.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 99.0 110.13 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -57.06 -31.13 64.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 99.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' ARG . 2.2 m-20 -45.27 -38.35 5.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 99.0 109.891 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.98 -37.95 3.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 99.0 110.033 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 128' ' ' ILE . 70.0 t -58.86 -73.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 99.0 110.234 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 127' ' ' VAL . 1.2 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 99.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.99 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 99.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 99.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 99.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.58 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 99.0 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 99.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 99.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 99.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 99.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 99.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 99.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 99.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 99.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 99.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 99.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 99.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 99.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 99.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 99.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 99.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 99.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 99.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 99.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 99.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 99.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 99.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 99.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 99.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 99.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 99.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 99.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 99.0 109.394 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 99.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 99.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 99.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 99.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 99.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 99.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 48' ' ' ILE . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 99.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 99.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 99.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 99.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 99.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 99.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG21 ' CE ' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 99.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 99.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 99.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 99.0 109.742 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 99.0 109.856 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 99.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 99.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 99.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 99.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 99.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 99.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.604 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 99.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.1 Cg_endo -73.85 156.94 48.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 27.5 p90 -134.26 106.25 7.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 99.0 109.988 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -94.08 1.91 56.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 99.0 110.443 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.8 m -68.61 -175.4 0.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 99.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 6.0 ttt180 -137.74 56.64 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 99.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 64' ' ' ARG . . . 65.01 -173.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 99.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.87 -170.18 2.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 99.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.32 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 99.0 110.398 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 110.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 99.0 110.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.1 -91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 99.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' OD1' HD21 ' A' ' 100' ' ' LEU . 3.5 t30 -130.74 157.51 42.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 99.0 110.118 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -144.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 99.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 60' ' ' PRO . . . -146.35 91.47 2.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 99.0 110.847 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 99.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 99.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 99.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 99.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 99.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 99.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 99.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 99.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 99.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 99.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -74.9 152.67 38.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 99.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.43 98.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 99.0 110.267 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -157.08 163.6 38.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.868 . . . . 99.0 110.111 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.26 114.55 28.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 99.0 110.206 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -149.96 152.99 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 99.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 tp 53.09 -174.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 99.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t -124.94 153.51 42.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 99.0 110.096 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 99.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 99.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 99.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 99.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 99.0 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 99.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 99.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 99.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 73' ' ' SER . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 99.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' HG22 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 99.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD21 ' OD1' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 99.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 99.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.424 ' SG ' HD12 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 99.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 99.0 110.222 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 99.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 99.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 3' ' ' VAL . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 99.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 99.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 99.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 99.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 99.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 99.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 99.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 99.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 99.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 99.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 99.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 99.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 99.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -42.16 130.37 3.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 99.0 110.431 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -41.55 87.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 99.0 109.935 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 16.9 t80 -70.23 -6.29 33.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 99.0 110.0 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.42 -8.07 5.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.903 . . . . 99.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' LEU . 7.5 mt-30 -54.75 -23.38 17.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 99.0 110.376 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -42.04 -33.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 99.0 110.487 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.9 -38.19 7.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.947 . . . . 99.0 110.256 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 124' ' ' GLN . 34.4 m -60.99 161.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 99.0 110.205 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.966 -1.016 . . . . 99.0 110.117 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.749 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.99 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 99.0 110.302 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 99.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 99.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.581 ' HA ' ' CD2' ' A' ' 115' ' ' TYR . 39.0 t30 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 99.0 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 99.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 99.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 99.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 99.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 99.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 99.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 99.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 99.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 99.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 99.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 99.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 99.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 99.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.58 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 99.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 99.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 16' ' ' TRP . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 99.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.459 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 99.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 99.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 99.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 99.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 25' ' ' GLU . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 99.0 110.192 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 99.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 99.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 99.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 99.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 99.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 99.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 99.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.475 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 99.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 99.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 99.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.525 ' HG3' ' CE2' ' A' ' 57' ' ' TYR . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 99.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 99.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 99.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 99.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 99.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 99.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 99.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 99.0 110.194 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 40' ' ' MET . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 99.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' S1 ' ' A' ' 130' ' ' FES . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 99.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 99.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 99.0 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 99.0 110.011 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 99.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 99.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 99.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 99.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 99.0 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 99.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.556 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 99.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo -72.56 148.03 46.98 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 62.84 171.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 99.0 110.237 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 0.6 OUTLIER -143.57 -166.73 2.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.928 . . . . 99.0 110.295 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 68' ' ' CYS . 27.7 m -154.51 64.36 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 99.0 110.402 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -108.11 -21.31 12.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 99.0 110.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.78 -31.88 3.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 99.0 110.146 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.13 159.48 17.2 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.521 -1.432 . . . . 99.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -179.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -1.144 . . . . 99.0 110.429 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.445 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -89.47 81.43 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 99.0 110.289 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.17 32.35 1.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.91 . . . . 99.0 110.084 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 81.0 m-20 -120.72 -126.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 99.0 110.074 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 70' ' ' ASN . 29.1 m 57.0 173.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 99.0 110.417 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . . . -168.81 117.18 0.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 99.0 109.983 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 99.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 99.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 99.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 99.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 99.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 99.0 109.36 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 99.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 48' ' ' ILE . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 99.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 99.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 99.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.28 156.78 27.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 99.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.68 126.09 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 99.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.78 128.1 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 99.0 110.041 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -100.5 67.33 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 99.0 110.317 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -111.61 -17.75 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 99.0 110.139 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pp -111.02 174.58 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 99.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -111.03 121.54 45.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 99.0 109.817 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 99.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 99.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 99.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 99.0 109.863 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 99.0 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 99.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 99.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 74' ' ' ILE . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 99.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 99.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 99.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.468 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 99.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 99.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 99.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 99.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 99.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 99.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 99.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 99.0 110.178 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 99.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 99.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 99.0 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 99.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 99.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 99.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CD2' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 99.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 99.0 109.916 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 99.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 99.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.521 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 99.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 55.9 tp -49.71 116.17 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 99.0 110.276 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -45.51 -35.63 3.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 99.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -30.73 69.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 99.0 110.164 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 -26.32 14.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 99.0 110.165 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.466 ' O ' HG23 ' A' ' 127' ' ' VAL . 2.3 mt-30 -70.11 -23.16 62.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 99.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.98 -5.42 17.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 99.0 110.646 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -82.73 4.98 22.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 99.0 110.376 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 124' ' ' GLN . 24.9 m -79.83 170.94 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 99.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.99 -1.005 . . . . 99.0 110.211 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.584 ' S1 ' HD21 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.99 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 99.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 99.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 99.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 99.0 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 99.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 99.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.418 HG21 ' HG3' ' A' ' 14' ' ' GLN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 99.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 17' ' ' ASP . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 99.0 109.765 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 99.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 99.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.418 ' HG3' HG21 ' A' ' 10' ' ' THR . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 99.0 110.116 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 99.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 99.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 11' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 99.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 99.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 99.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 99.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 99.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 99.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 99.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 99.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 99.0 110.231 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 99.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 99.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 99.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 99.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 99.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 99.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 99.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 99.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 99.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 99.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 99.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 99.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 99.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 99.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 99.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 99.0 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 99.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 99.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 99.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 99.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 99.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CE1' HG21 ' A' ' 103' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 99.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 99.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 99.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 99.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 99.0 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' HE2' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 99.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 99.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 99.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 99.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 99.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 99.0 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 99.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 99.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 42.2 Cg_endo -69.36 124.2 11.01 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.62 ' HB3' ' S2 ' ' A' ' 130' ' ' FES . 12.1 m-85 52.45 174.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 99.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -145.46 65.07 1.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 99.0 110.201 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 m -42.62 137.49 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 99.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 -69.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 99.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.0 -2.21 21.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 99.0 110.573 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.03 149.39 21.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.586 -1.406 . . . . 99.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . . . -86.04 159.87 19.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -1.154 . . . . 99.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 28.1 p -108.09 40.06 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 99.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 68' ' ' CYS . . . 67.77 71.76 0.33 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 99.0 110.238 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 88' ' ' LEU . 1.2 m-20 66.01 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 99.0 110.458 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 99.0 109.996 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 117' ' ' ALA . . . -145.39 80.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 99.0 110.424 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 99.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 74' ' ' ILE . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 99.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 99.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 99.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 99.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 99.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 99.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 99.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 105' ' ' SER . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 99.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 99.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 84' ' ' MET . 27.0 t0 -71.64 167.44 19.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 99.0 110.24 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.435 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -43.78 134.67 4.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 99.0 109.892 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 151.03 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 99.0 110.375 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.14 60.74 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 99.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.57 -61.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.846 . . . . 99.0 110.219 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.513 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 0.5 OUTLIER -58.95 157.2 10.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 99.0 110.063 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.48 140.97 29.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 99.0 110.267 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 99.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 99.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 99.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 99.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 99.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 99.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 99.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 99.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 99.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 99.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 99.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 99.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 99.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.512 HG21 ' CE1' ' A' ' 47' ' ' TYR . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 99.0 110.063 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 99.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 99.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 99.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 99.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 99.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 99.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 99.0 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 99.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 99.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 99.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 99.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 99.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 99.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 99.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 99.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -52.32 154.27 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 99.0 110.088 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 122' ' ' TYR . 7.2 p30 -61.77 -12.43 16.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 99.0 110.382 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 27.2 t80 -71.02 -26.4 63.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 99.0 110.308 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.0 mt -110.34 -33.46 6.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 99.0 110.305 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 99.0 110.193 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -6.59 35.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 99.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 123' ' ' LEU . 2.3 ttt180 -82.88 -19.5 37.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 99.0 110.204 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.5 t -71.72 156.85 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 99.0 110.285 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 128' ' ' ILE . 18.9 mm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 99.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.62 ' S2 ' ' HB3' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.99 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 4' ' ' GLU . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 99.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 99.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 99.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 99.0 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 99.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 99.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 99.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 99.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 99.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 99.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 99.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 99.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.543 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 99.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 99.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 99.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 99.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 99.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 99.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 99.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' CD1' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 99.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 99.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 99.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 99.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 99.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 99.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 99.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 99.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 99.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 99.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 99.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 99.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 99.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 99.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 99.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.502 ' CG2' HG22 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 99.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.507 ' CE ' HG21 ' A' ' 48' ' ' ILE . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 99.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 99.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 1' ' ' PRO . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 99.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 99.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 99.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 99.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 99.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 99.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.507 HG21 ' CE ' ' A' ' 40' ' ' MET . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 99.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 103' ' ' ILE . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 99.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 99.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 99.0 110.479 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 99.0 110.382 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 99.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 99.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 99.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 99.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 99.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 99.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.612 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 99.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 72' ' ' ALA . 45.5 Cg_endo -75.14 71.64 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 35.3 p90 -107.94 -163.18 0.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 99.0 110.15 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.572 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER 68.63 18.98 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 99.0 110.559 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 19.0 p -70.65 64.74 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 99.0 110.195 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -72.12 -15.11 61.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.85 . . . . 99.0 110.038 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.82 -179.72 8.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 99.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.4 -94.09 1.67 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.418 -1.473 . . . . 99.0 109.418 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 177.15 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 99.0 110.348 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.8 t -133.17 -91.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 99.0 109.923 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 58.18 13.23 2.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.042 . . . . 99.0 110.759 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.48 ' O ' ' CG1' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -154.49 17.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 99.0 110.438 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.63 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 5.5 m 42.51 -139.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.863 . . . . 99.0 110.065 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . -167.8 72.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.01 -1.056 . . . . 99.0 110.565 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 99.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 99.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 99.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 99.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 99.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 99.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.488 ' CB ' ' HB1' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 99.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 99.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 99.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 99.0 110.217 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -117.21 177.57 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 99.0 109.933 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.3 ttp -61.22 108.59 0.93 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.12 -0.988 . . . . 99.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -177.75 131.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 99.0 110.292 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.1 tp60 66.05 -149.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 99.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 tp -139.47 131.72 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 99.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.95 142.75 18.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 99.0 109.945 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p -130.17 153.59 48.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 99.0 110.326 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 99.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 99.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 99.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 99.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 99.0 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 99.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 99.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 92' ' ' GLU . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 99.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 99.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 99.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 99.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 102' ' ' CYS . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 99.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.494 ' N ' HG21 ' A' ' 101' ' ' THR . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 99.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' N ' HD22 ' A' ' 49' ' ' LEU . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 99.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 99.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 99.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' HB1' ' CB ' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 99.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 99.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 99.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 99.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 99.0 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 99.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 99.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 99.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 99.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 99.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 99.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 99.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 99.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -40.81 138.15 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 99.0 110.345 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.76 42.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 99.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.79 -30.49 68.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 99.0 109.799 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.59 -35.06 23.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 99.0 109.994 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -63.65 -23.72 67.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 99.0 110.133 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.59 -25.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.893 . . . . 99.0 110.283 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' VAL . 52.2 mtt180 -129.5 56.49 1.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 99.0 110.259 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.3 m -44.48 153.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 99.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.98 -1.01 . . . . 99.0 110.283 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.63 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.99 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' MET . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 99.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 99.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 99.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 115' ' ' TYR . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 99.0 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 99.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 99.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 99.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 99.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 99.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 99.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 99.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 99.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 99.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 99.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.461 ' HA ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 99.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 99.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 99.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 99.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 99.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 99.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 99.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 99.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 99.0 110.083 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 99.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 99.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 99.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 99.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.446 HD11 ' HB1' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 99.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 99.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 99.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 99.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 99.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 99.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 99.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 99.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.497 ' HE3' ' CG2' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 99.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 99.0 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 99.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 99.0 110.391 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 99.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 99.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 99.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 99.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.497 ' CG2' ' HE3' ' A' ' 40' ' ' MET . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 99.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 99.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 99.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB1' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 99.0 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 99.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 99.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 99.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 99.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 99.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 99.0 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 99.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 99.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 44.0 Cg_endo -70.36 89.89 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.85 72.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 99.0 110.399 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 60' ' ' PRO . 9.4 t -79.47 -0.29 32.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 99.0 110.069 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 151.48 13.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 99.0 110.28 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -117.35 -48.55 2.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 99.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.76 88.55 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.958 . . . . 99.0 110.299 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 64.47 113.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 99.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLY . . . 55.03 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -1.095 . . . . 99.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 17.8 p -170.93 33.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 99.0 110.223 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . 55.33 96.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 99.0 109.983 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' OD1' ' CA ' ' A' ' 99' ' ' ARG . 0.6 OUTLIER 57.95 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 99.0 109.86 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 56.9 m -106.83 -78.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 99.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 71' ' ' CYS . . . 174.28 88.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.018 . . . . 99.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 99.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 99.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 99.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 99.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 99.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 99.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 81' ' ' ASP . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 99.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 99.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 99.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 84' ' ' MET . 4.4 m-20 -93.54 166.69 12.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 99.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 84' ' ' MET . 2.5 ptt? -43.41 119.87 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 99.0 110.23 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -153.99 -61.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 99.0 110.278 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.22 149.38 31.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 99.0 110.292 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 mm -70.73 146.95 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 99.0 110.422 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 146.07 51.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 99.0 109.674 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -106.19 128.41 53.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 99.0 110.395 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 99.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 99.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HG2' ' CG1' ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 99.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 99.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 99.0 110.03 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 99.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 99.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 99.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG1' ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 99.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' CA ' ' OD1' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 99.0 110.463 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 99.0 110.059 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 99.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.403 ' HB2' HD22 ' A' ' 100' ' ' LEU . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 99.0 110.123 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 99.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 99.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 99.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 99.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 99.0 110.218 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 99.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 99.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 99.0 110.375 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 99.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 99.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 99.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 99.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 99.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB1' ' CA ' ' A' ' 73' ' ' SER . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 99.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 99.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 99.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -48.61 123.01 6.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 99.0 110.18 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.51 -27.61 65.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 99.0 110.451 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.485 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 33.6 t80 -64.34 -12.14 39.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 99.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.6 -40.58 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 99.0 110.173 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.28 -12.59 42.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 99.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -56.34 -25.55 49.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 99.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 128' ' ' ILE . 6.2 ttp180 -100.75 32.99 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 99.0 110.219 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' O ' HG11 ' A' ' 127' ' ' VAL . 13.2 p -47.24 153.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 99.0 110.201 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 126' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.11 -0.947 . . . . 99.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . 0.415 ' O ' ' HD3' ' A' ' 118' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.99 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 ' CG2' ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' MET . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 99.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 99.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 99.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 99.0 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' CA ' HG23 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 99.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 99.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 99.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 99.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 99.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 99.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 99.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 99.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.558 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 99.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 99.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 99.0 110.323 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 99.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 99.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.558 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 99.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 99.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 99.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 99.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 99.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 99.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 99.0 110.043 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 99.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 99.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 99.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 30' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 99.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 99.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 99.0 109.685 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 99.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 99.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 99.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 99.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.527 ' CG2' HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 99.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.559 ' HG3' ' CD2' ' A' ' 5' ' ' TYR . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 99.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 2' ' ' THR . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 99.0 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 99.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 99.0 110.273 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 99.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 99.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 99.0 110.17 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 102' ' ' CYS . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 99.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 99.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 99.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 99.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 99.0 109.969 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 99.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 99.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 99.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 99.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 99.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 99.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 99.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 99.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.56 141.39 31.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.63 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER 47.54 79.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 99.0 110.493 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.492 ' C ' ' S1 ' ' A' ' 130' ' ' FES . 2.3 p -59.19 -178.19 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 99.0 110.232 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.68 40.09 3.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 99.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -88.66 -41.89 12.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 99.0 110.319 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.22 90.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 99.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 179.15 33.16 0.06 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 99.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' GLY . . . 43.42 37.36 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 99.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 41.3 t -59.22 -84.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 99.0 110.282 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 49.41 36.29 9.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 99.0 110.109 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -172.95 109.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 99.0 110.199 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -177.07 3.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 99.0 110.279 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . . . -131.57 111.0 11.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 99.0 110.301 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 99.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 99.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 99.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 99.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 99.0 110.308 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 99.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 111' ' ' VAL . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 99.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 99.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.474 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 99.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 99.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 153.34 31.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 99.0 110.139 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 17.8 mtp -56.5 125.06 20.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 99.0 110.309 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' HG2' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -162.84 130.8 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 99.0 110.102 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.41 ' C ' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -92.92 66.03 4.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 99.0 110.369 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 85' ' ' GLN . 1.4 pp -136.05 32.17 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 99.0 110.002 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 172.88 16.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 99.0 110.034 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.08 135.23 35.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 99.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 99.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 99.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 99.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 99.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 99.0 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 99.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 99.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.545 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 99.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 99.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 99.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 99.0 109.971 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 99.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 99.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 99.0 109.911 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 99.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 99.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.528 ' HD3' ' CG1' ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.414 ' CB ' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 99.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 99.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 99.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 99.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 79' ' ' GLU . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 99.0 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 99.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 99.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 99.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.607 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 99.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.607 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 99.0 110.074 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 99.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 99.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 50.5 m-70 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 99.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.43 135.37 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 99.0 110.313 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 23.7 p-10 -67.37 -10.25 49.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 99.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -79.9 -42.49 24.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.912 . . . . 99.0 110.369 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -19.33 32.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.322 -0.861 . . . . 99.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -67.52 -29.89 69.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 99.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -55.35 -19.84 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 99.0 109.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.37 -16.99 62.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 99.0 110.164 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.08 168.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 99.0 110.313 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.016 -0.992 . . . . 99.0 110.152 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.66 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.63 ' S1 ' ' O ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.99 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 40' ' ' MET . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 99.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 99.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 99.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.502 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 99.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 99.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 99.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 99.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 99.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 99.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 99.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 99.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 99.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.557 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 99.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 99.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 99.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 99.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 99.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 99.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 99.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 6' ' ' LEU . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 99.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 99.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 99.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 99.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 99.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 99.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 99.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 99.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 99.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 99.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 99.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 99.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 99.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 99.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 99.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 99.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 99.0 110.262 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 99.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 99.0 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG21 ' CB ' ' A' ' 51' ' ' ALA . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 99.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 99.0 110.1 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 1' ' ' PRO . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 99.0 109.984 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 99.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 99.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 99.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 103' ' ' ILE . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 99.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.523 HD21 ' CA ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 99.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 99.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' CB ' HG21 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 99.0 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' CB ' ' HE3' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 99.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 99.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 99.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 99.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 99.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 99.0 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 99.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.634 ' HB3' ' S1 ' ' A' ' 130' ' ' FES . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 99.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 46.3 Cg_endo -73.33 176.39 9.28 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 2.8 t80 66.93 165.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.816 . . . . 99.0 110.419 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 m -74.22 54.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 99.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 99.0 110.169 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.1 148.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.31 -0.869 . . . . 99.0 110.445 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 44.64 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 99.0 110.443 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.1 -157.98 14.84 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.455 -1.458 . . . . 99.0 109.455 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.64 163.6 25.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 99.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.74 128.18 36.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 99.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.39 -16.91 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 99.0 109.919 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -161.5 63.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 99.0 110.139 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 99' ' ' ARG . 44.7 t -44.8 165.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.241 -0.912 . . . . 99.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' A' ' 117' ' ' ALA . . . -124.41 90.46 3.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 99.0 110.76 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 99.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 99.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 99.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 99.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.454 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 99.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 99.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 99.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 99.0 110.223 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 99.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.455 ' HE2' ' CD2' ' A' ' 88' ' ' LEU . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 99.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 -61.84 165.43 5.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 99.0 110.151 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.49 144.9 55.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.972 . . . . 99.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 86' ' ' GLN . 38.5 tt0 -174.94 141.27 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 99.0 110.31 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 85' ' ' GLN . 3.3 tt0 44.09 -168.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 99.0 110.468 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 88' ' ' LEU . 4.4 mt -69.11 -83.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 99.0 110.059 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.455 ' CD2' ' HE2' ' A' ' 82' ' ' MET . 0.5 OUTLIER 65.06 167.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.185 -0.947 . . . . 99.0 110.22 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 145.03 2.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 99.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 99.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 99.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 99.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 99.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 99.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 99.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 99.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 99.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 99.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 99.0 110.23 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 99.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.626 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 99.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 99.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 99.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 99.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 99.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 99.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 99.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 99.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 99.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 77' ' ' GLU . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 99.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 99.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 99.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 99.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 99.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.566 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.4 t30 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 99.0 109.884 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 99.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 99.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 99.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt -46.89 120.61 3.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 99.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -65.46 -19.81 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 99.0 110.372 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 29.1 t80 -79.52 -12.52 59.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 99.0 110.276 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.28 -32.78 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 99.0 110.415 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -51.03 -25.28 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 99.0 110.121 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 126' ' ' ARG . 29.7 p-10 -68.71 -28.39 66.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 99.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 6.9 tpt180 -60.06 -20.02 55.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 99.0 110.123 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.63 -40.33 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 99.0 110.131 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.442 HD12 HG22 ' A' ' 128' ' ' ILE . 11.5 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.992 -1.004 . . . . 99.0 110.19 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.634 ' S1 ' ' HB3' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.99 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 3' ' ' VAL . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' MET . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 99.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.521 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 99.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 99.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 99.0 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 99.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 99.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.479 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 99.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 99.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 99.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 99.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 99.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 99.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE3' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 99.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' HD22 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 99.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 99.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 99.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 99.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 99.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 99.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 ' CE3' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 99.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 99.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 99.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 99.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 99.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 99.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 99.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 99.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 99.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 99.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 99.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.47 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 99.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 99.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 99.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.508 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 99.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 3' ' ' VAL . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 99.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 99.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 99.0 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 99.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 99.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 99.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 99.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 99.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 99.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.527 HG21 ' CE ' ' A' ' 40' ' ' MET . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 99.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 99.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 99.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 99.0 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 99.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 99.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 99.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 99.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 99.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 99.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 99.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 99.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 47.3 Cg_endo -80.14 172.66 13.56 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.488 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.1 OUTLIER 45.57 69.49 0.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 99.0 110.165 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 63' ' ' CYS . 15.1 m -72.13 -15.06 61.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 99.0 110.116 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' C ' ' O ' ' A' ' 62' ' ' SER . 20.1 p 33.09 -147.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.231 0.538 . . . . 99.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -166.5 52.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 99.0 110.255 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 64' ' ' ARG . . . 54.83 52.56 11.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.917 . . . . 99.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' CYS . . . -148.19 -121.83 1.23 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.408 -1.477 . . . . 99.0 109.408 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.59 82.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 99.0 110.143 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -150.99 111.83 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 99.0 110.655 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.46 -21.53 13.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 99.0 109.568 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' HB2' ' CG1' ' A' ' 98' ' ' VAL . 1.8 p30 -141.84 130.6 22.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.492 -0.755 . . . . 99.0 109.74 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.503 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 96.2 m -75.3 -96.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.063 -1.023 . . . . 99.0 110.164 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . . . -178.75 36.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.979 -1.076 . . . . 99.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.483 ' OG ' ' CZ3' ' A' ' 59' ' ' TRP . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 99.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 99.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 97' ' ' ASP . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 99.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 99.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 99.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 99.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 99.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG21 ' O ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 99.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 99.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 99.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.92 -177.88 5.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 99.0 110.184 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tpt -65.68 92.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 99.0 110.104 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.24 178.19 9.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 99.0 110.352 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.87 94.83 1.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 99.0 110.013 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.14 -69.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 99.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.14 155.52 17.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 99.0 110.436 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t -106.75 140.91 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 99.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 99.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 99.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 99.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 99.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 99.0 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 99.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 99.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 75' ' ' VAL . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 99.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.493 ' CG1' ' HB2' ' A' ' 70' ' ' ASN . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 99.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' N ' HG11 ' A' ' 98' ' ' VAL . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 99.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 99.0 110.063 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.444 ' CG2' HG23 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 99.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 99.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 99.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 99.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 99.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 99.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 99.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 99.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 99.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 99.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 99.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 ' HB3' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 99.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 99.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 99.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 99.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.529 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 99.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 99.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 99.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -60.13 121.96 13.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 99.0 110.379 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.74 -26.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 99.0 110.173 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.67 -38.18 80.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 99.0 110.182 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 -36.31 31.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 99.0 110.087 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -61.41 -28.08 69.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.925 . . . . 99.0 110.041 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -56.69 -18.58 12.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.351 -0.843 . . . . 99.0 110.386 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -27.1 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 99.0 110.3 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.21 144.03 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 99.0 109.921 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.037 -0.983 . . . . 99.0 110.244 -179.817 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.503 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.99 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 99.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 99.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 99.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.597 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 99.0 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 99.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 99.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 HG22 HD13 ' A' ' 32' ' ' LEU . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 99.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 99.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 99.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 99.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 99.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 99.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.519 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 99.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 99.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 99.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 99.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 99.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 99.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 99.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 99.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 99.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 99.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 99.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 99.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 99.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 99.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 99.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 99.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 10' ' ' THR . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 99.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 99.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 99.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 99.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 99.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 99.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 99.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 99.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.476 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 99.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 99.0 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 99.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 99.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 99.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 99.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 99.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 99.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.461 HG21 ' HE3' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 99.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 99.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 99.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' HG21 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 99.0 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 99.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 99.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 99.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 99.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 99.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 99.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 99.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 99.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo -71.46 167.7 25.63 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 65.24 86.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.514 -0.741 . . . . 99.0 110.597 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.31 169.56 15.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 99.0 109.914 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 m -90.05 84.29 6.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 99.0 109.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -37.75 18.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 99.0 110.506 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.21 151.52 29.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 99.0 110.414 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.69 -33.14 62.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.346 -1.502 . . . . 99.0 109.346 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.42 77.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -1.13 . . . . 99.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.4 t -77.22 -81.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 99.0 110.353 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.26 25.46 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 99.0 109.915 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 1.3 m-20 -94.19 -68.11 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 99.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.621 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 4.5 m 67.16 172.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.303 -0.873 . . . . 99.0 109.543 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . -151.54 70.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.006 -1.059 . . . . 99.0 111.146 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 99.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 99.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 99.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 99.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 99.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 99.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 99.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 99.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 99.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 99.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 150.59 37.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 99.0 110.055 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 mtp -68.35 128.56 37.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 99.0 110.198 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -159.86 161.91 34.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 99.0 110.102 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -69.61 -163.09 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 99.0 110.39 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 86' ' ' GLN . 2.4 mp 59.58 168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 99.0 110.359 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.97 106.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 99.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.52 154.81 22.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 99.0 110.264 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 99.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 99.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 99.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 99.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 99.0 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 99.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 99.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.551 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 99.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 99.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 99.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 99.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 99.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 99.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 99.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 99.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 99.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 99.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.419 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 99.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 99.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 99.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 99.0 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 99.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 99.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 99.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 99.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 99.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.554 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 99.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 99.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 99.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -40.47 128.72 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 99.0 110.629 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.36 -10.16 30.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 99.0 109.798 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.95 -24.83 48.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 99.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.61 -22.45 12.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 99.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -23.62 29.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 99.0 110.473 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.41 -16.91 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 99.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.1 14.86 5.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 99.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.99 -26.12 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 99.0 110.143 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.006 -0.997 . . . . 99.0 110.259 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.621 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.99 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 99.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 99.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 99.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 99.0 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 99.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 99.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 99.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' CD1' ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 99.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 99.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 99.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 99.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 99.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.547 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 99.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 99.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.464 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 99.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 99.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 99.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 99.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 99.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.514 ' CD1' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 99.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 99.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 99.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 99.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 99.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 99.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 99.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 99.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 99.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 99.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 99.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 99.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 99.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.519 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 99.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 99.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 99.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 99.0 110.345 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.529 ' CE ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 99.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 99.0 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 40' ' ' MET . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 99.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' VAL . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 99.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 99.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 99.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 99.0 110.133 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 99.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.513 HG21 ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 99.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 99.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 99.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 99.0 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 99.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 99.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 99.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 99.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 99.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 99.0 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 99.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 99.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 46.3 Cg_endo -71.21 131.03 18.47 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.16 121.99 32.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 99.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -160.74 80.92 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 99.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 61.0 m -134.6 44.41 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 99.0 110.256 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 8.9 mtt-85 47.5 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 99.0 110.184 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' CYS . . . -177.99 153.85 0.84 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.083 -1.011 . . . . 99.0 110.134 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -103.62 3.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.395 -1.482 . . . . 99.0 109.395 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.25 167.22 16.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 99.0 110.118 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.0 OUTLIER -125.47 54.8 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 99.0 110.347 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.17 39.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 99.0 110.297 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.15 94.06 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 99.0 110.144 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -85.53 -145.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.343 -0.848 . . . . 99.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -145.02 68.27 1.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 99.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 99.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 99.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 99.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 99.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 99.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 99.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 99.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 99' ' ' ARG . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 99.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 99.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.495 ' HE3' ' CD2' ' A' ' 100' ' ' LEU . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 99.0 110.015 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 -46.91 143.88 2.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 99.0 110.169 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -52.47 144.77 12.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 99.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.2 mt-30 -167.18 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 99.0 110.381 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -102.51 150.64 23.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 99.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 mt -91.12 86.18 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 99.0 110.048 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 170.01 5.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 99.0 110.247 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -119.13 141.34 48.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.867 . . . . 99.0 110.007 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.477 ' O ' HG11 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 99.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 99.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 99.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 99.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 99.0 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 99.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 99.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 99.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 99.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 99.0 110.157 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' CD2' ' HE3' ' A' ' 82' ' ' MET . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 99.0 110.752 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 99.0 109.879 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 99.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 99.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 99.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 99.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 99.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 99.0 110.231 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 99.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 99.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 99.0 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 99.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 99.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 99.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 99.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 99.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 99.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 99.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 99.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -46.38 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 99.0 110.072 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.2 -14.41 60.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 99.0 110.248 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.25 -22.12 66.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 99.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -20.94 6.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 99.0 110.208 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.46 ' O ' HG11 ' A' ' 127' ' ' VAL . 4.8 tp60 -62.41 -14.73 43.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 99.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -49.53 -23.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 99.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -114.3 50.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 99.0 110.386 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 124' ' ' GLN . 18.7 m -46.76 172.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.952 . . . . 99.0 110.122 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.938 -1.029 . . . . 99.0 110.216 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.497 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.99 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 99.0 110.242 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 99.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 99.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.59 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 99.0 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 99.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 99.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 99.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 99.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 99.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 99.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 99.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 99.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD2' ' HB2' ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 99.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 99.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 99.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 99.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 99.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 99.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 99.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' HB2' ' CD2' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 99.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 37' ' ' TYR . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 99.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 99.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 99.0 110.443 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB3' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 99.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 99.0 110.21 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 99.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 99.0 110.313 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 99.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 99.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 99.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 99.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 99.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 99.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 99.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 99.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 3' ' ' VAL . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 99.0 110.01 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 99.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 99.0 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 99.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 99.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 99.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 99.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 99.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CD1' HG22 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 99.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 70' ' ' ASN . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 99.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 99.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 99.0 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 57' ' ' TYR . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 99.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 99.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 99.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 99.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 99.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 99.0 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 99.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 99.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo -71.81 173.57 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 8.2 m-85 -91.76 139.42 30.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.379 -0.826 . . . . 99.0 110.456 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -160.26 70.33 0.42 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 99.0 109.923 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.06 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 99.0 110.003 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -138.94 -152.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 99.0 110.081 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.58 20.49 4.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 99.0 110.327 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.59 -38.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 99.0 109.553 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 68' ' ' CYS . . . -139.19 156.67 46.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 99.0 110.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER 69.31 83.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 99.0 110.279 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.535 ' O ' ' S1 ' ' A' ' 130' ' ' FES . . . -126.26 -169.36 2.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 99.0 109.995 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 7.5 m120 55.05 88.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 99.0 110.154 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -162.0 -151.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 99.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 71' ' ' CYS . . . 67.89 98.76 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 99.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.463 ' O ' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 99.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 99.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 99.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 99.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 99.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 99.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 99.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 99.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 99.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.441 ' HE1' HG13 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 99.0 110.278 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -101.83 -173.27 2.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 99.0 110.251 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.22 86.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 99.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -153.91 117.18 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 99.0 110.299 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 55.18 177.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 99.0 110.445 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.65 160.05 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.41 -0.806 . . . . 99.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 89' ' ' SER . 4.1 tt -139.39 144.59 38.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 99.0 110.334 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.461 ' O ' HD22 ' A' ' 88' ' ' LEU . 4.0 m -96.26 146.95 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 99.0 110.239 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' O ' HG11 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 99.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 99.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 99.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 99.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 99.0 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 99.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 99.0 110.664 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 99.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 99.0 110.329 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 99.0 110.285 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.563 ' CD2' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 99.0 110.18 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 99.0 110.267 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 99.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 99.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 99.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 99.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 99.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 109' ' ' ASP . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 99.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 99.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 99.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 77' ' ' GLU . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 99.0 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 99.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 99.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 99.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 99.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 99.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 99.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD2' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 99.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 62.7 m-70 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 99.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -40.31 121.57 1.41 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 99.0 110.476 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -49.53 -28.6 5.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 99.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.539 ' CD2' HD22 ' A' ' 123' ' ' LEU . 38.6 t80 -66.48 -31.73 72.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 99.0 109.961 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.539 HD22 ' CD2' ' A' ' 122' ' ' TYR . 43.5 mt -103.37 -22.33 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.465 -0.772 . . . . 99.0 110.1 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.409 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -48.44 -32.14 7.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 99.0 110.215 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -57.42 -27.9 62.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 99.0 110.274 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -51.93 -42.49 62.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 99.0 110.364 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 124' ' ' GLN . 6.4 p -49.78 164.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 99.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.884 -1.055 . . . . 99.0 110.176 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.563 ' S2 ' ' CD2' ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.99 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.446 ' HB ' ' OE2' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' MET . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 99.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 99.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 99.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.527 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 99.0 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 99.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 99.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.437 HG22 HD23 ' A' ' 32' ' ' LEU . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 99.0 110.09 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 17' ' ' ASP . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 99.0 109.653 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 99.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 99.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 99.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 99.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 99.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.472 ' O ' HD12 ' A' ' 11' ' ' LEU . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 99.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 99.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 99.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 99.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 99.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 99.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 99.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 99.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 99.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 99.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 99.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 99.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 99.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 99.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 99.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 10' ' ' THR . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 99.0 110.377 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 99.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 99.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 99.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 99.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 99.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 99.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 99.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.518 ' CE ' HG21 ' A' ' 48' ' ' ILE . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 99.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 99.0 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 99.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 99.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 99.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 99.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 99.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 99.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 40' ' ' MET . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 99.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 101' ' ' THR . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 99.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 99.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 99.0 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 99.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 99.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 99.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 99.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 99.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 99.0 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 99.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 99.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.67 82.52 1.91 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' HB2' ' S2 ' ' A' ' 130' ' ' FES . 13.8 p90 -121.12 149.05 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 99.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -127.08 16.68 7.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 99.0 109.987 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.95 113.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 99.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -134.06 -36.19 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 99.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.07 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 99.0 110.158 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.04 154.69 52.87 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.566 -1.414 . . . . 99.0 109.566 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.74 161.68 7.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 99.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.5 t -119.09 117.64 29.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 99.0 110.502 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.59 -23.57 15.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 99.0 109.674 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -153.4 106.75 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.413 -0.804 . . . . 99.0 109.817 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 101' ' ' THR . 45.9 t -67.04 -102.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 99.0 110.494 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . . . -169.68 24.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 99.0 111.124 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 99.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 99.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' CA ' HD11 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 99.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 99.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 99.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 99.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 99.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 99.0 109.903 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 99.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.451 ' SD ' HD12 ' A' ' 88' ' ' LEU . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 99.0 110.116 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.0 127.48 35.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 99.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 85.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 99.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -167.5 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 99.0 110.231 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 1.2 tp-100 -152.61 170.64 19.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 99.0 110.322 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 133.03 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 99.0 110.208 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD12 ' SD ' ' A' ' 82' ' ' MET . 0.2 OUTLIER -134.77 139.43 45.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 99.0 110.288 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p -116.75 127.53 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 99.0 110.14 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 99.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 99.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 99.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 99.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 99.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 99.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 99.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' HB2' ' CG2' ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 99.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' SER . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 99.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 98' ' ' VAL . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 99.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HG ' ' S1 ' ' A' ' 130' ' ' FES . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 99.0 110.26 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 99.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.456 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 99.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 99.0 110.273 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 99.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 99.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 99.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 99.0 110.382 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 99.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.446 ' OE2' ' HB ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 99.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 99.0 110.181 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 99.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 99.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 99.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.573 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 99.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 99.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 99.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 99.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 99.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt -47.22 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 99.0 110.279 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.18 -15.3 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 99.0 110.073 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -79.04 -13.1 59.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 99.0 110.173 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -11.81 6.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 99.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -45.77 -30.87 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 99.0 110.231 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -45.9 -25.07 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.905 . . . . 99.0 110.001 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -25.31 67.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 99.0 110.144 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.77 111.68 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 99.0 110.185 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 128' ' ' ILE . 3.0 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.947 -1.025 . . . . 99.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.733 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.572 ' S2 ' ' HB2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.99 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 40' ' ' MET . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 99.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 99.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 99.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 99.0 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 99.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 99.0 109.805 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 99.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 99.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 99.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 99.0 109.917 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 99.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 99.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 99.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 99.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 99.0 110.148 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 99.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 99.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 99.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 99.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 99.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 99.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 99.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 99.0 110.231 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 99.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 99.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 99.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 99.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 99.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 99.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 99.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 99.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 99.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 99.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 99.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.561 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 99.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.447 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 99.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 99.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 99.0 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 99.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 99.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 99.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 99.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 99.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 99.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 99.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 99.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 99.0 110.26 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 99.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 99.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 99.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 99.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 99.0 109.755 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 99.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 99.0 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 99.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 99.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo -70.64 121.85 8.32 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -66.8 156.24 36.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 99.0 110.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.94 59.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 99.0 110.086 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.2 OUTLIER -159.89 175.97 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 99.0 110.228 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -79.3 178.2 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 99.0 110.097 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.66 152.18 37.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 99.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.21 59.89 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.471 -1.451 . . . . 99.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 51.75 20.36 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 99.0 110.24 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -97.44 120.42 37.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 99.0 110.085 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.611 ' O ' ' S2 ' ' A' ' 130' ' ' FES . . . -105.5 -148.74 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 99.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -56.88 167.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 99.0 110.382 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.49 76.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 99.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -176.37 88.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 99.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 99.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 99.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 99.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 99.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 99.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 99.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 99.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 99.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 99.0 109.866 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 99.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -64.99 178.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 99.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -49.08 105.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 99.0 110.231 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 84' ' ' MET . 2.5 tt0 -177.35 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 99.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -46.74 120.34 2.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 99.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -155.42 -39.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 99.0 110.026 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -66.48 167.01 11.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 99.0 110.203 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.26 141.61 37.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 99.0 110.28 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 99.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 99.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 99.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 99.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 99.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 99.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 99.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CB ' HG21 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 99.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 99.0 110.633 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 99.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 99' ' ' ARG . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 99.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 99.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 99.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 99.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 99.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 99.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' HG12 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 99.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 99.0 110.179 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 99.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 99.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 99.0 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 99.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 99.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 99.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 99.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' OD1' ' CZ ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 99.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 99.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 99.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.452 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 56.3 m-70 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 99.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -42.14 152.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 99.0 110.277 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -38.08 67.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 99.0 110.224 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -70.28 -4.89 24.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 99.0 110.183 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -39.59 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 99.0 110.36 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -62.52 -25.66 68.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 99.0 110.443 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -53.78 -23.7 12.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 99.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.99 -33.22 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 99.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.05 136.09 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 99.0 110.369 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.944 -1.027 . . . . 99.0 110.237 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.772 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.611 ' S2 ' ' O ' ' A' ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.9900000000000002 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 40' ' ' MET . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 111' ' ' VAL . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 50.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 50.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 50.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 12.5 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.595 ' CE2' HD12 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 50.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 50.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 50.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 50.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 50.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 50.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 50.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 50.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 50.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 50.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.439 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 50.0 110.848 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 50.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 50.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 50.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 50.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 50.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 50.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 50.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 50.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 50.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 50.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 50.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 50.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 50.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 50.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 50.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 50.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 50.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 50.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.514 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 50.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 10.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 50.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.695 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 50.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 12.5 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 10.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 50.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 25.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 10.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 10.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 10.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 106' ' ' PRO . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 10.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 10.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 50.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 12.5 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.695 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 10.0 110.084 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 10.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 50.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 10.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 10.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 12.5 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 10.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 50.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.314 0.578 . . . . 10.0 110.423 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 50.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 73' ' ' SER . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 50.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 50.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 50.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 25.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 50.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 50.0 110.242 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 10.0 110.216 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 50.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 50.0 110.043 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 12.5 110.074 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 10.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 50.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 50.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 12.5 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 50.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 25.0 110.376 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.756 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 50.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 50.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 50.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 10.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 10.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' HA ' HD22 ' A' ' 49' ' ' LEU . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 10.0 110.086 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 50.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 10.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 10.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 50.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 50.0 110.09 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 50.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 50.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 78' ' ' GLY . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 12.5 110.507 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 25.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 50.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 50.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 10.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 50.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 50.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 50.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.595 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 12.5 110.442 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.9900000000000002 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 50.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 50.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 50.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 12.5 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 114' ' ' VAL . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 50.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 50.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 50.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 50.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 50.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 50.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 50.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 50.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 50.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 50.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 50.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 50.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 50.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.72 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 50.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 50.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 50.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 50.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 50.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 50.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 50.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 50.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 50.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 50.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 50.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 50.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 50.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 50.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.836 ' HE2' ' HB2' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 12.5 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.84 HG11 ' HD3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 10.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 50.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 25.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 10.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 10.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 10.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.512 HD13 ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 10.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 10.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 50.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 12.5 110.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 10.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 10.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 50.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 10.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 10.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 12.5 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 10.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.027 ' HB3' HD11 ' A' ' 100' ' ' LEU . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 50.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CA ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 10.0 110.535 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.998 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 50.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 50.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 50.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 50.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 25.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 10.0 109.474 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.559 ' C ' HD12 ' A' ' 80' ' ' ILE . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 50.0 110.113 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.887 HG12 HG21 ' A' ' 101' ' ' THR . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 50.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 10.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 50.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 50.0 110.141 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.185 0.517 . . . . 12.5 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 10.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 50.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 50.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 10.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 12.5 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 50.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HG23 ' A' ' 98' ' ' VAL . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 25.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 50.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 96' ' ' LYS . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 50.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 50.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' A' ' 59' ' ' TRP . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 10.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 80' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 10.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 10.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 103' ' ' ILE . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 50.0 110.161 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 10.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 10.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.84 ' HD3' HG11 ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 50.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 50.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 50.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 50.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 12.5 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 25.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.998 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 10.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 113' ' ' ILE . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 50.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 50.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 10.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB3' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 50.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 50.0 110.114 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 50.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 12.5 110.31 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.445 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.9900000000000002 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' A' ' 111' ' ' VAL . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 50.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 50.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.691 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 50.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 10' ' ' THR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 12.5 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 50.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 50.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 50.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 50.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 50.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 50.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 50.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 50.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 50.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 50.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 50.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 50.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 50.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 50.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 50.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 16' ' ' TRP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 50.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 50.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 50.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 50.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 50.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 50.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 50.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 50.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 50.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 50.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 50.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 50.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.665 ' CG2' HG22 ' A' ' 2' ' ' THR . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 50.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.68 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 50.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 12.5 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 10.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 50.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 25.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 10.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 10.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 10.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 10.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 10.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 50.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 12.5 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 10.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 10.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 50.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 10.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 10.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.727 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 12.5 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 10.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CZ3' HG21 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 50.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.98 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.98 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.278 0.561 . . . . 10.0 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.631 ' CB ' HD11 ' A' ' 113' ' ' ILE . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 50.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 50.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 50.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 50.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 25.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 50.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 99' ' ' ARG . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 50.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 10.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 50.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 50.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.277 0.561 . . . . 12.5 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 10.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 50.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 50.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 10.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 12.5 110.192 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 25.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.727 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 50.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 50.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 50.0 109.876 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 10.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.527 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 10.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 50.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 10.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 10.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 50.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 50.0 110.363 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 50.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 50.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 108' ' ' ALA . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 12.5 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 25.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 1.022 HD13 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 10.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 1.022 ' N ' HD13 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 50.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 50.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 10.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.67 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.708 ' N ' ' HB1' ' A' ' 72' ' ' ALA . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 50.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 50.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 12.5 110.264 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.9900000000000002 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 111' ' ' VAL . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.944 ' OE1' HG23 ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 50.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 50.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.839 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 50.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 12.5 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE1' HD12 ' A' ' 120' ' ' LEU . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 50.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 50.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 50.0 109.905 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 50.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 50.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 50.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 50.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 50.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 50.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 50.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 50.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 50.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 50.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 50.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 50.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 16' ' ' TRP . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 50.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 50.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 50.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 50.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 50.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 50.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 50.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 50.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 50.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 50.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 50.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 50.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 50.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 50.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.944 HG23 ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 50.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 50.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 12.5 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 10.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 50.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 25.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 10.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 10.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 80' ' ' ILE . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 10.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 10.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 50.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 12.5 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 10.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 50.0 110.16 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 10.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 10.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 12.5 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 10.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 50.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD3' HD21 ' A' ' 116' ' ' ASN . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.382 0.61 . . . . 10.0 110.505 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.553 ' O ' HD13 ' A' ' 74' ' ' ILE . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 50.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 97' ' ' ASP . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 50.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 50.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 74' ' ' ILE . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 50.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 25.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 50.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 50.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 10.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 50.0 110.143 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 50.0 110.233 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 12.5 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 10.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 50.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 50.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 10.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 12.5 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 50.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 25.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.731 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 50.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 50.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 50.0 110.259 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HA ' HD13 ' A' ' 100' ' ' LEU . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 10.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 99' ' ' ARG . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 10.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 10.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 50.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 10.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 10.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 50.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 50.0 110.04 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 50.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 50.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 3' ' ' VAL . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 12.5 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 25.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 10.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 50.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 50.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 10.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 50.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 50.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 50.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 12.5 110.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 111' ' ' VAL . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 50.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 50.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 12.5 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 50.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 50.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 50.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 50.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 50.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 50.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 50.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 50.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.476 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 50.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 50.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 50.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 50.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 50.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CB ' HD11 ' A' ' 6' ' ' LEU . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 50.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 50.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 50.0 110.147 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 50.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 50.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 50.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 50.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 50.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 50.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 50.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 50.0 109.662 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 50.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.556 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 50.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 50.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 10.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 50.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.757 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 50.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 12.5 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' MET . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 10.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 25.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 10.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 10.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 10.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 10.0 110.087 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 10.0 110.342 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 50.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 12.5 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 10.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 10.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 50.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 10.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 12.5 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 50.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.227 0.537 . . . . 10.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 50.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 50.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 50.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HE3' ' HG3' ' A' ' 18' ' ' MET . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 50.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 25.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 10.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 50.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 50.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 10.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 50.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 50.0 110.359 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.211 0.529 . . . . 12.5 110.379 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 10.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 50.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 50.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 10.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 12.5 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 50.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 25.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.868 ' O ' HG12 ' A' ' 75' ' ' VAL . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 50.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' VAL . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 50.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 50.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 10.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 10.0 110.275 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.439 ' C ' HG13 ' A' ' 103' ' ' ILE . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 10.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 50.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 10.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 50.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 50.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 50.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 50.0 109.899 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 12.5 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 25.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.751 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 10.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 50.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 50.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 10.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 50.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 50.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 50.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 12.5 110.359 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.9900000000000002 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 50.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 50.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.589 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 50.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 12.5 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 50.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 50.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 50.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' TRP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 50.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 50.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 50.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 50.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.839 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 50.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.494 ' CA ' HD11 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 50.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.421 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 50.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 50.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 50.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 50.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 50.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 50.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 50.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 50.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 50.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 50.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 50.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 50.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 50.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 50.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 50.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 50.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 50.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 50.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 50.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 50.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 12.5 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 10.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 50.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 25.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 10.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' CD ' ' A' ' 50' ' ' GLU . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 10.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 10.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 10.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 102' ' ' CYS . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 10.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 49' ' ' LEU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 50.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 12.5 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 10.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 10.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 50.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 10.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 12.5 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 10.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 50.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.119 0.485 . . . . 10.0 110.035 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 50.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 50.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 97' ' ' ASP . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 50.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 25.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.684 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.896 ' HG2' ' HB2' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 50.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 50.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 10.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 50.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 50.0 109.973 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.231 0.539 . . . . 12.5 110.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 10.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 50.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 50.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 10.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 12.5 109.537 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 50.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 25.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 50.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 50.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 10.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 48' ' ' ILE . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 10.0 110.152 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.887 ' HA ' HD23 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 10.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 103' ' ' ILE . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 10.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 10.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 50.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 50.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 50.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 50.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 12.5 110.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 77' ' ' GLU . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 25.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 10.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 50.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 50.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 10.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.862 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 50.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 50.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 50.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 12.5 110.408 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.9900000000000002 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' CG2' ' A' ' 39' ' ' THR . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 111' ' ' VAL . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.528 ' N ' HG12 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 50.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 50.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 50.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.712 ' ND2' ' CE1' ' A' ' 115' ' ' TYR . 4.8 t-20 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 12.5 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 50.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 50.0 109.824 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 50.0 109.429 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.015 HD21 ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 50.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 50.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 50.0 109.858 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' OE1' HD21 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 50.0 109.975 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 50.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.729 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 50.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 1.015 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 50.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.596 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 50.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 50.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 50.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 50.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 50.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 50.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CD1' HD12 ' A' ' 6' ' ' LEU . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 50.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 50.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 50.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 50.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 37' ' ' TYR . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 50.0 109.91 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 50.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 50.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 50.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD21 ' OE1' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 50.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 50.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 50.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 50.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 50.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 50.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 10.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.52 ' CG2' HG23 ' A' ' 2' ' ' THR . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 50.0 110.136 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.918 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 50.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 12.5 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 10.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 50.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 25.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 10.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 10.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 10.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.758 HG23 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 10.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 10.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 50.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 12.5 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.918 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 10.0 110.319 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 10.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 50.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 10.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 10.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 12.5 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 10.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 50.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 43.8 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.136 0.494 . . . . 10.0 110.556 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.591 ' CB ' HD11 ' A' ' 113' ' ' ILE . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 50.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 50.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.663 ' CA ' HD12 ' A' ' 113' ' ' ILE . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 50.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 50.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 25.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 10.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 50.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 50.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 10.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 50.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 50.0 110.542 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.31 0.576 . . . . 12.5 110.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 10.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 50.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 50.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 98' ' ' VAL . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 10.0 109.786 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 12.5 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 50.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 25.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.631 ' HB2' HG23 ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 50.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 50.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 10.0 110.348 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 10.0 110.153 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 10.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 10.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 10.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 50.0 110.188 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.606 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 50.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 50.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 50.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' HG22 ' A' ' 3' ' ' VAL . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 12.5 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 25.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.663 HD12 ' CA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 10.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 50.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.712 ' CE1' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 50.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 10.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.587 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 50.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 50.0 110.12 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.593 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 50.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' OH ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 12.5 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.9900000000000002 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 50.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 50.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.703 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 50.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 12.5 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 50.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 50.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 50.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 50.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 50.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 50.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 50.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 50.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 50.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 50.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 50.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 50.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 50.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 50.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 50.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 50.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE2' HD12 ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 50.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 50.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 50.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 50.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 50.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 50.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 50.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 50.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 50.0 109.394 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 50.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 50.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 50.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 50.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.727 ' HE3' HG23 ' A' ' 48' ' ' ILE . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 12.5 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' CB ' ' A' ' 51' ' ' ALA . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 10.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 50.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 25.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 10.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 10.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.727 HG23 ' HE3' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 10.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.83 HD13 ' SG ' ' A' ' 102' ' ' CYS . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 10.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 50.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 12.5 109.742 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 10.0 109.856 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 10.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 50.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 10.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 12.5 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 10.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.604 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 50.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.298 0.57 . . . . 10.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 50.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 73' ' ' SER . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 50.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 50.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 50.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 25.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 50.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 50.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 10.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 50.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 50.0 110.274 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.207 0.527 . . . . 12.5 110.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 10.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 50.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 50.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 10.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 12.5 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 50.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 25.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' HG23 ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 50.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 96' ' ' LYS . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 50.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 50.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 10.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 10.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.83 ' SG ' HD13 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 10.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 103' ' ' ILE . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 50.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 10.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 10.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 50.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 50.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 50.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 50.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 12.5 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 25.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 10.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 50.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 50.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 10.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 50.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 50.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 50.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 12.5 110.431 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.9900000000000002 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 3' ' ' VAL . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 50.0 110.302 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 50.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 50.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.724 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 9.6 t-20 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 12.5 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 50.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 50.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 50.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 50.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 50.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 50.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 50.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.666 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 50.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 50.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 50.0 110.203 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 50.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 50.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 50.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 50.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.829 ' HB3' HD21 ' A' ' 6' ' ' LEU . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 50.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 50.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 50.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 50.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 50.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 50.0 110.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 50.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 50.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 50.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 50.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 50.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 50.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 50.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 50.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 50.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 50.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 50.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 12.5 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.696 HG11 ' CD ' ' A' ' 106' ' ' PRO . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 10.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 50.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 25.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 10.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 10.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 10.0 110.194 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.824 HD13 ' HB ' ' A' ' 101' ' ' THR . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 10.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ILE . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 10.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 50.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 12.5 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 10.0 110.011 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 10.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 50.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 10.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 10.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 12.5 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 10.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 50.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 10.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HD13 ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 50.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 50.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 50.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 50.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 25.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 10.0 109.36 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 50.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 50.0 110.18 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 10.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 50.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 50.0 110.174 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.199 0.523 . . . . 12.5 109.817 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 10.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 50.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 50.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 10.0 109.863 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 12.5 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 50.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 25.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 50.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 50.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 50.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 10.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.824 ' HB ' HD13 ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 10.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 10.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 50.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 10.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.696 ' CD ' HG11 ' A' ' 42' ' ' VAL . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 50.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 50.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 50.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 108' ' ' ALA . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 12.5 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 25.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 10.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 50.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.724 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 50.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 10.0 109.916 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 50.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 50.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 50.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD12 ' OH ' ' A' ' 8' ' ' TYR . 55.9 tp . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 12.5 110.276 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.9900000000000002 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 50.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 50.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.864 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 50.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.584 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 12.5 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 50.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 50.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 50.0 109.765 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 50.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 50.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 50.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 50.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 23' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 50.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 50.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 50.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 50.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 50.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 50.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 50.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 50.0 110.231 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 50.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 50.0 110.275 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 50.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 50.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 50.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 50.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 50.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 50.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 50.0 109.396 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 50.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.584 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 50.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 50.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 10.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 50.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.811 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 50.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 12.5 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 10.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 50.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 25.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 10.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 10.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 10.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 10.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 10.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 50.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 12.5 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.811 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 10.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 10.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 50.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 10.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 10.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 12.5 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 10.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 50.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.245 0.545 . . . . 10.0 110.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 50.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 50.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 50.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 50.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 25.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 10.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 50.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 81' ' ' ASP . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 50.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 10.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 50.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 50.0 110.24 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.203 0.525 . . . . 12.5 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 10.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 50.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 50.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 10.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 12.5 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 50.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 25.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 50.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 50.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 50.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 10.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 10.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 10.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 50.0 110.063 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 10.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 50.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 50.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 50.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 50.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 12.5 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 25.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 10.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 50.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 50.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 10.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 50.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 50.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 50.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 12.5 110.088 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.9900000000000002 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.521 HG23 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.92 HG22 ' HB ' ' A' ' 111' ' ' VAL . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 50.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 50.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 50.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 12.5 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.538 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 50.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 50.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 23' ' ' LEU . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 50.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 50.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 50.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 50.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 50.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CB ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 50.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 50.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 50.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 50.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 50.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 50.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 50.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 50.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 50.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 50.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 50.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 50.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 50.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 50.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 50.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 50.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 50.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 50.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 50.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 50.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 50.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 50.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 12.5 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 51' ' ' ALA . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 10.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 50.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 25.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 10.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 10.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 10.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.621 HG21 ' HG ' ' A' ' 100' ' ' LEU . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 10.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 101' ' ' THR . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 10.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 50.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.726 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 12.5 110.479 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 10.0 110.382 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 10.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 50.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 10.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 10.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 12.5 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 10.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 50.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.765 ' CG ' ' HB3' ' A' ' 72' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.765 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 10.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.948 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 50.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 50.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 50.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 25.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 10.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 50.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.447 HD13 HD12 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 50.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 10.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.404 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 50.0 110.217 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 50.0 109.933 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.257 0.551 . . . . 12.5 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.61 ' O ' HG12 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 10.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 50.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 50.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 90' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 10.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 12.5 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 50.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 25.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 50.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 50.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 50.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 48' ' ' ILE . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 10.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.77 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 10.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.558 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 10.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' CYS . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 50.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 10.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 50.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 50.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 50.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 50.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.92 ' HB ' HG22 ' A' ' 3' ' ' VAL . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 12.5 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 25.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 10.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.766 ' N ' HD13 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 50.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 50.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 10.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 50.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 50.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 50.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 12.5 110.345 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HB ' ' A' ' 111' ' ' VAL . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 50.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 50.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 50.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 6' ' ' LEU . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 12.5 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 50.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 50.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 50.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HG ' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 50.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 50.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 50.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 50.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 50.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 50.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.766 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 50.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 50.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 50.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 50.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 50.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 50.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 6' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 50.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 50.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 50.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 50.0 110.083 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 50.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 50.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 50.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 50.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 50.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 50.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 50.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 50.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 50.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 50.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 10.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 50.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.618 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 50.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 12.5 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' CB ' ' A' ' 51' ' ' ALA . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 10.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 50.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 25.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 10.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 10.0 110.126 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 10.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 10.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' THR . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 10.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 50.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 12.5 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.618 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 10.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 10.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 50.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 10.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 12.5 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 10.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 50.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 44.0 Cg_endo . . . . . 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.347 0.594 . . . . 10.0 110.376 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 50.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 73' ' ' SER . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 50.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 97' ' ' ASP . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 50.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 50.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 25.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 50.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 50.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 10.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 50.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 50.0 110.165 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.302 0.572 . . . . 12.5 110.395 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.635 ' O ' HG12 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 10.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 50.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 50.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 10.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 12.5 110.03 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 25.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.623 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 50.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 50.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 50.0 110.463 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 10.0 110.059 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 10.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 10.0 110.123 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 50.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 10.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 10.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 50.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 50.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 50.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 50.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.801 ' HB ' HG22 ' A' ' 3' ' ' VAL . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 12.5 110.375 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 25.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 10.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 50.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 50.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 10.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 50.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 50.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 50.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 12.5 110.18 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.9900000000000002 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG23 ' HB ' ' A' ' 111' ' ' VAL . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 50.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 50.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 50.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.829 ' N ' HD12 ' A' ' 6' ' ' LEU . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 12.5 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CA ' HG22 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 50.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 50.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 50.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 50.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 50.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 50.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 50.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 50.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 50.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 50.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.463 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 50.0 110.323 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 50.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 50.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 50.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 50.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.731 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 50.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 50.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 50.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 50.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 50.0 110.043 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 50.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 50.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 50.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 50.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 50.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 50.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 50.0 109.685 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 50.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 50.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 50.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 10.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 50.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.693 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 50.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 12.5 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.695 HG11 ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 10.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 50.0 110.273 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 25.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 10.0 110.17 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 10.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 10.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 10.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 50.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 12.5 109.969 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.693 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 10.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 10.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 50.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 10.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 10.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 12.5 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 10.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 50.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.228 0.537 . . . . 10.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 50.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 50.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 97' ' ' ASP . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 50.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 50.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 25.0 110.308 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 10.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 50.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HD11 ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 50.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 10.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 50.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 50.0 110.139 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.201 0.524 . . . . 12.5 110.225 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 10.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 50.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 50.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 98' ' ' VAL . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 10.0 109.849 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 12.5 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 50.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 25.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.706 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 50.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.712 ' O ' HG22 ' A' ' 93' ' ' VAL . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 50.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 50.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.811 HD22 HG22 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 10.0 109.971 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 10.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 10.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.811 HG22 HD22 ' A' ' 100' ' ' LEU . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 109.911 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 10.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.695 ' HD3' HG11 ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.824 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 50.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 50.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 50.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 50.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' A' ' 108' ' ' ALA . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 12.5 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 25.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 10.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 50.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 50.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' HB3' ' CE1' ' A' ' 119' ' ' HIS . 3.0 m-20 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 10.0 110.074 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 50.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HE2' ' CD2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 50.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.534 ' CE1' ' HB3' ' A' ' 116' ' ' ASN . 26.9 m170 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 50.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 12.5 110.313 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.9900000000000002 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG22 ' HB ' ' A' ' 111' ' ' VAL . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 50.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 50.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 50.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 12.5 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 50.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 50.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 50.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 50.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 50.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 50.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 50.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 50.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 50.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 50.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 50.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 50.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 50.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 50.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 50.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 50.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 50.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 50.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 50.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 50.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 50.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 50.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 50.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 50.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 50.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 50.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 50.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 50.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 50.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 50.0 110.262 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 48' ' ' ILE . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 50.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 12.5 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 48' ' ' ILE . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 10.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 1' ' ' PRO . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 50.0 110.1 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 25.0 109.984 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 10.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 10.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 10.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.669 HG23 ' SD ' ' A' ' 40' ' ' MET . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 10.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.917 HD23 ' HB ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 10.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.677 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 50.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 12.5 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 10.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 10.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 50.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 10.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 12.5 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 10.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 50.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.711 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 10.0 110.76 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.616 ' O ' HD13 ' A' ' 74' ' ' ILE . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 50.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 97' ' ' ASP . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 50.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 50.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 50.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 25.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.81 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 10.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 50.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.756 HG21 ' HG2' ' A' ' 99' ' ' ARG . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 50.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 10.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 83' ' ' ASP . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 50.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 50.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.145 0.497 . . . . 12.5 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 10.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 50.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 50.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.653 HG21 ' NH2' ' A' ' 99' ' ' ARG . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 10.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 12.5 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 50.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 25.0 110.48 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.696 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 50.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 50.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.756 ' HG2' HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 50.0 110.23 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 10.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.917 ' HB ' HD23 ' A' ' 49' ' ' LEU . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 10.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.541 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 10.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.887 HG12 HD13 ' A' ' 113' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 50.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 10.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 50.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 50.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 50.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 50.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.836 ' HB ' HG22 ' A' ' 3' ' ' VAL . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 12.5 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 25.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.887 HD13 HG12 ' A' ' 103' ' ' ILE . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 10.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 50.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 50.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 10.0 109.884 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 50.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.431 ' CG ' ' HG2' ' A' ' 9' ' ' GLU . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 50.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.561 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 12.5 110.059 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.9900000000000002 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 39' ' ' THR . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 111' ' ' VAL . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 50.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 50.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.919 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 12.5 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 50.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 50.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 50.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 50.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 50.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 50.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 50.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 50.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.652 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 50.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' O ' HD21 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 50.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 50.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 50.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 50.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 50.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 50.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD2' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 50.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 50.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 50.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 50.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 50.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 50.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 50.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 50.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 50.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 50.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 50.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 50.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 50.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 50.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 2' ' ' THR . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 50.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.792 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 50.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 12.5 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 10.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 50.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 25.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 10.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 10.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 10.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 101' ' ' THR . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 10.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 10.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 50.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 12.5 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.792 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 10.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 10.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 50.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 10.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 12.5 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 10.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 50.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.3 Cg_endo . . . . . 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.208 0.528 . . . . 10.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' HD11 ' A' ' 113' ' ' ILE . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 50.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 50.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 50.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 50.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 25.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 10.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 50.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.836 HG23 ' C ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 50.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 10.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 50.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 50.0 110.184 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.208 0.528 . . . . 12.5 110.014 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 10.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 50.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 50.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 10.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 12.5 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 50.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HB3' HG23 ' A' ' 98' ' ' VAL . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 25.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 50.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 96' ' ' LYS . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 50.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' HG2' HD12 ' A' ' 80' ' ' ILE . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 50.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 10.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.794 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 10.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 10.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.591 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 50.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 10.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.836 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 10.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 50.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 50.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 50.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 12.5 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 25.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.641 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 10.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 50.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 50.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 10.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.741 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 50.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 50.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 50.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 12.5 110.379 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.405 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.9900000000000002 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 50.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.993 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 50.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 12.5 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 50.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 50.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 50.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 50.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 50.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 50.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 50.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 50.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.844 ' O ' HD11 ' A' ' 11' ' ' LEU . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 50.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 50.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 50.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 50.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 50.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 50.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 50.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.993 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 50.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 50.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 50.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 50.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 50.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 50.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 50.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 50.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 50.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' LEU . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 50.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 50.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 50.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 50.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 50.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 50.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 10.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 50.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.752 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 50.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 12.5 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 10.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 50.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 25.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 10.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 10.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 10.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.554 HG23 ' CE ' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 10.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 10.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 50.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 12.5 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HB2' ' HE1' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 10.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 10.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 50.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 10.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 10.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 12.5 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 10.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.607 ' HZ3' ' HG ' ' A' ' 73' ' ' SER . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 50.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.314 0.578 . . . . 10.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.607 ' HG ' ' HZ3' ' A' ' 59' ' ' TRP . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 50.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.689 HG23 ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 50.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 50.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 50.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 25.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 50.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 50.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 10.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 50.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.201 0.524 . . . . 12.5 110.264 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 10.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 50.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 50.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 10.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 12.5 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 50.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 25.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.863 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 50.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 50.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 50.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 10.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 10.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 49' ' ' LEU . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 10.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 50.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 10.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 50.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 50.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 50.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 50.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 12.5 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 25.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 73' ' ' SER . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 10.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 50.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 50.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 10.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 50.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 50.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 50.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 12.5 110.629 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.9900000000000002 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.414 HG23 HG22 ' A' ' 39' ' ' THR . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 50.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 50.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.83 HD21 ' HB3' ' A' ' 23' ' ' LEU . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 50.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 12.5 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 50.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 50.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 50.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 50.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 50.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 50.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 50.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 50.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 50.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.46 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 50.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 50.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 50.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 50.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.83 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 50.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 50.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 50.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 50.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 50.0 109.901 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 50.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 50.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 50.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 50.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 50.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 50.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 50.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 50.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 10.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 50.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 50.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 12.5 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 10.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 50.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 25.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 10.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 10.0 110.133 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 10.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.463 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 10.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 10.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 50.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 12.5 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 10.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 10.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 50.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 10.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 10.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 12.5 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 10.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CE3' HG21 ' A' ' 101' ' ' THR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 50.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.334 0.588 . . . . 10.0 110.699 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' HD13 ' A' ' 74' ' ' ILE . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 50.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 73' ' ' SER . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 50.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 50.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 50.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 25.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 10.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 50.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 48' ' ' ILE . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 50.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 10.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 50.0 110.015 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 50.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.18 0.514 . . . . 12.5 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' O ' HG12 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 10.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 50.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 50.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 10.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 12.5 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 50.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CB ' HG23 ' A' ' 98' ' ' VAL . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 25.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 50.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' CB ' ' A' ' 96' ' ' LYS . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 50.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 10.0 110.752 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.61 HG21 ' CE3' ' A' ' 59' ' ' TRP . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 10.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 10.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 50.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 10.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.454 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 50.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 50.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 50.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 50.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 108' ' ' ALA . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 12.5 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 25.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 10.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 6' ' ' LEU . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 50.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 50.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 10.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 50.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 50.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 50.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 12.5 110.072 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.9900000000000002 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 50.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 50.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 50.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 6' ' ' LEU . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 12.5 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.813 ' HB2' HG12 ' A' ' 114' ' ' VAL . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 50.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 50.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 50.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 50.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 50.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 50.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 50.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.855 ' CE3' HD22 ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 50.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 50.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 50.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 50.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 50.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 50.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 50.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.855 HD22 ' CE3' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 50.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HA ' HD22 ' A' ' 6' ' ' LEU . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 50.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 50.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 50.0 110.443 -179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 50.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 50.0 110.21 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 50.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 50.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 50.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 50.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 50.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 50.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 50.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.664 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 50.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 10.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 50.0 110.01 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 50.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 12.5 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 10.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 50.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 25.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 10.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 10.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 10.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 10.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 50.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 12.5 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 10.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 10.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 50.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 10.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 10.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 12.5 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 10.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 50.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo . . . . . 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.29 0.567 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.544 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 50.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 50.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 50.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 50.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 25.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 10.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 48' ' ' ILE . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 50.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 10.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 50.0 110.278 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 50.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 12.5 110.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 10.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 50.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 50.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.769 HG21 HH21 ' A' ' 99' ' ' ARG . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 10.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 12.5 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 50.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 25.0 110.664 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 50.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 99' ' ' ARG . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 50.0 110.329 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.769 HH21 HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 50.0 110.285 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 10.0 110.18 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.466 ' HA ' HD13 ' A' ' 48' ' ' ILE . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 10.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 10.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 50.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 10.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 50.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 50.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 50.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 50.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 108' ' ' ALA . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 12.5 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 25.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 10.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.813 HG12 ' HB2' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 50.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 50.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 10.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.671 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 50.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 50.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 34.5 m170 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 50.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 12.5 110.476 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.9900000000000002 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 111' ' ' VAL . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 50.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 50.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.869 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 50.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 12.5 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 50.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 50.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 50.0 110.09 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 50.0 109.653 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 50.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 50.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 50.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 50.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 50.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 50.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 50.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 50.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 50.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 50.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 50.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 50.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 50.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 50.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 50.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 50.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 50.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 50.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 50.0 110.377 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 50.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 50.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 50.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 50.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 50.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 10.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 50.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 50.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 12.5 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 51' ' ' ALA . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 10.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 25.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 10.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 10.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 10.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HA ' HG11 ' A' ' 42' ' ' VAL . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 10.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 10.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 50.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 12.5 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 10.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 10.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 50.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 10.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 12.5 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 10.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.979 0.419 . . . . 10.0 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.724 ' OG ' HD11 ' A' ' 113' ' ' ILE . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 50.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.71 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 50.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 50.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 25.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 10.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 50.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 ' HD3' ' A' ' 99' ' ' ARG . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 50.0 109.903 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 10.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 50.0 110.116 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 50.0 110.356 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.181 0.515 . . . . 12.5 110.14 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 10.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 50.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 50.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 10.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 12.5 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 50.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 25.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.595 ' HB2' HG23 ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 50.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 96' ' ' LYS . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 50.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.613 ' HD3' HD12 ' A' ' 80' ' ' ILE . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 50.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 103' ' ' ILE . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 10.0 110.26 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 10.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 10.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' C ' HD21 ' A' ' 100' ' ' LEU . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 50.0 110.273 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 10.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 10.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 50.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 50.0 110.382 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 50.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 50.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 3' ' ' VAL . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 12.5 110.181 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 25.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.724 HD11 ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 10.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.869 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 50.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 50.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 10.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 50.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 50.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 50.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 12.5 110.279 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.9900000000000002 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.901 HG22 ' HB ' ' A' ' 111' ' ' VAL . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 50.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 50.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 50.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.562 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 12.5 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 114' ' ' VAL . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 50.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 50.0 109.805 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 50.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 50.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 50.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 50.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 50.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 50.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 50.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 50.0 110.148 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 50.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 50.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 50.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 50.0 110.152 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 50.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 50.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 50.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 50.0 110.231 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 50.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 50.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 50.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 50.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 50.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 50.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 50.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 10.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 50.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 50.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 12.5 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 10.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 50.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 25.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 10.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 10.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 10.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.701 ' C ' HD23 ' A' ' 49' ' ' LEU . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 10.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 50.0 110.26 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 12.5 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 10.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 10.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 50.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 8.6 mm-40 -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 10.0 109.755 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 10.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 12.5 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 10.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 50.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.644 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.811 HG23 ' HB2' ' A' ' 97' ' ' ASP . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 50.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 50.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 50.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 25.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 50.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 50.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 105' ' ' SER . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 10.0 109.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 50.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 50.0 110.213 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.306 0.574 . . . . 12.5 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 10.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 50.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 50.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 10.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 12.5 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 50.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 25.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.811 ' HB2' HG23 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 50.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 74' ' ' ILE . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 50.0 110.633 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.607 HD22 ' CG2' ' A' ' 103' ' ' ILE . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 10.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 10.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 10.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.607 ' CG2' HD22 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 50.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 10.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 10.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD3' HG11 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.792 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 50.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 50.0 110.179 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 50.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 50.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.901 ' HB ' HG22 ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 12.5 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 25.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.715 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 10.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 6' ' ' LEU . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 50.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 10.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 50.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 50.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 56.3 m-70 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 50.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 12.5 110.277 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.9900000000000002 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 40' ' ' MET . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 111' ' ' VAL . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 50.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 50.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 50.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 12.5 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.595 ' CE2' HD12 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 50.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 50.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 50.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 50.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 50.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 50.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 50.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 50.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 50.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 50.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.439 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 50.0 110.848 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 50.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 50.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 50.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 50.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 50.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 50.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 50.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 50.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 50.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 50.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 50.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 50.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 50.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 50.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 50.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 50.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 50.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 50.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.514 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 50.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 10.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 50.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.695 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 50.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 12.5 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 10.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 50.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 25.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 10.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 10.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 10.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 106' ' ' PRO . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 10.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 10.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 50.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 12.5 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.695 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 10.0 110.084 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 10.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 50.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 10.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 10.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 12.5 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 10.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 50.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 46.0 Cg_endo -72.4 77.78 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -48.48 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 10.0 110.262 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.493 ' C ' ' S1 ' ' A' ' 130' ' ' FES . 15.2 t -85.12 43.61 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 10.0 110.229 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.1 OUTLIER -83.4 120.02 25.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.92 . . . . 10.0 110.113 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.51 172.48 8.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 10.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.86 117.33 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 10.0 110.136 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 99.66 93.16 2.08 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.449 -1.46 . . . . 10.0 109.449 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 66' ' ' GLY . . . 50.92 -179.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -1.164 . . . . 10.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 11.6 t -174.81 158.5 2.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 10.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' N ' ' SG ' ' A' ' 68' ' ' CYS . . . -171.04 33.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 25.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.8 m-20 -150.13 69.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 50.0 109.92 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 100' ' ' LEU . 34.2 m -60.98 -120.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 10.0 109.979 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . -173.28 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.843 -1.161 . . . . 10.0 110.423 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 50.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 73' ' ' SER . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 50.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 50.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 50.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 25.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 50.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 50.0 110.242 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 10.0 110.216 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 50.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -57.5 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 50.0 110.043 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -49.37 -179.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 50.0 110.183 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 158.41 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.021 . . . . 16.66 110.464 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -178.4 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 50.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.3 mm -61.46 -50.12 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 50.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.12 168.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 12.5 110.223 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.77 138.98 36.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 12.5 110.074 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 10.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 50.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 50.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 12.5 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 50.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 25.0 110.376 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.756 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 50.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 50.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 50.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 10.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 10.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' HA ' HD22 ' A' ' 49' ' ' LEU . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 10.0 110.086 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 50.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 10.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 10.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 50.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 50.0 110.09 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 50.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 50.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 78' ' ' GLY . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 12.5 110.507 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 25.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 50.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 50.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 10.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 50.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 50.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 50.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.595 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -41.76 152.67 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 12.5 110.442 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.65 -19.38 41.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 50.0 110.01 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -7.81 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 16.66 110.178 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLN . 1.3 mt -129.7 -29.71 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 50.0 110.533 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 127' ' ' VAL . 1.2 tt0 -42.41 -43.03 3.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 50.0 110.532 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -65.82 -37.07 85.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 50.0 110.493 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -89.53 24.65 2.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 50.0 110.347 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 25.4 t -73.45 -45.36 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.149 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' OXT' HG22 ' A' ' 128' ' ' ILE . 23.6 mm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.932 -1.032 . . . . 50.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.745 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.493 ' S1 ' ' C ' ' A' ' 62' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.9900000000000002 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 50.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 50.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 50.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 12.5 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 114' ' ' VAL . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 50.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 50.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 50.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 50.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 50.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 50.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 50.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 50.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 50.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 50.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 50.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 50.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 50.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.72 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 50.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 50.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 50.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 50.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 50.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 50.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 50.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 50.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 50.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 50.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 50.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 50.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 50.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 50.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.836 ' HE2' ' HB2' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 12.5 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.84 HG11 ' HD3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 10.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 50.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 25.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 10.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 10.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 10.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.512 HD13 ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 10.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.535 HD11 ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 10.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 50.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 12.5 110.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 10.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 10.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 50.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 10.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 10.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 12.5 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 10.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.027 ' HB3' HD11 ' A' ' 100' ' ' LEU . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 50.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 45.0 Cg_endo -72.69 74.21 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' CD2' HD11 ' A' ' 49' ' ' LEU . 7.7 p90 -100.98 156.84 17.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 10.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.39 82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 10.0 109.874 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 3.7 m -82.52 9.95 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.91 . . . . 10.0 110.204 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -53.39 -26.11 18.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 10.0 110.089 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 66' ' ' GLY . . . -72.83 137.04 45.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 10.0 110.043 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.81 123.36 4.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 52.72 94.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -1.117 . . . . 10.0 110.231 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.9 t -54.45 133.06 45.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 10.0 110.278 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.86 -64.86 1.02 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 25.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 38.3 p-10 -127.87 162.52 26.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 50.0 110.295 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 100' ' ' LEU . 61.3 m -104.9 -103.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 10.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CA ' ' HB3' ' A' ' 117' ' ' ALA . . . -179.53 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.819 -1.176 . . . . 10.0 110.535 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.998 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 50.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 50.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 50.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 50.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 25.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 10.0 109.474 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' C ' HD12 ' A' ' 80' ' ' ILE . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 50.0 110.113 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.887 HG12 HG21 ' A' ' 101' ' ' THR . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 50.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 10.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 50.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.03 153.22 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 50.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 42.3 mtm -62.71 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 50.0 110.227 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -156.04 -174.6 5.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 16.66 110.09 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -139.06 85.65 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 50.0 110.308 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 68' ' ' CYS . 20.4 mm -95.57 -4.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 50.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.83 163.62 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 12.5 110.129 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -104.27 157.58 17.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 12.5 110.282 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 10.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 50.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 50.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 10.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 12.5 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 50.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HG23 ' A' ' 98' ' ' VAL . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 25.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 50.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 96' ' ' LYS . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 50.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 50.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' A' ' 59' ' ' TRP . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 10.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 80' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 10.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 10.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 103' ' ' ILE . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 50.0 110.161 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 10.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 10.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.84 ' HD3' HG11 ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 50.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 50.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 50.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 50.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 12.5 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 25.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.998 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 10.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 113' ' ' ILE . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 50.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 50.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 10.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB3' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 50.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HA ' HD22 ' A' ' 123' ' ' LEU . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 50.0 110.114 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 50.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -42.9 127.69 4.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 12.5 110.31 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.78 -28.16 54.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 50.0 110.347 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.46 -28.55 52.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 16.66 110.428 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -87.37 -35.53 18.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 50.0 110.272 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' LEU . 3.0 mt-30 -44.29 -26.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 50.0 110.336 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.34 -47.2 72.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 50.0 110.281 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -49.27 -38.4 27.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 50.0 110.286 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.43 131.41 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 50.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.07 -0.967 . . . . 50.0 110.207 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.445 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.9900000000000002 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' A' ' 111' ' ' VAL . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 50.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 50.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.691 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 50.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 10' ' ' THR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 12.5 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 50.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 50.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 50.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 50.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 50.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 50.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 50.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 50.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 50.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 50.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 50.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 50.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 50.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 50.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 50.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 16' ' ' TRP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 50.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 50.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 50.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 50.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 50.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 50.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 50.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 50.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 50.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 50.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 50.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 50.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.665 ' CG2' HG22 ' A' ' 2' ' ' THR . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 50.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.68 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 50.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 12.5 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 10.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 50.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 25.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 10.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 10.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 10.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 10.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 10.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 50.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 12.5 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 10.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 10.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 50.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 10.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 10.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.727 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 12.5 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 10.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CZ3' HG21 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 50.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.98 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 46.8 Cg_endo -72.68 73.44 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.81 102.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.32 -0.863 . . . . 10.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 t -140.16 29.7 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 10.0 110.423 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -167.91 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 10.0 110.045 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' ALA . 3.2 tpp180 -164.15 39.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 10.0 110.377 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 64' ' ' ARG . . . 44.22 90.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 10.0 110.09 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.97 -100.63 0.62 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.176 -1.57 . . . . 10.0 109.176 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.61 168.86 12.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 10.0 109.996 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.5 t -155.9 -80.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 10.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 46.43 25.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 25.0 110.323 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.4 m-80 -127.69 1.66 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 50.0 110.229 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -58.29 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 10.0 110.195 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.98 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . . . -161.55 86.15 0.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.117 -0.99 . . . . 10.0 110.625 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.631 ' CB ' HD11 ' A' ' 113' ' ' ILE . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 50.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 50.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 50.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 50.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 25.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 50.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 99' ' ' ARG . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 50.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 10.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 50.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.24 164.71 2.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 50.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.58 119.92 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 50.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -172.12 -155.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 16.66 110.011 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -92.02 95.48 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 50.0 110.271 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pt -74.3 169.28 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 50.0 110.223 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.3 mt -84.69 -171.46 3.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 12.5 110.244 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m -110.5 144.22 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 12.5 110.219 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 10.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 50.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 50.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 10.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 12.5 110.192 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 25.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.727 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 50.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 50.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 50.0 109.876 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.43 HD22 ' S1 ' ' A' ' 130' ' ' FES . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 10.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.527 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 10.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 50.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 10.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 10.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 50.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 50.0 110.363 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 50.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 50.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 108' ' ' ALA . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 12.5 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 25.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 1.022 HD13 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 10.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 1.022 ' N ' HD13 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 50.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 50.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 10.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.67 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.708 ' N ' ' HB1' ' A' ' 72' ' ' ALA . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 50.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 50.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -44.15 138.77 2.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 12.5 110.264 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.43 -29.52 41.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 50.0 110.07 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -76.65 -12.79 60.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 16.66 110.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.09 -34.33 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.932 ' O ' HG22 ' A' ' 127' ' ' VAL . 41.2 tt0 -70.65 -25.32 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 50.0 110.34 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -63.68 -10.86 21.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 50.0 110.215 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -60.31 -30.93 69.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 50.0 110.228 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.932 HG22 ' O ' ' A' ' 124' ' ' GLN . 16.2 m -78.21 92.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 50.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.023 -0.989 . . . . 50.0 110.278 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.43 ' S1 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.9900000000000002 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 111' ' ' VAL . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.944 ' OE1' HG23 ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 50.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 50.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.839 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 50.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 12.5 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE1' HD12 ' A' ' 120' ' ' LEU . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 50.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 50.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 50.0 109.905 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 50.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 50.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 50.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 50.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 50.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 50.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 50.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 50.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 50.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 50.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 50.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 50.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 16' ' ' TRP . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 50.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 50.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 50.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 50.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 50.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 50.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 50.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 50.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 50.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 50.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 50.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 50.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 50.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 50.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.944 HG23 ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 50.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 50.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 12.5 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 10.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 50.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 25.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 10.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 10.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 80' ' ' ILE . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 10.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 10.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 50.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 12.5 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 10.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 50.0 110.16 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 10.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 10.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 12.5 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 10.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 50.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD3' HD21 ' A' ' 116' ' ' ASN . 44.1 Cg_endo -70.83 109.13 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.554 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 12.5 p90 -137.5 121.99 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 10.0 110.682 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 64' ' ' ARG . 2.3 p -138.93 43.87 2.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 10.0 109.793 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.429 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -48.33 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 10.0 110.556 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.699 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 31.1 ttt180 -178.59 161.58 1.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 10.0 110.29 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 69.24 -67.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.897 . . . . 10.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . 177.25 117.89 0.53 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . 64.79 -165.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 10.0 110.188 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 71' ' ' CYS . 78.9 m -150.09 77.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 10.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.67 -58.67 4.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 25.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -39.07 57.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 50.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 68' ' ' CYS . 20.3 t -66.53 96.89 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.922 . . . . 10.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -153.01 145.15 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.553 ' O ' HD13 ' A' ' 74' ' ' ILE . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 50.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 97' ' ' ASP . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 50.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 50.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 74' ' ' ILE . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 50.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 25.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 50.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 50.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 10.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 50.0 110.143 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.66 140.44 47.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 50.0 110.233 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.67 120.55 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 50.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.16 -56.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.895 . . . . 16.66 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.13 161.17 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 50.0 110.175 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 87' ' ' ILE . 16.6 tt -80.68 130.87 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 50.0 110.427 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD21 HD23 ' A' ' 100' ' ' LEU . 89.5 mt -139.46 143.08 37.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 12.5 109.879 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.82 133.64 55.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 12.5 110.373 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 10.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 50.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 50.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 10.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 12.5 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 50.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 25.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.731 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 50.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 50.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 50.0 110.259 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 88' ' ' LEU . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 10.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 99' ' ' ARG . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 10.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 10.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 50.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 10.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 10.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 50.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 50.0 110.04 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 50.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 50.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 3' ' ' VAL . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 12.5 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 25.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 10.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 50.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 50.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 10.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 50.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 50.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 50.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -42.67 132.1 3.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 12.5 110.146 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.04 -31.92 73.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 50.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.526 ' HB3' HD23 ' A' ' 120' ' ' LEU . 12.8 t80 -65.55 -15.4 62.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 16.66 110.045 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -108.58 -25.26 10.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 50.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.21 -25.31 66.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 50.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.0 -24.05 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 50.0 110.145 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -83.66 -33.79 25.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.231 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.77 109.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 50.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 126' ' ' ARG . 36.2 pt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.047 -0.978 . . . . 50.0 110.138 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.712 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.554 ' S2 ' ' HA ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 111' ' ' VAL . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 50.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 50.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 12.5 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 50.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 50.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 50.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 50.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 50.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 50.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 50.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 50.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.476 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 50.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 50.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 50.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 50.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 50.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CB ' HD11 ' A' ' 6' ' ' LEU . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 50.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 50.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 50.0 110.147 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 50.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 50.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 50.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 50.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 50.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 50.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 50.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 50.0 109.662 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 50.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.556 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 50.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 50.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 10.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 50.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.757 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 50.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 12.5 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' MET . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 10.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 25.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 10.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 10.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 10.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 10.0 110.087 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 71' ' ' CYS . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 10.0 110.342 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 50.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 12.5 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 10.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 10.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 50.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 10.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 12.5 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 50.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo -76.72 -179.72 5.64 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.73 172.5 7.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.355 -0.841 . . . . 10.0 109.972 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.8 -35.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 10.0 110.397 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 174.05 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -0.974 . . . . 10.0 110.122 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -127.88 20.1 6.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 10.0 110.316 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.06 132.5 54.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -0.871 . . . . 10.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.76 -177.9 49.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 79.39 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -1.19 . . . . 10.0 110.15 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.567 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 3.4 t -57.87 117.92 4.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 10.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.76 -58.46 1.67 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 25.0 110.288 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' TRP . 2.8 p30 -159.0 103.69 1.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 50.0 110.148 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.525 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER 175.41 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 10.0 110.188 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.37 108.42 2.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 10.0 109.937 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 50.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 50.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 50.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HE3' ' HG3' ' A' ' 18' ' ' MET . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 50.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 25.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 10.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 50.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 50.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 10.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 50.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.21 176.93 4.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 50.0 110.359 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.454 ' O ' ' OE1' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -74.3 157.89 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 50.0 110.27 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -164.07 173.61 12.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 16.66 110.211 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 -4.51 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 50.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 87' ' ' ILE . 4.0 tp -94.6 14.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 50.0 110.305 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.47 142.04 32.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 12.5 109.972 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -135.89 123.36 22.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 12.5 110.379 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 10.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 50.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 50.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 10.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 12.5 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 50.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 25.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.868 ' O ' HG12 ' A' ' 75' ' ' VAL . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 50.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' VAL . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 50.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 50.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.44 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 10.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 10.0 110.275 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 10.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 50.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 10.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 50.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 50.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 50.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 50.0 109.899 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 12.5 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 25.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.751 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 10.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 50.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 50.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 10.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 50.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 50.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 50.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -41.69 113.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 12.5 110.359 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 0.9 OUTLIER -61.83 -30.2 70.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 50.0 110.015 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.99 -21.2 28.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 16.66 109.917 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.38 -20.68 12.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -0.819 . . . . 50.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -57.78 -33.18 68.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 50.0 110.305 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.0 -18.49 65.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 50.0 110.104 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -85.4 -14.68 45.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 50.0 110.324 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 124' ' ' GLN . 8.5 p -54.53 -23.0 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 50.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 128' ' ' ILE . 9.7 pt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.064 -0.969 . . . . 50.0 110.278 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.567 ' S2 ' ' HA ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.9900000000000002 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 50.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 50.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.589 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 50.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 12.5 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 50.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 50.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 50.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' TRP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 50.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 50.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 50.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 50.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.839 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 50.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.494 ' CA ' HD11 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 50.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.421 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 50.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 50.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 50.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 50.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 50.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 50.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 50.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 50.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 50.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 50.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 50.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 50.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 50.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 50.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 50.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 50.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 50.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 50.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 50.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 50.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 12.5 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 10.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 50.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 25.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 10.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' CD ' ' A' ' 50' ' ' GLU . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 10.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 10.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 10.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 102' ' ' CYS . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 10.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 49' ' ' LEU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 50.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 12.5 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 10.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 10.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 50.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 10.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 12.5 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 10.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 50.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 45.5 Cg_endo -72.1 -172.54 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 5.2 t80 67.97 147.43 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 10.0 110.383 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -178.44 122.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 10.0 110.043 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.6 65.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 10.0 110.415 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' SER . 31.2 ttm-85 62.32 14.75 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 10.0 110.364 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.63 -162.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 10.0 110.063 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -89.33 1.0 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.93 8.62 18.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 10.0 110.396 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 148.03 38.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 10.0 110.174 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.73 -89.7 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 25.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.544 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 5.0 p30 179.53 156.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 50.0 110.218 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 2.5 p -167.38 131.5 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.97 . . . . 10.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . 176.68 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 10.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 50.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 50.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 97' ' ' ASP . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 50.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 25.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.684 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.896 ' HG2' ' HB2' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 50.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 50.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 10.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 50.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -46.08 162.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 50.0 109.973 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 1.3 mmt -64.09 145.14 56.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 50.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.7 mt-30 -178.19 -36.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 16.66 110.172 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.1 129.65 34.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 50.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -46.58 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 50.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.62 178.87 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 12.5 110.026 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t -155.45 163.17 40.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 12.5 110.324 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 10.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 50.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 50.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 10.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 12.5 109.537 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 50.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 25.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 50.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 50.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 10.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 48' ' ' ILE . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 10.0 110.152 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.887 ' HA ' HD23 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 10.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 103' ' ' ILE . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 10.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 10.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 50.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 50.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 50.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 50.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 12.5 110.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 77' ' ' GLU . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 25.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 10.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 50.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 50.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 10.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.862 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 50.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 50.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 50.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -46.48 143.11 2.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 12.5 110.408 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -45.53 71.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 50.0 110.289 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.6 -25.68 18.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 16.66 109.582 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -92.61 -35.81 13.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 50.0 109.921 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -43.74 97.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 110.142 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.18 -9.86 44.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.493 -0.755 . . . . 50.0 110.09 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.14 8.01 38.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 50.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.04 136.51 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.234 -0.916 . . . . 50.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.963 -1.018 . . . . 50.0 110.152 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.544 ' S2 ' ' HA ' ' A' ' 70' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.9900000000000002 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' CG2' ' A' ' 39' ' ' THR . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 111' ' ' VAL . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' N ' HG12 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 50.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 50.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 50.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.712 ' ND2' ' CE1' ' A' ' 115' ' ' TYR . 4.8 t-20 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 12.5 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 50.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 50.0 109.824 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 50.0 109.429 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.015 HD21 ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 50.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 50.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 50.0 109.858 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' OE1' HD21 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 50.0 109.975 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 50.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.729 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 50.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 1.015 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 50.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.596 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 50.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 50.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 50.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 50.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 50.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 50.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CD1' HD12 ' A' ' 6' ' ' LEU . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 50.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 50.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 50.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 50.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 37' ' ' TYR . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 50.0 109.91 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 50.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 50.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 50.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD21 ' OE1' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 50.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 50.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 50.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 50.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 50.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 50.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 10.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.52 ' CG2' HG23 ' A' ' 2' ' ' THR . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 50.0 110.136 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.918 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 50.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 12.5 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 10.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 50.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 25.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 10.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 10.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 10.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.758 HG23 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 10.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 10.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 50.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 12.5 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.918 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 10.0 110.319 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 10.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 50.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 10.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 10.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 12.5 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 10.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 50.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 43.8 Cg_endo -70.61 101.22 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -69.09 72.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.88 . . . . 10.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 p -85.98 5.56 32.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 10.0 110.118 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.92 104.74 16.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 10.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 77.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 10.0 110.252 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.77 -40.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 10.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.12 -14.12 6.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.321 -1.512 . . . . 10.0 109.321 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.6 109.08 4.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -1.106 . . . . 10.0 109.915 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.4 t -142.98 148.7 37.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 10.0 110.217 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.75 10.99 1.61 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 25.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -145.76 141.19 27.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 50.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 100' ' ' LEU . 15.3 m -116.2 -136.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 10.0 110.106 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -144.25 58.58 1.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 10.0 110.556 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.591 ' CB ' HD11 ' A' ' 113' ' ' ILE . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 50.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 50.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.663 ' CA ' HD12 ' A' ' 113' ' ' ILE . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 50.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 50.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 25.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 10.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 50.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 50.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 10.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 50.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.43 175.58 0.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 50.0 110.542 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ttp -79.98 85.25 5.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 50.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -173.13 -153.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.957 . . . . 16.66 110.42 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -148.26 -87.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 50.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 19.5 mt 56.54 170.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 50.0 110.662 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 13.5 mt 61.16 177.68 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 12.5 110.423 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -133.19 156.74 46.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.361 -0.837 . . . . 12.5 110.0 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 10.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 50.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 50.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 98' ' ' VAL . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 10.0 109.786 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 12.5 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 50.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 25.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.631 ' HB2' HG23 ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 50.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 50.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 10.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 10.0 110.153 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 10.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 10.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 10.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 50.0 110.188 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.606 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 50.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 50.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 50.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' HG22 ' A' ' 3' ' ' VAL . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 12.5 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 25.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.663 HD12 ' CA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 10.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 50.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.712 ' CE1' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 50.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 10.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.594 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 50.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.639 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 50.0 110.12 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.593 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 50.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' OH ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -43.56 141.1 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 12.5 110.25 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.75 -28.95 52.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 50.0 110.29 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -72.29 -10.93 60.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 16.66 110.004 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -113.43 -37.94 4.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 50.0 110.13 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -57.06 -31.13 64.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 50.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' ARG . 2.2 m-20 -45.27 -38.35 5.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 50.0 109.891 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.98 -37.95 3.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 50.0 110.033 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 128' ' ' ILE . 70.0 t -58.86 -73.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 50.0 110.234 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 127' ' ' VAL . 1.2 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 50.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.9900000000000002 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 50.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 50.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.703 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 50.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 12.5 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 50.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 50.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 50.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 50.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 50.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 50.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 50.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 50.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 50.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 50.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 50.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 50.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 50.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 50.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 50.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 50.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE2' HD12 ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 50.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 50.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 50.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 50.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 50.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 50.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 50.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 50.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 50.0 109.394 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 50.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 50.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 50.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 50.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.727 ' HE3' HG23 ' A' ' 48' ' ' ILE . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 12.5 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' CB ' ' A' ' 51' ' ' ALA . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 10.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 50.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 25.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 10.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 10.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.727 HG23 ' HE3' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 10.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.83 HD13 ' SG ' ' A' ' 102' ' ' CYS . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 10.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 50.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 12.5 109.742 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 10.0 109.856 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 10.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 50.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 10.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 12.5 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 10.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.604 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 50.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 47.1 Cg_endo -73.85 156.94 48.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 27.5 p90 -134.26 106.25 7.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 10.0 109.988 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -94.08 1.91 56.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 10.0 110.443 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.8 m -68.61 -175.4 0.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 10.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 6.0 ttt180 -137.74 56.64 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 10.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 65.01 -173.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 10.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.87 -170.18 2.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.32 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 10.0 110.398 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 110.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 10.0 110.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.1 -91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 25.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.74 157.51 42.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 50.0 110.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -144.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 10.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -146.35 91.47 2.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 10.0 110.847 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 50.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 73' ' ' SER . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 50.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 50.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 50.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 25.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 50.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 50.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 10.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 50.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -74.9 152.67 38.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 50.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.43 98.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 50.0 110.267 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -157.08 163.6 38.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.868 . . . . 16.66 110.111 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.26 114.55 28.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 50.0 110.206 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -149.96 152.99 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 50.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' A' ' 98' ' ' VAL . 3.4 tp 53.09 -174.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 12.5 110.116 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t -124.94 153.51 42.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 12.5 110.096 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 10.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 50.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 50.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 10.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 12.5 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 50.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 25.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' HG23 ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 50.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 96' ' ' LYS . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 50.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 50.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 10.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 10.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.83 ' SG ' HD13 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 10.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 103' ' ' ILE . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 50.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 10.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 10.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 50.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 50.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 50.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 50.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 12.5 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 25.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 10.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 50.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 50.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 10.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 50.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 50.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 50.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -42.16 130.37 3.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 12.5 110.431 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -41.55 87.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 50.0 109.935 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 16.9 t80 -70.23 -6.29 33.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 16.66 110.0 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.42 -8.07 5.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.903 . . . . 50.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 1.008 ' O ' HG22 ' A' ' 127' ' ' VAL . 7.5 mt-30 -54.75 -23.38 17.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 50.0 110.376 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -42.04 -33.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 50.0 110.487 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.9 -38.19 7.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.947 . . . . 50.0 110.256 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 124' ' ' GLN . 34.4 m -60.99 161.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 50.0 110.205 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.966 -1.016 . . . . 50.0 110.117 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.749 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.9900000000000002 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 3' ' ' VAL . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 50.0 110.302 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 50.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 50.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.724 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 9.6 t-20 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 12.5 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 50.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 50.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 50.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 50.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 50.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 50.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 50.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.666 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 50.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 50.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 50.0 110.203 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 50.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 50.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 50.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 50.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.829 ' HB3' HD21 ' A' ' 6' ' ' LEU . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 50.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 50.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 50.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 50.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 50.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 50.0 110.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 50.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 50.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 50.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 50.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 50.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 50.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 50.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 50.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 50.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 50.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 50.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 12.5 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG11 ' CD ' ' A' ' 106' ' ' PRO . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 10.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 50.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 25.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 10.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 10.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 10.0 110.194 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.824 HD13 ' HB ' ' A' ' 101' ' ' THR . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 10.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.637 HD22 ' S1 ' ' A' ' 130' ' ' FES . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 10.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 50.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 12.5 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 10.0 110.011 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 10.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 50.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 10.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 10.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 12.5 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 10.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 50.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo -72.56 148.03 46.98 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 62.84 171.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 10.0 110.237 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 0.6 OUTLIER -143.57 -166.73 2.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.928 . . . . 10.0 110.295 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 62' ' ' SER . 27.7 m -154.51 64.36 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 10.0 110.402 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -108.11 -21.31 12.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 10.0 110.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.78 -31.88 3.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 10.0 110.146 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.13 159.48 17.2 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -179.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -1.144 . . . . 10.0 110.429 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -89.47 81.43 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 10.0 110.289 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.17 32.35 1.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.91 . . . . 25.0 110.084 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 81.0 m-20 -120.72 -126.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 50.0 110.074 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 70' ' ' ASN . 29.1 m 57.0 173.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 10.0 110.417 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -168.81 117.18 0.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 10.0 109.983 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HD13 ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 50.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 50.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 50.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 50.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 25.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 10.0 109.36 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 50.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 50.0 110.18 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 10.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 50.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.28 156.78 27.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 50.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.68 126.09 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 50.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.78 128.1 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 16.66 110.041 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -100.5 67.33 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 50.0 110.317 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -111.61 -17.75 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 50.0 110.139 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 93' ' ' VAL . 1.2 pp -111.02 174.58 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 12.5 110.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -111.03 121.54 45.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 12.5 109.817 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 10.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 50.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 50.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 88' ' ' LEU . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 10.0 109.863 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 12.5 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 50.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 25.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 50.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 50.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 50.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 10.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.824 ' HB ' HD13 ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 10.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 10.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 50.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 10.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.696 ' CD ' HG11 ' A' ' 42' ' ' VAL . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 50.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 50.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 50.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 108' ' ' ALA . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 12.5 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 25.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 10.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 50.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.724 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 50.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 10.0 109.916 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 50.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 50.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.533 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 50.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 123' ' ' LEU . 55.9 tp -49.71 116.17 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 12.5 110.276 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -45.51 -35.63 3.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 50.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -30.73 69.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 16.66 110.164 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.74 HD12 HD23 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -97.93 -26.32 14.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 50.0 110.165 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 mt-30 -70.11 -23.16 62.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 50.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.98 -5.42 17.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 50.0 110.646 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -82.73 4.98 22.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 50.0 110.376 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 124' ' ' GLN . 24.9 m -79.83 170.94 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 50.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.99 -1.005 . . . . 50.0 110.211 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.637 ' S1 ' HD22 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.9900000000000002 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 50.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 50.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.864 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 50.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.584 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 12.5 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 50.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 50.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 50.0 109.765 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 50.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 50.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 50.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 50.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 23' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 50.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 50.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 50.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 50.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 50.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 50.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 50.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 50.0 110.231 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 50.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 50.0 110.275 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 50.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 50.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 50.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 50.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 50.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 50.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 50.0 109.396 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 50.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.584 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 50.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 50.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 10.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 50.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.811 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 50.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 12.5 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 10.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 50.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 25.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 10.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 10.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 10.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 10.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 10.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 50.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 12.5 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.811 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 10.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 10.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 50.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 10.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 10.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 12.5 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 10.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 50.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 42.2 Cg_endo -69.36 124.2 11.01 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.644 ' HB3' ' S2 ' ' A' ' 130' ' ' FES . 12.1 m-85 52.45 174.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 10.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -145.46 65.07 1.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 10.0 110.201 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 m -42.62 137.49 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 10.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 -69.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 10.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.0 -2.21 21.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 10.0 110.573 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.03 149.39 21.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . . . -86.04 159.87 19.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -1.154 . . . . 10.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 28.1 p -108.09 40.06 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 10.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 67.77 71.76 0.33 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 25.0 110.238 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 88' ' ' LEU . 1.2 m-20 66.01 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 50.0 110.458 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 10.0 109.996 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -145.39 80.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 10.0 110.424 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 50.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 50.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 50.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 50.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 25.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 10.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 50.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 81' ' ' ASP . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 50.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 10.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 50.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 84' ' ' MET . 27.0 t0 -71.64 167.44 19.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 50.0 110.24 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.435 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -43.78 134.67 4.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 50.0 109.892 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.51 ' OE1' HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -155.39 151.03 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 16.66 110.375 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.14 60.74 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 50.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.57 -61.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.846 . . . . 50.0 110.219 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 0.5 OUTLIER -58.95 157.2 10.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 12.5 110.063 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.48 140.97 29.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 12.5 110.267 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 10.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 50.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 50.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 10.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 12.5 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 50.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 25.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 50.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 50.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 50.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 10.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 10.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 10.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 50.0 110.063 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 10.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 50.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 50.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 50.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 50.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 12.5 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 25.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 10.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 50.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 50.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 10.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 50.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 123' ' ' LEU . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 50.0 110.021 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 50.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -52.32 154.27 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 12.5 110.088 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 122' ' ' TYR . 7.2 p30 -61.77 -12.43 16.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 50.0 110.382 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 27.2 t80 -71.02 -26.4 63.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 16.66 110.308 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 118' ' ' LYS . 3.0 mt -110.34 -33.46 6.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 50.0 110.305 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 50.0 110.193 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -6.59 35.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 50.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 123' ' ' LEU . 2.3 ttt180 -82.88 -19.5 37.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 50.0 110.204 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.5 t -71.72 156.85 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 50.0 110.285 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 128' ' ' ILE . 18.9 mm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 50.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.644 ' S2 ' ' HB3' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.9900000000000002 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.521 HG23 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.92 HG22 ' HB ' ' A' ' 111' ' ' VAL . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 50.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 50.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 50.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 12.5 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.538 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 50.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 50.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 23' ' ' LEU . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 50.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 50.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 50.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 50.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 50.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CB ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 50.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 50.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 50.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 50.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 50.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 50.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 50.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 50.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 50.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 50.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 50.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 50.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 50.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 50.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 50.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 50.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 50.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 50.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 50.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 50.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 50.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 50.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 12.5 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 51' ' ' ALA . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 10.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 50.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 25.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 10.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 10.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 10.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.621 HG21 ' HG ' ' A' ' 100' ' ' LEU . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 10.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 101' ' ' THR . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 10.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 50.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.726 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 12.5 110.479 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 10.0 110.382 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 10.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 50.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 10.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 10.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 12.5 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 10.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 50.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.765 ' CG ' ' HB3' ' A' ' 72' ' ' ALA . 45.5 Cg_endo -75.14 71.64 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 35.3 p90 -107.94 -163.18 0.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 10.0 110.15 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER 68.63 18.98 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 10.0 110.559 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 19.0 p -70.65 64.74 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 10.0 110.195 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 62' ' ' SER . 1.9 mmp_? -72.12 -15.11 61.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.85 . . . . 10.0 110.038 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.82 -179.72 8.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 10.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 67' ' ' ALA . . . 95.4 -94.09 1.67 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . 177.15 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 10.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 51.8 t -133.17 -91.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 10.0 109.923 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 58.18 13.23 2.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.042 . . . . 25.0 110.759 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.48 ' O ' ' CG1' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -154.49 17.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 50.0 110.438 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.606 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 5.5 m 42.51 -139.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.863 . . . . 10.0 110.065 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.765 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . -167.8 72.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.01 -1.056 . . . . 10.0 110.565 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.948 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 50.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 50.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 50.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 25.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 10.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 50.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.447 HD13 HD12 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 50.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 10.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 50.0 110.217 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -117.21 177.57 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 50.0 109.933 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.3 ttp -61.22 108.59 0.93 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.12 -0.988 . . . . 50.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -177.75 131.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 16.66 110.292 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.1 tp60 66.05 -149.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 50.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ILE . 6.3 tp -139.47 131.72 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 50.0 110.287 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.95 142.75 18.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 12.5 109.945 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p -130.17 153.59 48.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 12.5 110.326 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.61 ' O ' HG12 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 10.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 50.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 50.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 90' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 10.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 12.5 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 50.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 25.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 50.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 50.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 50.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 48' ' ' ILE . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 10.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.77 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 10.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.558 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 10.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' CYS . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 50.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 10.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 50.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 50.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 50.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 50.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.92 ' HB ' HG22 ' A' ' 3' ' ' VAL . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 12.5 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 25.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 10.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.766 ' N ' HD13 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 50.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 50.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 10.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 50.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 50.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 50.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -40.81 138.15 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 12.5 110.345 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.76 42.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 50.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.79 -30.49 68.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 16.66 109.799 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.9 mm? -84.59 -35.06 23.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 50.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -63.65 -23.72 67.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 50.0 110.133 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.59 -25.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.893 . . . . 50.0 110.283 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' VAL . 52.2 mtt180 -129.5 56.49 1.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 50.0 110.259 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 127' ' ' VAL . 2.3 m -44.48 153.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 50.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.98 -1.01 . . . . 50.0 110.283 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.606 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HB ' ' A' ' 111' ' ' VAL . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 50.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 50.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 50.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 6' ' ' LEU . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 12.5 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 50.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 50.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 50.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HG ' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 50.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 50.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 50.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 50.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 50.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 50.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.766 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 50.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 50.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 50.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 50.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 50.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 50.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 6' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 50.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 50.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 50.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 50.0 110.083 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 50.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 50.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 50.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 50.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 50.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 50.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 50.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 50.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 50.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 50.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 10.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 50.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.618 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 50.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 12.5 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' CB ' ' A' ' 51' ' ' ALA . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 10.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 50.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 25.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 10.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 10.0 110.126 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 10.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 10.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' THR . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 10.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 50.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 12.5 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.618 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 10.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 10.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 50.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 10.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 12.5 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 10.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 50.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 44.0 Cg_endo -70.36 89.89 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.85 72.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 10.0 110.399 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 60' ' ' PRO . 9.4 t -79.47 -0.29 32.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 10.0 110.069 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 151.48 13.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 10.0 110.28 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -117.35 -48.55 2.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 10.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.76 88.55 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.958 . . . . 10.0 110.299 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 64.47 113.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HB1' HE22 ' A' ' 86' ' ' GLN . . . 55.03 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -1.095 . . . . 10.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.8 p -170.93 33.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 10.0 110.223 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 55.33 96.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 25.0 109.983 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.499 HD21 HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER 57.95 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 50.0 109.86 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.9 m -106.83 -78.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 10.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' CYS . . . 174.28 88.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.018 . . . . 10.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 50.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 73' ' ' SER . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 50.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 97' ' ' ASP . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 50.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 50.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 25.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 50.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 50.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 10.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 50.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 84' ' ' MET . 4.4 m-20 -93.54 166.69 12.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 50.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.475 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.5 ptt? -43.41 119.87 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 50.0 110.23 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -153.99 -61.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 16.66 110.278 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.571 HE22 ' HB1' ' A' ' 67' ' ' ALA . 1.3 mt-30 -148.22 149.38 31.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 50.0 110.292 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 mm -70.73 146.95 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 50.0 110.422 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 70' ' ' ASN . 0.0 OUTLIER -133.12 146.07 51.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 12.5 109.674 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.19 128.41 53.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 12.5 110.395 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.635 ' O ' HG12 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 10.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 50.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 50.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 10.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 12.5 110.03 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 25.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.623 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 50.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 50.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' CA ' ' OD1' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 50.0 110.463 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 10.0 110.059 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 10.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 10.0 110.123 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 50.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 10.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 10.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 50.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 50.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 50.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 50.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.801 ' HB ' HG22 ' A' ' 3' ' ' VAL . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 12.5 110.375 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 25.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 10.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 50.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 50.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 10.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 50.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 50.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 50.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -48.61 123.01 6.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 12.5 110.18 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.51 -27.61 65.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 50.0 110.451 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.717 ' HB3' HD23 ' A' ' 120' ' ' LEU . 33.6 t80 -64.34 -12.14 39.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 16.66 110.06 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.6 -40.58 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 50.0 110.173 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.28 -12.59 42.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 50.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -56.34 -25.55 49.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 50.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 128' ' ' ILE . 6.2 ttp180 -100.75 32.99 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 50.0 110.219 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 p -47.24 153.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 50.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 126' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.11 -0.947 . . . . 50.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ACE . . . . . 0.409 ' O ' ' HD3' ' A' ' 118' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.9900000000000002 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG23 ' HB ' ' A' ' 111' ' ' VAL . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 50.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 50.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 50.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.829 ' N ' HD12 ' A' ' 6' ' ' LEU . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 12.5 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CA ' HG22 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 50.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 50.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 50.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 50.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 50.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 50.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 50.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 50.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 50.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 50.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.463 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 50.0 110.323 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 50.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 50.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 50.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 50.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.731 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 50.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 50.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 50.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 50.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 50.0 110.043 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 50.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 50.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 50.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 50.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 50.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 50.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 50.0 109.685 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 50.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 50.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 50.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 10.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 50.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.693 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 50.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 12.5 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.695 HG11 ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 10.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 50.0 110.273 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 25.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 10.0 110.17 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 10.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 10.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 10.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 50.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 12.5 109.969 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.693 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 10.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 10.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 50.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 10.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 10.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 12.5 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 10.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 50.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.56 141.39 31.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.63 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER 47.54 79.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 10.0 110.493 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 2.3 p -59.19 -178.19 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 10.0 110.232 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.68 40.09 3.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 10.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -88.66 -41.89 12.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 10.0 110.319 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.22 90.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 10.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 179.15 33.16 0.06 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' GLY . . . 43.42 37.36 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 10.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 41.3 t -59.22 -84.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 10.0 110.282 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 49.41 36.29 9.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 25.0 110.109 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -172.95 109.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 50.0 110.199 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -177.07 3.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 10.0 110.279 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -131.57 111.0 11.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 10.0 110.301 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 50.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 50.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 97' ' ' ASP . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 50.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 50.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 25.0 110.308 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 10.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 50.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HD11 ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 50.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 10.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 50.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 153.34 31.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 50.0 110.139 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 17.8 mtp -56.5 125.06 20.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 50.0 110.309 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.464 ' HG2' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -162.84 130.8 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 16.66 110.102 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 66.03 4.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 50.0 110.369 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.464 HG12 ' HG2' ' A' ' 85' ' ' GLN . 1.4 pp -136.05 32.17 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 50.0 110.002 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 172.88 16.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 12.5 110.034 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.08 135.23 35.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 12.5 110.225 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 10.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 50.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 50.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 98' ' ' VAL . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 10.0 109.849 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 12.5 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 50.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 25.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.706 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 50.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.712 ' O ' HG22 ' A' ' 93' ' ' VAL . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 50.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 50.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.811 HD22 HG22 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 10.0 109.971 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 10.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 10.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.811 HG22 HD22 ' A' ' 100' ' ' LEU . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 109.911 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 10.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.695 ' HD3' HG11 ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.824 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 50.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 50.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 50.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 50.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' A' ' 108' ' ' ALA . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 12.5 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 25.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 10.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 50.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 50.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.575 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 3.0 m-20 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 10.0 110.074 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 50.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 50.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 50.5 m-70 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 50.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.43 135.37 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 12.5 110.313 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 23.7 p-10 -67.37 -10.25 49.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 50.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -79.9 -42.49 24.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.912 . . . . 16.66 110.369 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -19.33 32.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.322 -0.861 . . . . 50.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -67.52 -29.89 69.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 50.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -55.35 -19.84 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 50.0 109.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.37 -16.99 62.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 50.0 110.164 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.08 168.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.313 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.016 -0.992 . . . . 50.0 110.152 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.66 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.63 ' S1 ' ' O ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.9900000000000002 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG22 ' HB ' ' A' ' 111' ' ' VAL . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 50.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 50.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 50.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 12.5 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 50.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 50.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 50.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 50.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 50.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 50.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 50.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 50.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 50.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 50.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 50.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 50.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 50.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 50.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 50.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 50.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 50.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 50.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 50.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 50.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 50.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 50.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 50.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 50.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 50.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 50.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 50.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 50.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 50.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 50.0 110.262 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 48' ' ' ILE . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 50.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 12.5 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 48' ' ' ILE . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 10.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 1' ' ' PRO . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 50.0 110.1 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 25.0 109.984 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 10.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 10.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 10.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.669 HG23 ' SD ' ' A' ' 40' ' ' MET . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 10.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.917 HD23 ' HB ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 10.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.677 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 50.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 12.5 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 10.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 10.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 50.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 10.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 12.5 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 10.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.661 ' HB3' ' S1 ' ' A' ' 130' ' ' FES . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 50.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 46.3 Cg_endo -73.33 176.39 9.28 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 2.8 t80 66.93 165.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.816 . . . . 10.0 110.419 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 m -74.22 54.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 10.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 10.0 110.169 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.1 148.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.31 -0.869 . . . . 10.0 110.445 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 44.64 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 10.0 110.443 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.1 -157.98 14.84 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.455 -1.458 . . . . 10.0 109.455 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.64 163.6 25.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 10.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.74 128.18 36.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 10.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.39 -16.91 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 25.0 109.919 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -161.5 63.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 50.0 110.139 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' ARG . 44.7 t -44.8 165.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.241 -0.912 . . . . 10.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.711 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -124.41 90.46 3.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 10.0 110.76 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.616 ' O ' HD13 ' A' ' 74' ' ' ILE . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 50.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 97' ' ' ASP . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 50.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 50.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 50.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 25.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.81 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 10.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 50.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.756 HG21 ' HG2' ' A' ' 99' ' ' ARG . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 50.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 10.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 83' ' ' ASP . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 50.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 -61.84 165.43 5.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 50.0 110.151 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.49 144.9 55.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.972 . . . . 50.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 86' ' ' GLN . 38.5 tt0 -174.94 141.27 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 16.66 110.31 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 85' ' ' GLN . 3.3 tt0 44.09 -168.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 50.0 110.468 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 88' ' ' LEU . 4.4 mt -69.11 -83.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 50.0 110.059 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.666 ' N ' HG22 ' A' ' 87' ' ' ILE . 0.5 OUTLIER 65.06 167.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.185 -0.947 . . . . 12.5 110.22 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 145.03 2.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 12.5 110.239 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 10.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 50.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 50.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.653 HG21 ' NH2' ' A' ' 99' ' ' ARG . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 10.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 12.5 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 50.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 25.0 110.48 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.696 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 50.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 50.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.756 ' HG2' HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 50.0 110.23 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 10.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.917 ' HB ' HD23 ' A' ' 49' ' ' LEU . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 10.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 10.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.887 HG12 HD13 ' A' ' 113' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 50.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 10.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 50.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 50.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 50.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 50.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.836 ' HB ' HG22 ' A' ' 3' ' ' VAL . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 12.5 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 25.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.887 HD13 HG12 ' A' ' 103' ' ' ILE . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 10.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 50.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 50.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 10.0 109.884 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 50.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.431 ' CG ' ' HG2' ' A' ' 9' ' ' GLU . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 50.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.561 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt -46.89 120.61 3.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 12.5 110.059 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -65.46 -19.81 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 50.0 110.372 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 29.1 t80 -79.52 -12.52 59.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 16.66 110.276 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.28 -32.78 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 50.0 110.415 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -51.03 -25.28 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 50.0 110.121 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 126' ' ' ARG . 29.7 p-10 -68.71 -28.39 66.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 50.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 6.9 tpt180 -60.06 -20.02 55.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 50.0 110.123 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 75.5 t -68.63 -40.33 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 50.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 11.5 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.992 -1.004 . . . . 50.0 110.19 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.661 ' S1 ' ' HB3' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.9900000000000002 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 39' ' ' THR . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 111' ' ' VAL . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 50.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 50.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.919 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 12.5 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 50.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 50.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 50.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 50.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 50.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 50.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 50.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 50.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.652 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 50.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' O ' HD21 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 50.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 50.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 50.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 50.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 50.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 50.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD2' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 50.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 50.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 50.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 50.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 50.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 50.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 50.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 50.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 50.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 50.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 50.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 50.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 50.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 50.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 2' ' ' THR . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 50.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.792 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 50.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 12.5 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 10.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 50.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 25.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 10.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 10.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 10.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 101' ' ' THR . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 10.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 10.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 50.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 12.5 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.792 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 10.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 10.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 50.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 10.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 12.5 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 10.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 50.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.3 Cg_endo -80.14 172.66 13.56 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.488 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.1 OUTLIER 45.57 69.49 0.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 10.0 110.165 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 63' ' ' CYS . 15.1 m -72.13 -15.06 61.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 10.0 110.116 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' C ' ' O ' ' A' ' 62' ' ' SER . 20.1 p 33.09 -147.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.231 0.538 . . . . 10.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -166.5 52.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 10.0 110.255 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 54.83 52.56 11.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.917 . . . . 10.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' CYS . . . -148.19 -121.83 1.23 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.59 82.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 10.0 110.143 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -150.99 111.83 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 10.0 110.655 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.46 -21.53 13.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 25.0 109.568 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.909 ' HB2' HG11 ' A' ' 98' ' ' VAL . 11.1 p-10 -141.84 130.6 22.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.492 -0.755 . . . . 50.0 109.74 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 100' ' ' LEU . 96.2 m -75.3 -96.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.063 -1.023 . . . . 10.0 110.164 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -178.75 36.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.979 -1.076 . . . . 10.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' HD11 ' A' ' 113' ' ' ILE . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 50.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 50.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 50.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 50.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 25.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 10.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 50.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.836 HG23 ' C ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 50.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 10.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 50.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.92 -177.88 5.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 50.0 110.184 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tpt -65.68 92.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 110.104 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -160.24 178.19 9.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 16.66 110.352 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.87 94.83 1.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 50.0 110.013 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' HG2' ' A' ' 85' ' ' GLN . 3.0 mt -129.14 -69.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 50.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.14 155.52 17.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 12.5 110.436 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t -106.75 140.91 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 12.5 110.014 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 10.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 50.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 50.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 10.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 12.5 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 50.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HB3' HG23 ' A' ' 98' ' ' VAL . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 25.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 50.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.909 HG11 ' HB2' ' A' ' 70' ' ' ASN . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 50.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' HG2' HD12 ' A' ' 80' ' ' ILE . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 50.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.647 HD13 ' SG ' ' A' ' 71' ' ' CYS . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 10.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.794 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 10.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 10.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.591 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 50.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 10.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.836 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 10.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 50.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 50.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 50.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 12.5 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 25.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.641 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 10.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 50.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 50.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 10.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.741 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 50.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 50.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 50.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -60.13 121.96 13.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 12.5 110.379 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.74 -26.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 50.0 110.173 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.67 -38.18 80.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 16.66 110.182 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 -36.31 31.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 50.0 110.087 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -61.41 -28.08 69.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.925 . . . . 50.0 110.041 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -56.69 -18.58 12.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.351 -0.843 . . . . 50.0 110.386 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -27.1 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 50.0 110.3 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.21 144.03 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 50.0 109.921 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.513 ' OXT' HG22 ' A' ' 128' ' ' ILE . 20.9 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.037 -0.983 . . . . 50.0 110.244 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.509 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.405 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.9900000000000002 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 50.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.993 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 50.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 12.5 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 50.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 50.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 50.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 50.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 50.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 50.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 50.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 50.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.844 ' O ' HD11 ' A' ' 11' ' ' LEU . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 50.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 50.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 50.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 50.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 50.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 50.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 50.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.993 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 50.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 50.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 50.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 50.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 50.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 50.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 50.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 50.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 50.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' LEU . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 50.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 50.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 50.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 50.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 50.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 50.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 10.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 50.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.752 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 50.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 12.5 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 10.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 50.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 25.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 10.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 10.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 10.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.554 HG23 ' CE ' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 10.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 10.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 50.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 12.5 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HB2' ' HE1' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 10.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 10.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 50.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 10.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 10.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 12.5 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 10.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.607 ' HZ3' ' HG ' ' A' ' 73' ' ' SER . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 50.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo -71.46 167.7 25.63 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 65.24 86.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.514 -0.741 . . . . 10.0 110.597 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.31 169.56 15.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 10.0 109.914 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 m -90.05 84.29 6.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 10.0 109.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -37.75 18.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 10.0 110.506 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.21 151.52 29.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 10.0 110.414 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.69 -33.14 62.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.42 77.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -1.13 . . . . 10.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.4 t -77.22 -81.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 10.0 110.353 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.26 25.46 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 25.0 109.915 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 1.3 m-20 -94.19 -68.11 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 50.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.578 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 4.5 m 67.16 172.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.303 -0.873 . . . . 10.0 109.543 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -151.54 70.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.006 -1.059 . . . . 10.0 111.146 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.607 ' HG ' ' HZ3' ' A' ' 59' ' ' TRP . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 50.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.689 HG23 ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 50.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 50.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 50.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 25.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 50.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 50.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 10.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 150.59 37.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 50.0 110.055 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 mtp -68.35 128.56 37.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 50.0 110.198 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -159.86 161.91 34.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 16.66 110.102 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -69.61 -163.09 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 50.0 110.39 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 86' ' ' GLN . 2.4 mp 59.58 168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 50.0 110.359 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER 61.97 106.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 12.5 110.227 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.52 154.81 22.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 12.5 110.264 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 10.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 50.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 50.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 10.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 12.5 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 50.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 25.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.863 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 50.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 50.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 50.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 10.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 10.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 49' ' ' LEU . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 10.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 50.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 10.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 50.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 50.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 50.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 50.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 12.5 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 25.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 73' ' ' SER . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 10.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 50.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 50.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 10.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 50.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 50.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 50.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -40.47 128.72 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 12.5 110.629 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.36 -10.16 30.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 50.0 109.798 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.95 -24.83 48.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 16.66 110.237 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.61 -22.45 12.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 50.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -55.67 -23.62 29.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 50.0 110.473 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.41 -16.91 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.1 14.86 5.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 50.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 124' ' ' GLN . 7.2 p -75.99 -26.12 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 50.0 110.143 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.006 -0.997 . . . . 50.0 110.259 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.578 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.9900000000000002 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.414 HG23 HG22 ' A' ' 39' ' ' THR . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 50.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 50.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.83 HD21 ' HB3' ' A' ' 23' ' ' LEU . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 50.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 12.5 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 50.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 50.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 50.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 50.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 50.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 50.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 50.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 50.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 50.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.46 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 50.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 50.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 50.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 50.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.83 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 50.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 50.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 50.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 50.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 50.0 109.901 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 50.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 50.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 50.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 50.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 50.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 50.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 50.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 50.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 10.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 50.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 50.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 12.5 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 10.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 50.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 25.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 10.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 10.0 110.133 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 10.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.463 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 10.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 10.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 50.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 12.5 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 10.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 10.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 50.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 10.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 10.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 12.5 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 10.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CE3' HG21 ' A' ' 101' ' ' THR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 50.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.21 131.03 18.47 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.16 121.99 32.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -160.74 80.92 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 10.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 61.0 m -134.6 44.41 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 10.0 110.256 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 8.9 mtt-85 47.5 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -177.99 153.85 0.84 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.083 -1.011 . . . . 10.0 110.134 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -103.62 3.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.395 -1.482 . . . . 10.0 109.395 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.25 167.22 16.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 10.0 110.118 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.0 OUTLIER -125.47 54.8 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 10.0 110.347 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.17 39.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 25.0 110.297 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.15 94.06 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 50.0 110.144 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -85.53 -145.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.343 -0.848 . . . . 10.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -145.02 68.27 1.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 10.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' HD13 ' A' ' 74' ' ' ILE . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 50.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 73' ' ' SER . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 50.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 50.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 50.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 25.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 10.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 50.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 48' ' ' ILE . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 50.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 10.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 50.0 110.015 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 -46.91 143.88 2.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 50.0 110.169 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -52.47 144.77 12.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 50.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.5 mt-30 -167.18 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 16.66 110.381 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -102.51 150.64 23.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 50.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 mt -91.12 86.18 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 50.0 110.048 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 170.01 5.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 12.5 110.247 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -119.13 141.34 48.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.867 . . . . 12.5 110.007 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' O ' HG12 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 10.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 50.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 50.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 10.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 12.5 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 50.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CB ' HG23 ' A' ' 98' ' ' VAL . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 25.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 50.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' CB ' ' A' ' 96' ' ' LYS . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 50.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 71' ' ' CYS . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 10.0 110.752 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.61 HG21 ' CE3' ' A' ' 59' ' ' TRP . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 10.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 10.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 50.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 10.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.454 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 50.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 50.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 50.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 50.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 108' ' ' ALA . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 12.5 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 25.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 10.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 6' ' ' LEU . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 50.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 50.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 10.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 50.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 50.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 50.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -46.38 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 12.5 110.072 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.2 -14.41 60.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 50.0 110.248 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.25 -22.12 66.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 16.66 110.386 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -20.94 6.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 50.0 110.208 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 127' ' ' VAL . 4.8 tp60 -62.41 -14.73 43.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 50.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -49.53 -23.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 50.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -114.3 50.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 50.0 110.386 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 124' ' ' GLN . 18.7 m -46.76 172.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.952 . . . . 50.0 110.122 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.938 -1.029 . . . . 50.0 110.216 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.497 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.9900000000000002 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 50.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 50.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 50.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 6' ' ' LEU . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 12.5 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.813 ' HB2' HG12 ' A' ' 114' ' ' VAL . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 50.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 50.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 50.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 50.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 50.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 50.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 50.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.855 ' CE3' HD22 ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 50.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 50.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 50.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 50.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 50.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 50.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 50.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.855 HD22 ' CE3' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 50.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HA ' HD22 ' A' ' 6' ' ' LEU . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 50.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 50.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 50.0 110.443 -179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 50.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 50.0 110.21 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 50.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 50.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 50.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 50.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 50.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 50.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 50.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.664 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 50.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 10.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 50.0 110.01 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 50.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 12.5 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 10.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 50.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 25.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 10.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 10.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 10.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 10.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 50.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 12.5 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 10.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 10.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 50.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 10.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 10.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 12.5 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 10.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 50.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo -71.81 173.57 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 8.2 m-85 -91.76 139.42 30.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.379 -0.826 . . . . 10.0 110.456 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 2.5 t -160.26 70.33 0.42 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 10.0 109.923 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.06 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 10.0 110.003 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -138.94 -152.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 10.0 110.081 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.58 20.49 4.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 10.0 110.327 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.59 -38.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 68' ' ' CYS . . . -139.19 156.67 46.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 10.0 110.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER 69.31 83.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 10.0 110.279 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.535 ' O ' ' S1 ' ' A' ' 130' ' ' FES . . . -126.26 -169.36 2.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 25.0 109.995 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 7.5 m120 55.05 88.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 50.0 110.154 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.676 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -162.0 -151.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 10.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.676 ' HB3' ' O ' ' A' ' 71' ' ' CYS . . . 67.89 98.76 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 10.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.544 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 50.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 50.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 50.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 50.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 25.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 10.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 48' ' ' ILE . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 50.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 10.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 50.0 110.278 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -101.83 -173.27 2.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 50.0 110.251 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.22 86.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 50.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -153.91 117.18 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 16.66 110.299 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 55.18 177.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 50.0 110.445 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.65 160.05 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.41 -0.806 . . . . 50.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 tt -139.39 144.59 38.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 12.5 110.334 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 4.0 m -96.26 146.95 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 12.5 110.239 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 10.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 50.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 50.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.769 HG21 HH21 ' A' ' 99' ' ' ARG . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 10.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 12.5 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 50.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 25.0 110.664 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 50.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 99' ' ' ARG . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 50.0 110.329 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.769 HH21 HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 50.0 110.285 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.083 HD23 ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 10.0 110.18 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.466 ' HA ' HD13 ' A' ' 48' ' ' ILE . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 10.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 10.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 50.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 10.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 50.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 50.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 50.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 50.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 108' ' ' ALA . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 12.5 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 25.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 10.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.813 HG12 ' HB2' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 50.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 50.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 10.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.671 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 50.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 50.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 34.5 m170 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 50.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -40.31 121.57 1.41 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 12.5 110.476 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -49.53 -28.6 5.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 50.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.48 -31.73 72.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 16.66 109.961 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.37 -22.33 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.465 -0.772 . . . . 50.0 110.1 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.635 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -48.44 -32.14 7.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 50.0 110.215 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -57.42 -27.9 62.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 50.0 110.274 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -51.93 -42.49 62.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 50.0 110.364 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 124' ' ' GLN . 6.4 p -49.78 164.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 50.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.884 -1.055 . . . . 50.0 110.176 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' FES . . . . . 1.083 ' S2 ' HD23 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.9900000000000002 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 111' ' ' VAL . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 50.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 50.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.869 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 50.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 12.5 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 50.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 50.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 50.0 110.09 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 50.0 109.653 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 50.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 50.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 50.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 50.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 50.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 50.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 50.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 50.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 50.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 50.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 50.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 50.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 50.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 50.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 50.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 50.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 50.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 50.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 50.0 110.377 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 50.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 50.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 50.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 50.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 50.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 10.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 50.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 50.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 12.5 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 51' ' ' ALA . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 10.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 25.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 10.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 10.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 10.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HA ' HG11 ' A' ' 42' ' ' VAL . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 10.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 10.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 50.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 12.5 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 10.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 10.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 50.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 10.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 12.5 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 10.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.67 82.52 1.91 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' HB2' ' S2 ' ' A' ' 130' ' ' FES . 13.8 p90 -121.12 149.05 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 10.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -127.08 16.68 7.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 10.0 109.987 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.95 113.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 10.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -134.06 -36.19 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 10.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.07 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 10.0 110.158 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.04 154.69 52.87 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.566 -1.414 . . . . 10.0 109.566 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.74 161.68 7.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 10.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.5 t -119.09 117.64 29.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 10.0 110.502 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.59 -23.57 15.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 25.0 109.674 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -153.4 106.75 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.413 -0.804 . . . . 50.0 109.817 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 101' ' ' THR . 45.9 t -67.04 -102.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 10.0 110.494 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . -169.68 24.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 10.0 111.124 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.724 ' OG ' HD11 ' A' ' 113' ' ' ILE . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 50.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.71 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 50.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 50.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 25.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 10.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 50.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 ' HD3' ' A' ' 99' ' ' ARG . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 50.0 109.903 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 10.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 50.0 110.116 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.0 127.48 35.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 50.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 85.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 50.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -167.5 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 16.66 110.231 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -152.61 170.64 19.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 50.0 110.322 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 133.03 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.77 139.43 45.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 12.5 110.288 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p -116.75 127.53 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 12.5 110.14 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 10.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 50.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 50.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 10.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 12.5 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 50.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 25.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.595 ' HB2' HG23 ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 50.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 96' ' ' LYS . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 50.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.613 ' HD3' HD12 ' A' ' 80' ' ' ILE . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 50.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 103' ' ' ILE . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 10.0 110.26 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.746 HG22 ' SG ' ' A' ' 71' ' ' CYS . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 10.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 10.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' C ' HD21 ' A' ' 100' ' ' LEU . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 50.0 110.273 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 10.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 10.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 50.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 50.0 110.382 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 50.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 50.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 3' ' ' VAL . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 12.5 110.181 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 25.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.724 HD11 ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 10.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.869 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 50.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 50.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 10.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 50.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 50.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 50.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt -47.22 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 12.5 110.279 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.18 -15.3 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 50.0 110.073 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -79.04 -13.1 59.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 16.66 110.173 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -11.81 6.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 50.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -45.77 -30.87 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 50.0 110.231 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -45.9 -25.07 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.905 . . . . 50.0 110.001 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -25.31 67.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 50.0 110.144 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.77 111.68 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 50.0 110.185 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 128' ' ' ILE . 3.0 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.947 -1.025 . . . . 50.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.733 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.577 ' S2 ' ' HB2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.9900000000000002 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.901 HG22 ' HB ' ' A' ' 111' ' ' VAL . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 50.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 50.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 50.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.562 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 12.5 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 114' ' ' VAL . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 50.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 50.0 109.805 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 50.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 50.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 50.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 50.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 50.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 50.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 50.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 50.0 110.148 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 50.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 50.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 50.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 50.0 110.152 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 50.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 50.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 50.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 50.0 110.231 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 50.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 50.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 50.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 50.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 50.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 50.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 50.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 10.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 50.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 50.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 12.5 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 10.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 50.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 25.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 10.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 10.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 10.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 69' ' ' ALA . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 10.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 50.0 110.26 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 12.5 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 10.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 10.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 50.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 8.6 mm-40 -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 10.0 109.755 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 10.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 12.5 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 10.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 50.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo -70.64 121.85 8.32 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -66.8 156.24 36.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 10.0 110.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.94 59.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 10.0 110.086 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.2 OUTLIER -159.89 175.97 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 10.0 110.228 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -79.3 178.2 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 10.0 110.097 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.66 152.18 37.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 10.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.21 59.89 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.471 -1.451 . . . . 10.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 51.75 20.36 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 10.0 110.24 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -97.44 120.42 37.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 10.0 110.085 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 49' ' ' LEU . . . -105.5 -148.74 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 25.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -56.88 167.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 50.0 110.382 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -171.49 76.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 10.0 110.157 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -176.37 88.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 10.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.644 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.811 HG23 ' HB2' ' A' ' 97' ' ' ASP . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 50.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 50.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 50.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 25.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 50.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 50.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 105' ' ' SER . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 10.0 109.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 50.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -64.99 178.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 50.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -49.08 105.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 50.0 110.231 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' MET . 4.1 tt0 -177.35 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 16.66 110.016 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -46.74 120.34 2.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 50.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -155.42 -39.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 50.0 110.026 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' N ' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -66.48 167.01 11.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 12.5 110.203 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.26 141.61 37.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 12.5 110.28 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 10.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 50.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 50.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 10.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 12.5 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 50.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 25.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.811 ' HB2' HG23 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 50.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 74' ' ' ILE . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 50.0 110.633 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.607 HD22 ' CG2' ' A' ' 103' ' ' ILE . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 10.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 10.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 10.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.607 ' CG2' HD22 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 50.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 10.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 10.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD3' HG11 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.792 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 50.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 50.0 110.179 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 50.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 50.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.901 ' HB ' HG22 ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 12.5 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 25.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.715 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 10.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 6' ' ' LEU . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 50.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 10.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 50.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 50.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.517 ' CE1' ' OD1' ' A' ' 116' ' ' ASN . 20.3 m80 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 50.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -42.14 152.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 12.5 110.277 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -38.08 67.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 50.0 110.224 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -70.28 -4.89 24.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 16.66 110.183 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -39.59 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 50.0 110.36 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 4.8 tt0 -62.52 -25.66 68.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.443 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -53.78 -23.7 12.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 50.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.99 -33.22 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 50.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.05 136.09 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 50.0 110.369 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.944 -1.027 . . . . 50.0 110.237 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.772 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.611 ' S2 ' ' O ' ' A' ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.9900000000000002 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 40' ' ' MET . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 111' ' ' VAL . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 50.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 50.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 50.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 12.5 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.595 ' CE2' HD12 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 50.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 50.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 50.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 50.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 50.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 50.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 50.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 50.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 50.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 50.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.439 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 50.0 110.848 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 50.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 50.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 50.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 50.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 50.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 50.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 50.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 50.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 50.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 50.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 50.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 50.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 50.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 50.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 50.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 50.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 50.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 50.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.514 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 50.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 10.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 50.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.695 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 50.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 12.5 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 10.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 50.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 25.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 10.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 10.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 10.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 106' ' ' PRO . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 10.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 10.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 50.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 12.5 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.695 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 10.0 110.084 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 10.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 50.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 10.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 10.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 12.5 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 10.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 50.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.314 0.578 . . . . 10.0 110.423 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 50.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 73' ' ' SER . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 50.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 50.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 50.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 25.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 50.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 50.0 110.242 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 10.0 110.216 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 50.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 50.0 110.043 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.253 0.549 . . . . 12.5 110.074 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 10.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 50.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 50.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 12.5 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 50.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 25.0 110.376 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.756 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 50.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 50.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 50.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 10.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 10.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' HA ' HD22 ' A' ' 49' ' ' LEU . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 10.0 110.086 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 50.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 10.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 10.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 50.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 50.0 110.09 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 50.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 50.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 78' ' ' GLY . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 12.5 110.507 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 25.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 50.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 50.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.4 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 10.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 50.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 50.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 50.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.595 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 12.5 110.442 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.9900000000000002 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 50.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 50.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 50.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 12.5 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 114' ' ' VAL . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 50.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 50.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 50.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 50.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 50.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 50.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 50.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 50.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 50.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 50.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 50.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 50.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 50.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.72 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 50.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 50.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 50.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 50.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 50.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 50.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 50.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 50.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 50.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 50.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 50.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 50.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 50.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 50.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.836 ' HE2' ' HB2' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 12.5 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.84 HG11 ' HD3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 10.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 50.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 25.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 10.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 10.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 10.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.512 HD13 ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 10.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 10.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 50.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 12.5 110.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 10.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 10.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 50.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 10.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 10.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 12.5 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 10.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.027 ' HB3' HD11 ' A' ' 100' ' ' LEU . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 50.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CA ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 10.0 110.535 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.998 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 50.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 50.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 50.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 50.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 25.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 10.0 109.474 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.559 ' C ' HD12 ' A' ' 80' ' ' ILE . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 50.0 110.113 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.887 HG12 HG21 ' A' ' 101' ' ' THR . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 50.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 10.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 50.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 50.0 110.141 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.185 0.517 . . . . 12.5 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 10.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 50.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 50.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 10.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 12.5 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 50.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HG23 ' A' ' 98' ' ' VAL . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 25.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 50.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 96' ' ' LYS . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 50.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 50.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' A' ' 59' ' ' TRP . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 10.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 80' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 10.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 10.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 103' ' ' ILE . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 50.0 110.161 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 10.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 10.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.84 ' HD3' HG11 ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 50.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 50.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 50.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 50.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 12.5 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 25.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.998 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 10.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 113' ' ' ILE . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 50.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 50.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 10.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB3' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 50.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 50.0 110.114 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 50.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 12.5 110.31 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.445 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.9900000000000002 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' A' ' 111' ' ' VAL . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 50.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 50.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.691 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 50.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 10' ' ' THR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 12.5 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 50.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 50.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 50.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 50.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 50.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 50.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 50.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 50.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 50.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 50.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 50.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 50.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 50.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 50.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 50.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 16' ' ' TRP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 50.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 50.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 50.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 50.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 50.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 50.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 50.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 50.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 50.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 50.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 50.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 50.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.665 ' CG2' HG22 ' A' ' 2' ' ' THR . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 50.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.68 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 50.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 12.5 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 10.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 50.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 25.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 10.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 10.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 10.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 10.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 10.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 50.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 12.5 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 10.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 10.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 50.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 10.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 10.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.727 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 12.5 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 10.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CZ3' HG21 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 50.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.98 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.98 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.278 0.561 . . . . 10.0 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.631 ' CB ' HD11 ' A' ' 113' ' ' ILE . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 50.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 50.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 50.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 50.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 25.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 50.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 99' ' ' ARG . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 50.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 10.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 50.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 50.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.277 0.561 . . . . 12.5 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 10.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 50.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 50.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 10.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 12.5 110.192 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 25.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.727 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 50.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 50.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 50.0 109.876 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 10.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.527 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 10.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 50.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 10.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 10.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 50.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 50.0 110.363 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 50.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 50.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 108' ' ' ALA . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 12.5 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 25.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 1.022 HD13 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 10.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 1.022 ' N ' HD13 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 50.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 50.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 10.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.67 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.708 ' N ' ' HB1' ' A' ' 72' ' ' ALA . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 50.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 50.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 12.5 110.264 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.9900000000000002 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 111' ' ' VAL . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.944 ' OE1' HG23 ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 50.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 50.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.839 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 50.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 12.5 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE1' HD12 ' A' ' 120' ' ' LEU . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 50.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 50.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 50.0 109.905 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 50.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 50.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 50.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 50.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 50.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 50.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 50.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 50.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 50.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 50.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 50.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 50.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 16' ' ' TRP . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 50.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 50.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 50.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 50.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 50.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 50.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 50.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 50.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 50.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 50.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 50.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 50.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 50.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 50.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.944 HG23 ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 50.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 50.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 12.5 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 10.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 50.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 25.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 10.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 10.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 80' ' ' ILE . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 10.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 10.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 50.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 12.5 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 10.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 50.0 110.16 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 10.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 10.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 12.5 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 10.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 50.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.382 0.61 . . . . 10.0 110.505 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.553 ' O ' HD13 ' A' ' 74' ' ' ILE . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 50.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 97' ' ' ASP . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 50.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 50.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 74' ' ' ILE . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 50.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 25.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 50.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 50.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 10.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 50.0 110.143 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 50.0 110.233 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 12.5 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 10.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 50.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 50.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 10.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 12.5 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 50.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 25.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.731 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 50.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 50.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 50.0 110.259 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HA ' HD13 ' A' ' 100' ' ' LEU . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 10.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 99' ' ' ARG . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 10.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 10.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 50.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 10.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 10.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 50.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 50.0 110.04 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 50.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 50.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 3' ' ' VAL . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 12.5 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 25.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 10.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 50.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 50.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.548 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 10.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 50.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 50.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 50.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 12.5 110.146 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 111' ' ' VAL . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 50.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 50.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 12.5 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 50.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 50.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 50.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 50.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 50.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 50.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 50.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 50.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.476 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 50.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 50.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 50.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 50.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 50.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CB ' HD11 ' A' ' 6' ' ' LEU . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 50.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 50.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 50.0 110.147 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 50.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 50.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 50.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 50.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 50.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 50.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 50.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 50.0 109.662 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 50.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.556 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 50.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 50.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 10.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 50.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.757 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 50.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 12.5 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' MET . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 10.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 25.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 10.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 10.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 10.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 10.0 110.087 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 10.0 110.342 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 50.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 12.5 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 10.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 10.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 50.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 10.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 12.5 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 50.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.227 0.537 . . . . 10.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 50.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 50.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 50.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HE3' ' HG3' ' A' ' 18' ' ' MET . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 50.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 25.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 10.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 50.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 50.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 10.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 50.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 50.0 110.359 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.211 0.529 . . . . 12.5 110.379 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 10.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 50.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 50.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 10.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 12.5 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 50.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 25.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.868 ' O ' HG12 ' A' ' 75' ' ' VAL . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 50.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' VAL . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 50.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 50.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 10.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 10.0 110.275 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.439 ' C ' HG13 ' A' ' 103' ' ' ILE . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 10.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 50.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 10.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 50.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 50.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 50.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 50.0 109.899 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 12.5 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 25.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.751 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 10.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 50.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 50.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 10.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 50.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 50.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 50.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 12.5 110.359 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.9900000000000002 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 50.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 50.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.589 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 50.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 12.5 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 50.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 50.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 50.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' TRP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 50.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 50.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 50.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 50.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.839 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 50.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.494 ' CA ' HD11 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 50.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.421 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 50.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 50.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 50.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 50.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 50.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 50.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 50.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 50.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 50.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 50.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 50.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 50.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 50.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 50.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 50.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 50.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 50.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 50.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 50.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 50.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 12.5 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 10.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 50.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 25.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 10.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' CD ' ' A' ' 50' ' ' GLU . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 10.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 10.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 10.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 102' ' ' CYS . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 10.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 49' ' ' LEU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 50.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 12.5 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 10.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 10.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 50.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 10.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 12.5 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 10.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 50.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.119 0.485 . . . . 10.0 110.035 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 50.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 50.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 97' ' ' ASP . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 50.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 25.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.684 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.896 ' HG2' ' HB2' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 50.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 50.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 10.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 50.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 50.0 109.973 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.231 0.539 . . . . 12.5 110.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 10.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 50.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 50.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 10.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 12.5 109.537 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 50.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 25.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 50.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 50.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 10.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 48' ' ' ILE . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 10.0 110.152 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.887 ' HA ' HD23 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 10.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 103' ' ' ILE . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 10.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 10.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 50.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 50.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 50.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 50.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 12.5 110.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 77' ' ' GLU . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 25.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 10.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 50.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 50.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 10.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.862 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 50.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 50.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 50.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 12.5 110.408 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.9900000000000002 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' CG2' ' A' ' 39' ' ' THR . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 111' ' ' VAL . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.528 ' N ' HG12 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 50.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 50.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 50.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' OD1' ' CE1' ' A' ' 115' ' ' TYR . 66.8 t30 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 12.5 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 50.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 50.0 109.824 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 50.0 109.429 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.015 HD21 ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 50.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 50.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 50.0 109.858 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' HD21 ' A' ' 32' ' ' LEU . 4.2 mm-40 -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 50.0 109.975 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 50.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.729 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 50.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 1.015 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 50.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.596 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 50.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 50.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 50.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 50.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 50.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 50.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CD1' HD12 ' A' ' 6' ' ' LEU . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 50.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 50.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 50.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 50.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 37' ' ' TYR . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 50.0 109.91 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 50.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 50.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 50.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD21 ' NE2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 50.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 50.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 50.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 50.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 50.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 50.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 10.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.52 ' CG2' HG23 ' A' ' 2' ' ' THR . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 50.0 110.136 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.918 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 50.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 12.5 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 10.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 50.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 25.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 10.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 10.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 10.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.758 HG23 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 10.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 10.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 50.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 12.5 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.918 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 10.0 110.319 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 10.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 50.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 10.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 10.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 12.5 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 10.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 50.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 43.8 Cg_endo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.136 0.494 . . . . 10.0 110.556 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.591 ' CB ' HD11 ' A' ' 113' ' ' ILE . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 50.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 50.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.663 ' CA ' HD12 ' A' ' 113' ' ' ILE . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 50.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 50.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 25.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 10.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 50.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 50.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 10.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 50.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 50.0 110.542 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.31 0.576 . . . . 12.5 110.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 10.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 50.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 50.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 98' ' ' VAL . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 10.0 109.786 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 12.5 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 50.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 25.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.631 ' HB2' HG23 ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 50.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 50.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 10.0 110.348 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 10.0 110.153 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 10.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 10.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 10.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 50.0 110.188 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.606 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 50.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 50.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 50.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' HG22 ' A' ' 3' ' ' VAL . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 12.5 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 25.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.663 HD12 ' CA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 10.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 50.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.568 ' CE1' ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 50.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 10.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.587 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 50.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 50.0 110.12 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.593 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 50.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' OH ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 12.5 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.9900000000000002 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 50.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 50.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.703 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 50.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 12.5 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 50.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 50.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 50.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 50.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 50.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 50.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 50.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 50.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 50.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 50.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 50.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 50.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 50.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 50.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 50.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 50.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE2' HD12 ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 50.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 50.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 50.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 50.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 50.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 50.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 50.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 50.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 50.0 109.394 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 50.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 50.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 50.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 50.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.727 ' HE3' HG23 ' A' ' 48' ' ' ILE . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 12.5 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' CB ' ' A' ' 51' ' ' ALA . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 10.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 50.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 25.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 10.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 10.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.727 HG23 ' HE3' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 10.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.83 HD13 ' SG ' ' A' ' 102' ' ' CYS . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 10.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 50.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 12.5 109.742 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 10.0 109.856 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 10.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 50.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 10.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 12.5 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 10.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.604 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 50.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.298 0.57 . . . . 10.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 50.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 73' ' ' SER . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 50.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 50.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 50.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 25.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 50.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 50.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 10.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 50.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 50.0 110.274 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.207 0.527 . . . . 12.5 110.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 10.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 50.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 50.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 10.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 12.5 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 50.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 25.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' HG23 ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 50.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 96' ' ' LYS . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 50.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 50.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 10.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 10.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.83 ' SG ' HD13 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 10.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 103' ' ' ILE . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 50.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 10.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 10.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 50.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 50.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 50.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 50.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 12.5 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 25.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 10.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 50.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 50.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 10.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 50.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 50.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 50.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 12.5 110.431 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.9900000000000002 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 3' ' ' VAL . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 50.0 110.302 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 50.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 50.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.574 ' OD1' ' CE2' ' A' ' 115' ' ' TYR . 39.0 t30 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 12.5 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 50.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 50.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 50.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 50.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 50.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 50.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 50.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.666 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 50.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 50.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 50.0 110.203 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 50.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 50.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 50.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 50.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.829 ' HB3' HD21 ' A' ' 6' ' ' LEU . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 50.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 50.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 50.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 50.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 50.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 50.0 110.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 50.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 50.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 50.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 50.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 50.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 50.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 50.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 50.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 50.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 50.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 50.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 12.5 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.696 HG11 ' CD ' ' A' ' 106' ' ' PRO . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 10.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 50.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 25.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 10.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 10.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 10.0 110.194 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.824 HD13 ' HB ' ' A' ' 101' ' ' THR . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 10.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' ILE . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 10.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 50.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 12.5 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 10.0 110.011 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 10.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 50.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 10.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 10.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 12.5 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 10.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 50.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo . . . . . 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 10.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HD13 ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 50.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 50.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 50.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 50.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 25.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 10.0 109.36 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 50.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 50.0 110.18 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 10.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 50.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 50.0 110.174 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.199 0.523 . . . . 12.5 109.817 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 10.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 50.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 50.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 10.0 109.863 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 12.5 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 50.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 25.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 50.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 50.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 50.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 10.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.824 ' HB ' HD13 ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 10.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 10.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 50.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 10.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.696 ' CD ' HG11 ' A' ' 42' ' ' VAL . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 50.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 50.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 50.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 108' ' ' ALA . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 12.5 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 25.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 10.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 50.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.574 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 50.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 10.0 109.916 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 50.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 50.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 50.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD12 ' OH ' ' A' ' 8' ' ' TYR . 55.9 tp . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 12.5 110.276 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.9900000000000002 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 50.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 50.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.864 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 50.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.584 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 12.5 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 50.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 50.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 50.0 109.765 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 50.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 50.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 50.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 50.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 23' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 50.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 50.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 50.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 50.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 50.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 50.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 50.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 50.0 110.231 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 50.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 50.0 110.275 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 50.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 50.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 50.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 50.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 50.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 50.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 50.0 109.396 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 50.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.584 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 50.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 50.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 10.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 50.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.811 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 50.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 12.5 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 10.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 50.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 25.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 10.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 10.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 10.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 10.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 10.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 50.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 12.5 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.811 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 10.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 10.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 50.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 10.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 10.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 12.5 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 10.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 50.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.245 0.545 . . . . 10.0 110.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 50.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 50.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 50.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 50.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 25.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 10.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 50.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 81' ' ' ASP . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 50.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 10.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 50.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 50.0 110.24 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.203 0.525 . . . . 12.5 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 10.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 50.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 50.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 10.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 12.5 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 50.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 25.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 50.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 50.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 50.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 10.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 10.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 10.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 50.0 110.063 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 10.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 50.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 50.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 50.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 50.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 12.5 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 25.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 10.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 50.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 50.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 10.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 50.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 50.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 50.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 12.5 110.088 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.9900000000000002 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.521 HG23 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.92 HG22 ' HB ' ' A' ' 111' ' ' VAL . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 50.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 50.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 50.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 12.5 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.538 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 50.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 50.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 23' ' ' LEU . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 50.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 50.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 50.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 50.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 50.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CB ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 50.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 50.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 50.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 50.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 50.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 50.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 50.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 50.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 50.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 50.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 50.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 50.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 50.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 50.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 50.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 50.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 50.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 50.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 50.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 50.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 50.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 50.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 12.5 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 51' ' ' ALA . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 10.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 50.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 25.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 10.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 10.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 10.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.621 HG21 ' HG ' ' A' ' 100' ' ' LEU . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 10.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 101' ' ' THR . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 10.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 50.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.726 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 12.5 110.479 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 10.0 110.382 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 10.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 50.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 10.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 10.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 12.5 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 10.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 50.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.765 ' CG ' ' HB3' ' A' ' 72' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.765 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 10.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.948 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 50.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 50.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 50.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 25.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 10.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 50.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.447 HD13 HD12 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 50.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 10.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.404 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 50.0 110.217 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 50.0 109.933 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.257 0.551 . . . . 12.5 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.61 ' O ' HG12 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 10.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 50.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 50.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 90' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 10.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 12.5 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 50.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 25.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 50.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 50.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 50.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 48' ' ' ILE . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 10.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.77 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 10.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.558 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 10.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' CYS . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 50.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 10.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 50.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 50.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 50.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 50.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.92 ' HB ' HG22 ' A' ' 3' ' ' VAL . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 12.5 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 25.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 10.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.766 ' N ' HD13 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 50.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 50.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 10.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 50.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 50.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 50.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 12.5 110.345 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HB ' ' A' ' 111' ' ' VAL . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 50.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 50.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 50.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 6' ' ' LEU . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 12.5 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 50.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 50.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 50.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HG ' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 50.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 50.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 50.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 50.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 50.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 50.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.766 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 50.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 50.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 50.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 50.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 50.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 50.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 6' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 50.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 50.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 50.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 50.0 110.083 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 50.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 50.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 50.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 50.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 50.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 50.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 50.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 50.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 50.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 50.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 10.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 50.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.618 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 50.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 12.5 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' CB ' ' A' ' 51' ' ' ALA . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 10.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 50.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 25.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 10.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 10.0 110.126 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 10.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 10.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' THR . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 10.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 50.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 12.5 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.618 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 10.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 10.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 50.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 10.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 12.5 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 10.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 50.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 44.0 Cg_endo . . . . . 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.347 0.594 . . . . 10.0 110.376 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 50.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 73' ' ' SER . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 50.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 97' ' ' ASP . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 50.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 50.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 25.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 50.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 50.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 10.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 50.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 50.0 110.165 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.302 0.572 . . . . 12.5 110.395 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.635 ' O ' HG12 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 10.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 50.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 50.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 10.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 12.5 110.03 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 25.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.623 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 50.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 50.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 50.0 110.463 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 10.0 110.059 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 10.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 10.0 110.123 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 50.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 10.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 10.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 50.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 50.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 50.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 50.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.801 ' HB ' HG22 ' A' ' 3' ' ' VAL . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 12.5 110.375 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 25.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 10.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 50.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 50.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 10.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 50.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 50.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 50.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 12.5 110.18 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.9900000000000002 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG23 ' HB ' ' A' ' 111' ' ' VAL . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 50.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 50.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 50.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.829 ' N ' HD12 ' A' ' 6' ' ' LEU . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 12.5 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CA ' HG22 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 50.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 50.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 50.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 50.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 50.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 50.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 50.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 50.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 50.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 50.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.463 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 50.0 110.323 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 50.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 50.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 50.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 50.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.731 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 50.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 50.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 50.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 50.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 50.0 110.043 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 50.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 50.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 50.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 50.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 50.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 50.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 50.0 109.685 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 50.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 50.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 50.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 10.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 50.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.693 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 50.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 12.5 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.695 HG11 ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 10.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 50.0 110.273 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 25.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 10.0 110.17 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 10.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 10.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 10.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 50.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 12.5 109.969 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.693 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 10.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 10.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 50.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 10.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 10.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 12.5 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 10.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 50.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.228 0.537 . . . . 10.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 50.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 50.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 97' ' ' ASP . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 50.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 50.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 25.0 110.308 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 10.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 50.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HD11 ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 50.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 10.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 50.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 50.0 110.139 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.201 0.524 . . . . 12.5 110.225 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 10.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 50.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 50.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 98' ' ' VAL . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 10.0 109.849 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 12.5 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 50.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 25.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.706 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 50.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.712 ' O ' HG22 ' A' ' 93' ' ' VAL . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 50.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 50.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.811 HD22 HG22 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 10.0 109.971 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 10.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 10.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.811 HG22 HD22 ' A' ' 100' ' ' LEU . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 109.911 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 10.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.695 ' HD3' HG11 ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.824 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 50.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 50.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 50.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 50.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' A' ' 108' ' ' ALA . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 12.5 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 25.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 10.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 50.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.607 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 50.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.607 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 10.0 110.074 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 50.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 50.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 50.5 m-70 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 50.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 12.5 110.313 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.9900000000000002 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG22 ' HB ' ' A' ' 111' ' ' VAL . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 50.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 50.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 50.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 12.5 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 50.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 50.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 50.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 50.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 50.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 50.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 50.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 50.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 50.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 50.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 50.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 50.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 50.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 50.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 50.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 50.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 50.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 50.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 50.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 50.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 50.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 50.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 50.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 50.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 50.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 50.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 50.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 50.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 50.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 50.0 110.262 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 48' ' ' ILE . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 50.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 12.5 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 48' ' ' ILE . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 10.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 1' ' ' PRO . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 50.0 110.1 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 25.0 109.984 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 10.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 10.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 10.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.669 HG23 ' SD ' ' A' ' 40' ' ' MET . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 10.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.917 HD23 ' HB ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 10.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.677 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 50.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 12.5 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 10.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 10.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 50.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 10.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 12.5 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 10.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 50.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.711 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 10.0 110.76 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.616 ' O ' HD13 ' A' ' 74' ' ' ILE . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 50.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 97' ' ' ASP . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 50.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 50.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 50.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 25.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.81 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 10.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 50.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.756 HG21 ' HG2' ' A' ' 99' ' ' ARG . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 50.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 10.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 83' ' ' ASP . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 50.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 50.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.145 0.497 . . . . 12.5 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 10.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 50.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 50.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.653 HG21 ' NH2' ' A' ' 99' ' ' ARG . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 10.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 12.5 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 50.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 25.0 110.48 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.696 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 50.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 50.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.756 ' HG2' HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 50.0 110.23 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 10.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.917 ' HB ' HD23 ' A' ' 49' ' ' LEU . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 10.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.541 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 10.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.887 HG12 HD13 ' A' ' 113' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 50.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 10.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 50.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 50.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 50.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 50.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.836 ' HB ' HG22 ' A' ' 3' ' ' VAL . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 12.5 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 25.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.887 HD13 HG12 ' A' ' 103' ' ' ILE . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 10.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 50.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 50.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.566 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.4 t30 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 10.0 109.884 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 50.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 50.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.561 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 12.5 110.059 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.9900000000000002 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 39' ' ' THR . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 111' ' ' VAL . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 50.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 50.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.919 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 12.5 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 50.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 50.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 50.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 50.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 50.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 50.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 50.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 50.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.652 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 50.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' O ' HD21 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 50.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 50.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 50.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 50.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 50.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 50.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD2' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 50.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 50.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 50.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 50.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 50.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 50.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 50.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 50.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 50.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 50.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 50.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 50.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 50.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 50.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 2' ' ' THR . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 50.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.792 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 50.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 12.5 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 10.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 50.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 25.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 10.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 10.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 10.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 101' ' ' THR . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 10.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 10.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 50.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 12.5 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.792 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 10.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 10.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 50.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 10.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 12.5 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 10.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 50.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.3 Cg_endo . . . . . 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.208 0.528 . . . . 10.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' HD11 ' A' ' 113' ' ' ILE . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 50.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 50.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 50.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 50.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 25.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 10.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 50.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.836 HG23 ' C ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 50.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 10.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 50.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 50.0 110.184 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.208 0.528 . . . . 12.5 110.014 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 10.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 50.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 50.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 10.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 12.5 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 50.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HB3' HG23 ' A' ' 98' ' ' VAL . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 25.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 50.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 96' ' ' LYS . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 50.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' HG2' HD12 ' A' ' 80' ' ' ILE . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 50.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 10.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.794 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 10.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 10.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.591 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 50.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 10.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.836 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 10.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 50.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 50.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 50.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 12.5 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 25.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.641 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 10.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 50.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 50.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 10.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.741 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 50.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 50.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 50.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 12.5 110.379 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.405 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.9900000000000002 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 50.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.993 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 50.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 12.5 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 50.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 50.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 50.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 50.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 50.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 50.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 50.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 50.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.844 ' O ' HD11 ' A' ' 11' ' ' LEU . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 50.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 50.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 50.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 50.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 50.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 50.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 50.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.993 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 50.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 50.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 50.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 50.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 50.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 50.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 50.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 50.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 50.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' LEU . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 50.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 50.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 50.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 50.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 50.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 50.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 10.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 50.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.752 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 50.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 12.5 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 10.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 50.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 25.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 10.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 10.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 10.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.554 HG23 ' CE ' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 10.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 10.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 50.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 12.5 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HB2' ' HE1' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 10.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 10.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 50.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 10.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 10.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 12.5 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 10.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.607 ' HZ3' ' HG ' ' A' ' 73' ' ' SER . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 50.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.314 0.578 . . . . 10.0 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.607 ' HG ' ' HZ3' ' A' ' 59' ' ' TRP . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 50.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.689 HG23 ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 50.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 50.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 50.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 25.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 50.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 50.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 10.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 50.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.201 0.524 . . . . 12.5 110.264 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 10.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 50.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 50.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 10.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 12.5 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 50.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 25.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.863 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 50.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 50.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 50.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 10.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 10.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 49' ' ' LEU . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 10.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 50.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 10.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 50.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 50.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 50.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 50.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 12.5 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 25.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 73' ' ' SER . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 10.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 50.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 50.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 10.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 50.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 50.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 50.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 12.5 110.629 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.9900000000000002 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.414 HG23 HG22 ' A' ' 39' ' ' THR . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 50.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 50.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.83 HD21 ' HB3' ' A' ' 23' ' ' LEU . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 50.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 12.5 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 50.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 50.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 50.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 50.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 50.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 50.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 50.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 50.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 50.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.46 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 50.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 50.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 50.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 50.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.83 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 50.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 50.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 50.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 50.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 50.0 109.901 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 50.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 50.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 50.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 50.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 50.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 50.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 50.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 50.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 10.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 50.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 50.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 12.5 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 10.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 50.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 25.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 10.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 10.0 110.133 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 10.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.463 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 10.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 10.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 50.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 12.5 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 10.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 10.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 50.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 10.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 10.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 12.5 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 10.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CE3' HG21 ' A' ' 101' ' ' THR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 50.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.334 0.588 . . . . 10.0 110.699 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' HD13 ' A' ' 74' ' ' ILE . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 50.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 73' ' ' SER . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 50.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 50.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 50.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 25.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 10.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 50.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 48' ' ' ILE . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 50.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 10.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 50.0 110.015 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 50.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.18 0.514 . . . . 12.5 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' O ' HG12 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 10.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 50.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 50.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 10.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 12.5 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 50.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CB ' HG23 ' A' ' 98' ' ' VAL . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 25.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 50.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' CB ' ' A' ' 96' ' ' LYS . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 50.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 10.0 110.752 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.61 HG21 ' CE3' ' A' ' 59' ' ' TRP . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 10.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 10.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 50.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 10.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.454 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 50.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 50.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 50.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 50.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 108' ' ' ALA . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 12.5 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 25.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 10.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 6' ' ' LEU . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 50.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 50.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 10.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 50.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 50.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 50.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 12.5 110.072 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.9900000000000002 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 50.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 50.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 50.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 6' ' ' LEU . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 12.5 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.813 ' HB2' HG12 ' A' ' 114' ' ' VAL . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 50.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 50.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 50.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 50.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 50.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 50.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 50.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.855 ' CE3' HD22 ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 50.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 50.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 50.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 50.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 50.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 50.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 50.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.855 HD22 ' CE3' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 50.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HA ' HD22 ' A' ' 6' ' ' LEU . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 50.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 50.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 50.0 110.443 -179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 50.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 50.0 110.21 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 50.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 50.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 50.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 50.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 50.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 50.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 50.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.664 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 50.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 10.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 50.0 110.01 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 50.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 12.5 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 10.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 50.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 25.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 10.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 10.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 10.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 10.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 50.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 12.5 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 10.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 10.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 50.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 10.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 10.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 12.5 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 10.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 50.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo . . . . . 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.29 0.567 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.544 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 50.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 50.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 50.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 50.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 25.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 10.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 48' ' ' ILE . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 50.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 10.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 50.0 110.278 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 50.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 12.5 110.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 10.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 50.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 50.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.769 HG21 HH21 ' A' ' 99' ' ' ARG . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 10.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 12.5 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 50.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 25.0 110.664 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 50.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 99' ' ' ARG . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 50.0 110.329 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.769 HH21 HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 50.0 110.285 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 10.0 110.18 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.466 ' HA ' HD13 ' A' ' 48' ' ' ILE . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 10.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 10.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 50.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 10.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 50.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 50.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 50.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 50.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 108' ' ' ALA . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 12.5 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 25.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 10.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.813 HG12 ' HB2' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 50.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 50.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 10.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.671 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 50.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 50.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 62.7 m-70 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 50.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 12.5 110.476 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.9900000000000002 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 111' ' ' VAL . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 50.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 50.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.869 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 50.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 12.5 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 50.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 50.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 50.0 110.09 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 50.0 109.653 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 50.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 50.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 50.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 50.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 50.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 50.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 50.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 50.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 50.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 50.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 50.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 50.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 50.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 50.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 50.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 50.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 50.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 50.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 50.0 110.377 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 50.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 50.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 50.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 50.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 50.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 10.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 50.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 50.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 12.5 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 51' ' ' ALA . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 10.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 25.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 10.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 10.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 10.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HA ' HG11 ' A' ' 42' ' ' VAL . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 10.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 10.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 50.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 12.5 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 10.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 10.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 50.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 10.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 12.5 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 10.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.979 0.419 . . . . 10.0 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.724 ' OG ' HD11 ' A' ' 113' ' ' ILE . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 50.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.71 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 50.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 50.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 25.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 10.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 50.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 ' HD3' ' A' ' 99' ' ' ARG . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 50.0 109.903 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 10.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 50.0 110.116 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 50.0 110.356 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.181 0.515 . . . . 12.5 110.14 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 10.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 50.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 50.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 10.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 12.5 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 50.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 25.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.595 ' HB2' HG23 ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 50.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 96' ' ' LYS . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 50.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.613 ' HD3' HD12 ' A' ' 80' ' ' ILE . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 50.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 103' ' ' ILE . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 10.0 110.26 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.462 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 10.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 10.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' C ' HD21 ' A' ' 100' ' ' LEU . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 50.0 110.273 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 10.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 10.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 50.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 50.0 110.382 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 50.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 50.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 3' ' ' VAL . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 12.5 110.181 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 25.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.724 HD11 ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 10.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.869 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 50.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 50.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 10.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 50.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 50.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 50.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 12.5 110.279 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.9900000000000002 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.901 HG22 ' HB ' ' A' ' 111' ' ' VAL . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 50.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 50.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 50.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.562 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 12.5 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 114' ' ' VAL . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 50.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 50.0 109.805 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 50.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 50.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 50.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 50.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 50.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 50.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 50.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 50.0 110.148 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 50.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 50.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 50.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 50.0 110.152 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 50.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 50.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 50.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 50.0 110.231 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 50.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 50.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 50.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 50.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 50.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 50.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 50.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 10.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 50.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 50.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 12.5 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 10.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 50.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 25.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 10.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 10.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 10.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.701 ' C ' HD23 ' A' ' 49' ' ' LEU . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 10.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 50.0 110.26 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 12.5 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 10.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 10.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 50.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 10.0 109.755 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 10.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 12.5 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 10.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 50.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.644 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.811 HG23 ' HB2' ' A' ' 97' ' ' ASP . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 50.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 50.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 50.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 25.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 50.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 50.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 105' ' ' SER . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 10.0 109.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 50.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 50.0 110.213 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.306 0.574 . . . . 12.5 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 10.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 50.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 50.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 10.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 12.5 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 50.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 25.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.811 ' HB2' HG23 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 50.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 74' ' ' ILE . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 50.0 110.633 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.607 HD22 ' CG2' ' A' ' 103' ' ' ILE . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 10.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 10.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 10.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.607 ' CG2' HD22 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 50.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 10.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 10.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD3' HG11 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.792 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 50.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 50.0 110.179 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 50.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 50.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.901 ' HB ' HG22 ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 12.5 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 25.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.715 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 10.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 6' ' ' LEU . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 50.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.478 ' OD1' ' CZ ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 10.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 50.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 50.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 56.3 m-70 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 50.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 12.5 110.277 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 110.261 -0.707 . . . . 4.9900000000000002 110.261 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 40' ' ' MET . 67.8 m -120.24 144.32 47.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 3.73 110.516 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 111' ' ' VAL . 99.2 t -132.26 124.47 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.837 . . . . 10.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -83.94 122.36 28.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 50.0 110.836 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 48.3 p90 -101.89 135.71 42.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 50.0 110.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.03 124.07 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 50.0 110.195 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 66.2 t30 -59.55 117.81 5.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 12.5 110.452 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.595 ' CE2' HD12 ' A' ' 120' ' ' LEU . 13.4 t80 -57.86 -28.07 63.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 50.0 109.766 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -66.47 -39.12 88.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 50.0 109.557 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.0 m -62.39 -25.21 67.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 50.0 109.679 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' LEU . 17.0 tp -65.95 -42.62 89.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 50.0 109.945 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -77.56 -53.21 7.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 50.0 109.923 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.5 -56.79 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 50.0 109.965 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 50.0 110.027 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.7 36.67 93.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.378 -1.489 . . . . 50.0 109.378 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -104.31 -173.37 2.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 50.0 110.259 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.4 m-20 -113.77 166.95 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.878 . . . . 50.0 110.049 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.439 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -79.93 -37.31 34.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 50.0 110.848 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 47.7 p30 -126.1 -10.33 6.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.006 -1.059 . . . . 50.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 1.5 t0 -71.37 -72.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.073 -1.017 . . . . 50.0 110.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -80.18 12.34 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 50.0 110.84 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' GLU . 50.5 m-20 46.8 53.42 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 50.0 109.851 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -39.5 -44.06 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.486 -0.759 . . . . 50.0 110.628 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -54.24 -27.79 37.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.954 . . . . 50.0 109.987 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 22' ' ' ASP . 11.9 mt-10 -97.57 -38.24 9.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 50.0 110.367 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -73.75 -33.13 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 50.0 110.348 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.29 -27.87 67.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 50.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.47 -16.95 60.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 50.0 109.882 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.68 -13.53 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 50.0 110.131 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.39 -72.62 0.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 50.0 110.165 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.59 70.91 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.326 -1.509 . . . . 50.0 109.326 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.81 -176.04 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 50.0 110.203 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.3 112.56 0.83 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 50.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -48.37 -33.7 11.96 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.301 -1.52 . . . . 50.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.13 -9.83 59.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -1.086 . . . . 50.0 110.054 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 22.5 m-20 -101.05 -42.58 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 50.0 110.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.514 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 6.0 t80 -129.52 148.82 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 50.0 110.141 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.57 160.47 10.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 10.0 109.558 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.13 116.67 25.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 50.0 110.097 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.695 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 tmm? -84.72 148.19 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 50.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.61 112.92 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 12.5 110.092 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 46' ' ' GLU . 2.0 p -136.09 144.66 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 10.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.45 26.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 50.0 110.148 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.57 122.89 18.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 25.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -16.57 29.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.186 -1.566 . . . . 10.0 109.186 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 2.4 tt0 -86.96 129.41 34.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.097 . . . . 10.0 109.981 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -50.74 117.1 2.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 10.0 110.345 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 106' ' ' PRO . 60.5 mt -49.82 -63.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.871 . . . . 10.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -41.45 -37.99 1.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -0.794 . . . . 10.0 110.279 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.33 -53.66 9.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.875 . . . . 50.0 110.093 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -52.76 -40.62 63.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 12.5 110.182 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.695 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.06 -31.87 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 10.0 110.084 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.1 -27.21 65.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 10.0 109.917 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.42 -26.92 60.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 50.0 110.124 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -83.77 -12.88 55.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 10.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.09 -6.38 19.54 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.457 -1.457 . . . . 10.0 109.457 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 24.2 m-85 -64.04 123.48 19.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 12.5 110.239 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 21.1 t0 -102.43 150.79 23.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 10.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 53.5 m95 -136.06 144.25 47.44 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 50.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 46.0 Cg_endo -72.4 77.78 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.949 1.499 . . . . 10.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -48.48 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 10.0 110.262 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.493 ' C ' ' S1 ' ' A' ' 130' ' ' FES . 15.2 t -85.12 43.61 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 10.0 110.229 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.1 OUTLIER -83.4 120.02 25.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.92 . . . . 10.0 110.113 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.51 172.48 8.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 10.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.86 117.33 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 10.0 110.136 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 99.66 93.16 2.08 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.449 -1.46 . . . . 10.0 109.449 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 66' ' ' GLY . . . 50.92 -179.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -1.164 . . . . 10.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 11.6 t -174.81 158.5 2.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 10.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' N ' ' SG ' ' A' ' 68' ' ' CYS . . . -171.04 33.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 25.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.8 m-20 -150.13 69.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 50.0 109.92 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 100' ' ' LEU . 34.2 m -60.98 -120.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 10.0 109.979 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . . . -173.28 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.843 -1.161 . . . . 10.0 110.423 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 74' ' ' ILE . 45.1 m -145.94 177.03 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.329 -0.857 . . . . 50.0 109.834 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 73' ' ' SER . 35.2 mm -144.76 88.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 50.0 110.171 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.6 p -53.91 118.58 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 50.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.49 -14.09 53.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 50.0 110.179 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.2 mm-40 172.51 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.872 . . . . 25.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 126.37 -177.42 17.22 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -131.29 147.47 52.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 50.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.2 147.45 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.307 -0.871 . . . . 50.0 110.242 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.8 159.1 15.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 10.0 110.216 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.0 ptm -167.47 177.26 6.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.163 -0.961 . . . . 50.0 110.353 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -57.5 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 50.0 110.043 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -49.37 -179.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 50.0 110.183 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 158.41 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.021 . . . . 16.66 110.464 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -178.4 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 50.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.3 mm -61.46 -50.12 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 50.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.12 168.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 12.5 110.223 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.77 138.98 36.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 12.5 110.074 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.77 -39.81 59.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 10.0 110.242 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -55.54 -27.99 52.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.875 . . . . 50.0 109.719 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.12 -37.8 66.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.431 -0.793 . . . . 50.0 109.837 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 15.9 t -77.94 -18.81 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -96.47 -40.64 8.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 12.5 110.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -92.02 -23.62 19.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 50.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -119.04 -16.37 9.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 25.0 110.376 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.756 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.0 m-20 56.07 21.14 4.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 50.0 110.42 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.5 p -82.54 168.27 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.981 . . . . 50.0 109.82 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.76 -169.11 0.2 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.996 -1.065 . . . . 50.0 110.942 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 1.4 mp -98.94 120.42 39.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.421 -0.799 . . . . 10.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 31.6 m -115.18 -20.16 10.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 10.0 110.231 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' HA ' HD22 ' A' ' 49' ' ' LEU . 83.7 m -55.02 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 10.0 110.086 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.24 32.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 50.0 110.021 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.408 . . . . 10.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -111.83 166.1 11.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.357 -1.084 . . . . 10.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 48' ' ' ILE . 46.1 Cg_endo -73.37 131.4 16.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.997 1.525 . . . . 10.0 110.621 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.94 -21.15 19.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 50.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.4 -173.65 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 50.0 110.09 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' THR . 27.4 t70 -85.04 -71.37 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.935 . . . . 50.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.8 mt-10 -96.75 106.21 18.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 50.0 109.74 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 78' ' ' GLY . 24.3 t -121.58 127.86 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 12.5 110.507 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 80.2 mttt -96.44 145.49 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 25.0 109.867 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.4 tt -160.03 147.75 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.251 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -92.82 135.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 50.0 109.829 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.29 163.94 12.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 50.0 110.146 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.4 OUTLIER 65.8 41.27 3.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.334 -0.854 . . . . 10.0 110.473 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -63.17 -20.54 65.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 50.0 109.951 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 3.0 pttt -42.46 -28.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 50.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 92.1 m-70 -62.29 -23.02 66.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 50.0 109.992 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.595 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -41.76 152.67 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.842 . . . . 12.5 110.442 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.65 -19.38 41.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 50.0 110.01 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -7.81 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 16.66 110.178 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLN . 1.3 mt -129.7 -29.71 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 50.0 110.533 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 127' ' ' VAL . 1.2 tt0 -42.41 -43.03 3.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 50.0 110.532 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -65.82 -37.07 85.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 50.0 110.493 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -89.53 24.65 2.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 50.0 110.347 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 25.4 t -73.45 -45.36 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.149 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' OXT' HG22 ' A' ' 128' ' ' ILE . 23.6 mm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.932 -1.032 . . . . 50.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.745 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.493 ' S1 ' ' C ' ' A' ' 62' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 110.411 -0.649 . . . . 4.9900000000000002 110.411 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.8 m -113.18 101.72 9.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 3.73 110.171 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.3 t -109.9 112.97 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 10.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 11.7 tt0 -82.47 119.39 24.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.935 . . . . 50.0 110.532 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 39.6 p90 -96.49 138.1 34.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 50.0 110.204 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -127.94 131.56 49.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.32 -0.862 . . . . 50.0 110.035 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 63.3 t30 -64.42 115.23 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 12.5 110.15 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 114' ' ' VAL . 10.5 t80 -58.48 -18.29 27.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 50.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.3 mt-10 -73.56 -41.62 62.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 50.0 109.869 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -57.48 -32.72 67.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 50.0 109.509 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.1 tp -73.28 -40.06 64.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 50.0 109.611 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -79.82 -42.51 24.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.79 . . . . 50.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -65.42 -40.09 92.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 50.0 110.105 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.42 -32.8 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.68 10.89 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.535 -1.426 . . . . 50.0 109.535 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CE2' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -109.46 -165.32 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -1.129 . . . . 50.0 110.333 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -121.73 147.85 45.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.787 . . . . 50.0 110.383 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.4 mtm -78.69 -33.82 46.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 25.2 p-10 -89.18 -40.71 12.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 50.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -79.07 -82.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 50.0 110.233 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' OD1' ' CE2' ' A' ' 16' ' ' TRP . 17.1 t70 -53.1 -19.35 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 50.0 110.386 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.73 56.86 3.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 50.0 110.107 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.72 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -39.51 -33.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.555 -0.716 . . . . 50.0 110.497 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.3 m-85 -55.3 -25.36 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 50.0 109.734 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.61 -43.26 4.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.375 -0.828 . . . . 50.0 110.243 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -22.46 64.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.52 -25.56 64.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -28.18 67.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 50.0 110.086 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -95.65 9.63 39.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 50.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.74 -22.84 12.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 50.0 110.102 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.74 27.35 54.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.48 -1.448 . . . . 50.0 109.48 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 139.32 41.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 50.0 110.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.35 156.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 50.0 110.128 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.37 -27.52 67.72 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.508 -1.437 . . . . 50.0 109.508 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.74 -6.8 22.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -1.118 . . . . 50.0 110.278 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 50.0 m-20 -117.72 -49.24 2.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 50.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -127.21 140.77 52.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 50.0 110.203 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.24 168.42 25.16 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 10.6 m -90.16 124.86 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -1.103 . . . . 50.0 110.33 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.836 ' HE2' ' HB2' ' A' ' 52' ' ' ALA . 2.2 tmm? -88.48 137.81 31.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.0 110.028 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 117.39 33.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 12.5 110.327 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.84 HG11 ' HD3' ' A' ' 106' ' ' PRO . 56.2 t -109.44 118.41 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 10.0 110.187 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -74.74 127.86 34.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 50.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -45.91 116.74 1.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 25.0 110.115 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.71 0.9 36.88 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.443 -1.463 . . . . 10.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 76.9 mm-40 -116.62 133.88 55.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -1.227 . . . . 10.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 38.2 m-85 -63.28 133.41 54.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 10.0 110.358 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.512 HD13 ' OG1' ' A' ' 101' ' ' THR . 7.5 mt -45.48 -64.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 10.0 110.188 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.535 HD11 ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -46.13 -30.84 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 10.0 110.079 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 3.0 tt0 -79.68 -46.93 16.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 50.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.3 81.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -0.94 . . . . 12.5 110.146 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' MET . . . -77.95 -27.07 49.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.436 -0.79 . . . . 10.0 110.051 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 3.5 mm-40 -62.68 -36.56 83.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 10.0 109.867 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.5 -4.8 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.753 . . . . 50.0 109.953 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.93 -23.42 14.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.873 . . . . 10.0 110.256 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.42 3.04 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.524 -1.431 . . . . 10.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.505 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 25.1 m-85 -101.99 102.0 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -1.125 . . . . 12.5 110.107 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 7.2 p-10 -88.54 113.55 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 10.0 110.495 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.027 ' HB3' HD11 ' A' ' 100' ' ' LEU . 38.3 m95 -102.07 140.21 20.97 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 50.0 109.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HG2' ' CB ' ' A' ' 72' ' ' ALA . 45.0 Cg_endo -72.69 74.21 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 10.0 110.31 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' CD2' HD11 ' A' ' 49' ' ' LEU . 7.7 p90 -100.98 156.84 17.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 10.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.39 82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 10.0 109.874 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 3.7 m -82.52 9.95 8.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.91 . . . . 10.0 110.204 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -53.39 -26.11 18.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 10.0 110.089 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 66' ' ' GLY . . . -72.83 137.04 45.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 10.0 110.043 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.81 123.36 4.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 52.72 94.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -1.117 . . . . 10.0 110.231 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.9 t -54.45 133.06 45.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 10.0 110.278 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.86 -64.86 1.02 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 25.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 38.3 p-10 -127.87 162.52 26.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 50.0 110.295 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 100' ' ' LEU . 61.3 m -104.9 -103.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 10.0 110.162 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.535 ' CA ' ' HB3' ' A' ' 117' ' ' ALA . . . -179.53 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.819 -1.176 . . . . 10.0 110.535 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.998 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -150.92 123.38 8.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 50.0 110.114 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 97' ' ' ASP . 23.7 mm -86.63 79.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 50.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.57 111.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 50.0 109.817 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -82.28 -12.51 57.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 50.0 110.674 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -178.79 161.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.016 -1.052 . . . . 25.0 110.413 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 83.63 159.33 28.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.474 -1.45 . . . . 10.0 109.474 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' C ' HD12 ' A' ' 80' ' ' ILE . 8.9 tt0 -132.15 161.69 32.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 50.0 110.113 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.887 HG12 HG21 ' A' ' 101' ' ' THR . 4.6 mp -120.86 162.08 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 50.0 110.062 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -121.02 125.08 46.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 10.0 110.428 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -178.97 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 50.0 109.989 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.03 153.22 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 50.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 42.3 mtm -62.71 91.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 50.0 110.227 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -156.04 -174.6 5.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 16.66 110.09 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -139.06 85.65 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 50.0 110.308 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 68' ' ' CYS . 20.4 mm -95.57 -4.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 50.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.83 163.62 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 12.5 110.129 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -104.27 157.58 17.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 12.5 110.282 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -60.79 -47.16 87.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 10.0 110.159 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -54.55 -20.16 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 50.0 109.694 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.74 -44.04 57.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 50.0 109.853 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 8.4 t -79.75 -13.4 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 10.0 109.776 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.6 -29.98 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 12.5 109.863 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -91.51 -42.14 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.813 . . . . 50.0 110.023 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HG23 ' A' ' 98' ' ' VAL . 9.6 tttt -115.15 -14.15 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 25.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.5 OUTLIER 61.31 25.86 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.205 -0.935 . . . . 50.0 110.005 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 96' ' ' LYS . 97.5 t -75.42 131.4 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 50.0 110.692 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER 176.04 96.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 50.0 110.072 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' A' ' 59' ' ' TRP . 3.7 tt -94.71 -8.13 38.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 10.0 110.294 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.887 HG21 HG12 ' A' ' 80' ' ' ILE . 43.6 p 43.56 77.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 10.0 110.232 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.17 -14.21 44.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 10.0 110.022 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 103' ' ' ILE . 17.6 mt -145.93 55.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 50.0 110.161 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.64 162.57 33.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.456 -1.458 . . . . 10.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -104.67 153.08 39.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -1.215 . . . . 10.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.84 ' HD3' HG11 ' A' ' 42' ' ' VAL . 48.3 Cg_endo -75.95 131.29 13.07 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.049 1.552 . . . . 10.0 110.348 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.6 -42.94 7.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 50.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.47 137.04 47.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.903 . . . . 50.0 110.28 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 1.6 p30 -60.41 -35.53 76.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 50.0 110.177 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 22.6 mt-10 -125.69 107.72 10.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 50.0 109.942 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 108' ' ' ALA . 62.3 t -117.1 122.3 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 12.5 110.543 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.3 mttt -92.21 139.8 30.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 25.0 109.592 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.998 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.21 151.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 10.0 110.597 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 113' ' ' ILE . 25.0 t -107.77 124.21 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 50.0 109.689 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.63 166.05 14.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 50.0 110.648 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 69.37 44.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.362 -0.836 . . . . 10.0 110.548 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HB3' ' CA ' ' A' ' 72' ' ' ALA . . . -66.78 -8.79 30.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.16 -0.962 . . . . 50.0 110.089 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' HA ' HD22 ' A' ' 123' ' ' LEU . 4.9 ptmt -60.75 -19.09 58.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 50.0 110.114 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 73.4 m-70 -72.37 -23.0 61.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 50.0 110.313 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -42.9 127.69 4.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 12.5 110.31 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.78 -28.16 54.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 50.0 110.347 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -77.46 -28.55 52.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 16.66 110.428 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -87.37 -35.53 18.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 50.0 110.272 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' LEU . 3.0 mt-30 -44.29 -26.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 50.0 110.336 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.34 -47.2 72.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 50.0 110.281 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -49.27 -38.4 27.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 50.0 110.286 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.43 131.41 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 50.0 110.231 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.07 -0.967 . . . . 50.0 110.207 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.445 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.453 -0.633 . . . . 4.9900000000000002 110.453 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -115.62 127.16 55.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 3.73 110.365 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' A' ' 111' ' ' VAL . 88.3 t -120.92 115.67 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 10.0 110.057 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.9 tt0 -81.59 115.65 20.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 50.0 110.605 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 33.9 p90 -90.99 140.34 29.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.955 . . . . 50.0 110.232 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.691 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -129.01 116.43 19.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 50.0 110.374 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 10' ' ' THR . 42.8 p-10 -52.95 123.85 12.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 12.5 110.083 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 7.0 t80 -58.68 -16.19 15.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 50.0 110.079 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -34.14 74.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 50.0 110.563 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 4.3 m -69.83 -31.84 69.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.117 -0.989 . . . . 50.0 110.17 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.7 -40.17 69.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 50.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.58 -54.05 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.377 -0.827 . . . . 50.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.66 -49.45 47.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 50.0 109.805 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -82.0 -19.49 40.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 50.0 109.896 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.33 38.7 96.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.366 -1.494 . . . . 50.0 109.366 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.05 -172.07 3.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -1.145 . . . . 50.0 110.164 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 32.6 m-20 -93.67 173.86 7.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 50.0 110.164 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mtp -80.12 -46.48 16.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 50.0 110.922 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.53 4.82 2.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.089 -1.007 . . . . 50.0 110.856 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 4.0 m-20 -78.17 -61.06 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 50.0 110.095 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 2.3 p30 -80.07 7.98 8.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.88 . . . . 50.0 110.364 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.2 m-20 46.84 53.47 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 50.0 109.821 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 16' ' ' TRP . 16.4 tp -38.74 -44.04 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 50.0 110.762 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 72.9 m-85 -49.36 -28.66 5.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 50.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.78 -40.69 13.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.602 -0.686 . . . . 50.0 110.058 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.6 mmtm -69.43 -19.59 63.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.327 -0.858 . . . . 50.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.85 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 109.878 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -28.52 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 50.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.15 -10.37 59.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.43 -13.48 23.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 50.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.97 34.48 83.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.41 -1.476 . . . . 50.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.89 170.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 50.0 110.407 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.89 165.47 24.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 50.0 110.083 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.37 -22.44 70.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.601 -1.399 . . . . 50.0 109.601 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 8.47 6.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 50.0 110.616 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -132.11 -45.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 20.8 t80 -133.12 135.67 45.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 50.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 172.95 165.86 30.57 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.665 ' CG2' HG22 ' A' ' 2' ' ' THR . 45.3 m -90.47 115.31 27.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -1.19 . . . . 50.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.68 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.98 97.28 9.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 50.0 110.294 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -94.59 106.46 18.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 12.5 109.971 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 51' ' ' ALA . 5.8 m -118.78 154.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 10.0 110.318 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 136.56 53.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 50.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 115.06 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 25.0 110.147 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.38 16.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.539 . . . . 10.0 109.251 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.11 149.02 39.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -1.186 . . . . 10.0 110.215 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 m-30 -79.12 125.29 29.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 10.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.4 mt -47.45 -55.66 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 10.0 110.466 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.24 -35.66 5.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 10.0 110.268 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.92 -49.62 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.971 . . . . 50.0 110.168 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -53.46 -43.72 68.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 12.5 110.172 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 57' ' ' TYR . . . -80.0 -32.15 39.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 10.0 110.144 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -55.03 -33.41 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 10.0 110.273 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -9.79 58.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 50.0 110.435 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -103.62 -27.21 12.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 10.0 110.271 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.26 28.75 1.92 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.65 -1.38 . . . . 10.0 109.65 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.727 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 46.1 m-85 -87.64 134.84 33.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 12.5 110.273 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 15.1 t70 -99.05 150.52 21.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 10.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CZ3' HG21 ' A' ' 101' ' ' THR . 66.9 m95 -143.42 159.64 54.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 50.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.98 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 46.8 Cg_endo -72.68 73.44 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 10.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.81 102.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.32 -0.863 . . . . 10.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 t -140.16 29.7 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 10.0 110.423 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -167.91 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 10.0 110.045 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' ALA . 3.2 tpp180 -164.15 39.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 10.0 110.377 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 64' ' ' ARG . . . 44.22 90.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 10.0 110.09 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.97 -100.63 0.62 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.176 -1.57 . . . . 10.0 109.176 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.61 168.86 12.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -1.182 . . . . 10.0 109.996 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.5 t -155.9 -80.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 10.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 46.43 25.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.138 -0.976 . . . . 25.0 110.323 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 71' ' ' CYS . 1.4 m-80 -127.69 1.66 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 50.0 110.229 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -58.29 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 10.0 110.195 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.98 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . . . -161.55 86.15 0.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.117 -0.99 . . . . 10.0 110.625 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.631 ' CB ' HD11 ' A' ' 113' ' ' ILE . 3.4 m -148.68 111.51 4.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 50.0 109.557 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.7 mm -88.64 79.48 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 50.0 110.531 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.8 p -50.39 110.87 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -0.876 . . . . 50.0 109.842 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.9 tppt? -83.6 -9.92 58.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.012 . . . . 50.0 110.506 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 179.98 168.38 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 25.0 110.283 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 78.53 -168.1 53.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -153.24 136.78 15.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -1.144 . . . . 50.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 99' ' ' ARG . 30.6 mt -99.45 175.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 50.0 110.095 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 t70 -122.7 158.18 30.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -0.906 . . . . 10.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.86 137.42 16.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 50.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.24 164.71 2.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 50.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.58 119.92 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 50.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -172.12 -155.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 16.66 110.011 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -92.02 95.48 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 50.0 110.271 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pt -74.3 169.28 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 50.0 110.223 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.3 mt -84.69 -171.46 3.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 12.5 110.244 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 5.0 m -110.5 144.22 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 12.5 110.219 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -47.39 -47.25 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 10.0 110.486 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -53.99 -29.01 41.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 50.0 109.791 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 7.1 mt-10 -79.9 -38.29 32.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 50.0 109.822 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -79.89 -18.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 10.0 110.14 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -92.07 -44.12 9.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 12.5 110.192 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 -21.22 19.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.4 -15.29 9.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 25.0 110.464 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.727 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.3 m-20 49.39 22.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 50.0 110.011 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' SER . 72.7 t -75.45 146.08 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 50.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HG2' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -157.79 168.29 27.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 50.0 109.876 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.43 HD22 ' S1 ' ' A' ' 130' ' ' FES . 45.2 mt -88.84 129.17 35.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 10.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.527 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 31.0 m -117.61 -8.39 10.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 10.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 88.6 m -68.14 -88.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.93 47.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 50.0 109.774 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.31 149.17 18.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.027 -1.229 . . . . 10.0 110.027 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 1.6 t -116.98 142.25 29.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.415 -1.05 . . . . 10.0 110.006 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 48.3 Cg_endo -73.41 147.78 41.99 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.939 1.494 . . . . 10.0 110.456 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.18 -33.61 4.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 50.0 110.527 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.79 157.06 21.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 50.0 110.363 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.8 -53.32 56.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 50.0 110.058 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.67 110.62 17.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.366 -0.834 . . . . 50.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 108' ' ' ALA . 45.7 t -117.23 137.3 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.224 -0.923 . . . . 12.5 110.439 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.9 mtmt -101.74 137.74 39.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 25.0 110.215 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 1.022 HD13 ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -160.13 143.96 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 10.0 110.351 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 1.022 ' N ' HD13 ' A' ' 113' ' ' ILE . 39.6 t -96.67 123.44 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 50.0 109.821 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -89.14 158.16 18.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 50.0 110.503 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.9 t-20 69.39 32.64 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 10.0 110.332 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.67 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.07 -17.77 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.063 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.708 ' N ' ' HB1' ' A' ' 72' ' ' ALA . 8.0 ptmt -54.78 -18.27 4.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 50.0 110.007 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 76.8 m-70 -74.36 -16.9 60.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 50.0 110.175 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -44.15 138.77 2.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 12.5 110.264 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.43 -29.52 41.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 50.0 110.07 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -76.65 -12.79 60.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 16.66 110.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.09 -34.33 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.932 ' O ' HG22 ' A' ' 127' ' ' VAL . 7.4 tt0 -70.65 -25.32 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 50.0 110.34 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -63.68 -10.86 21.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 50.0 110.215 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -60.31 -30.93 69.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 50.0 110.228 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.932 HG22 ' O ' ' A' ' 124' ' ' GLN . 16.2 m -78.21 92.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 50.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.023 -0.989 . . . . 50.0 110.278 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.43 ' S1 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.489 1.256 0 N-CA-C 110.466 -0.628 . . . . 4.9900000000000002 110.466 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ASP . 6.8 m -96.94 142.44 28.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 3.73 110.044 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 111' ' ' VAL . 23.1 t -140.5 126.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 10.0 110.38 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.944 ' OE1' HG23 ' A' ' 39' ' ' THR . 2.0 tp10 -87.49 117.04 26.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 50.0 110.075 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 47.9 p90 -95.5 135.7 36.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 50.0 110.642 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.839 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -129.79 122.37 28.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 50.0 109.831 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . 35.9 p-10 -57.13 128.93 39.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.885 . . . . 12.5 110.445 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE1' HD12 ' A' ' 120' ' ' LEU . 22.0 t80 -57.53 -18.26 18.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.86 . . . . 50.0 109.929 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -44.61 86.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.404 -0.81 . . . . 50.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.4 m -60.4 -35.15 75.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 50.0 109.905 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.12 -44.05 80.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 50.0 110.15 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -80.03 -60.68 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 50.0 110.129 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' ASP . 49.3 t0 -43.23 -51.4 6.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 50.0 110.229 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HB3' ' CE3' ' A' ' 16' ' ' TRP . 9.7 mm-40 -73.51 -35.56 65.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 50.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.14 52.9 5.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 50.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -111.3 -169.45 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 50.0 110.281 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 4.9 t0 -96.99 -168.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 50.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.6 mtt -76.08 -45.29 34.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 50.0 110.091 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -143.75 19.17 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 50.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 30.1 t0 -67.75 -65.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 50.0 110.33 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 9.0 t0 -80.09 9.35 5.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 50.0 110.513 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.0 51.91 12.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 50.0 109.906 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 16' ' ' TRP . 59.3 mt -44.08 -35.37 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 50.0 110.273 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 40.6 m-85 -57.11 -19.65 20.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 50.0 109.937 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.29 -43.26 5.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 50.0 110.178 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -20.55 60.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 50.0 110.061 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -63.93 -26.4 68.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.95 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.88 -13.68 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 50.0 110.088 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.53 -33.3 31.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 50.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.98 -52.9 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 50.0 110.162 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.0 71.69 0.92 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.431 -1.468 . . . . 50.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 12.7 mt -81.39 169.23 17.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -1.179 . . . . 50.0 110.079 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.49 146.32 16.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 50.0 110.202 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.83 82.13 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.337 -1.505 . . . . 50.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 18.4 pt-20 -79.39 4.26 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 50.0 109.963 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' ASN . 11.3 m-20 -116.4 -46.1 2.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 50.0 110.211 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 9.2 t80 -134.08 131.21 38.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 50.0 110.189 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 165.57 -179.23 40.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.944 HG23 ' OE1' ' A' ' 4' ' ' GLU . 1.2 m -94.53 136.38 34.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -1.134 . . . . 50.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 ttp -99.92 157.15 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 50.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -128.15 105.75 8.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 12.5 109.871 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 51' ' ' ALA . 6.5 t -109.19 128.84 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 10.0 110.571 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -79.83 125.11 29.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 50.0 109.953 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -42.09 117.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.233 -0.917 . . . . 25.0 110.301 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.56 3.42 40.48 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 1.7 mt-10 -117.56 126.81 53.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 10.0 110.232 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 103' ' ' ILE . 21.6 m-85 -54.91 138.49 43.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 10.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HG23 ' A' ' 80' ' ' ILE . 8.6 mt -49.32 -65.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 10.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -41.84 -33.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 10.0 110.053 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.6 tt0 -79.39 -48.04 14.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 50.0 109.872 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -53.07 -55.79 21.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 12.5 110.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -66.38 -32.33 73.66 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.546 -0.721 . . . . 10.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -64.15 -22.65 67.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.016 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.51 68.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 50.0 110.16 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -83.18 -24.55 32.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 10.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.31 7.92 5.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 10.0 109.767 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 12.1 m-85 -69.43 159.6 32.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.257 . . . . 12.5 109.963 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 40.6 t0 -126.86 138.68 53.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 10.0 110.69 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 15.2 m95 -135.89 149.22 68.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 50.0 109.752 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -70.83 109.13 2.44 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.898 1.472 . . . . 10.0 109.967 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.554 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 12.5 p90 -137.5 121.99 18.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 10.0 110.682 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 64' ' ' ARG . 2.3 p -138.93 43.87 2.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 10.0 109.793 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.429 ' HA ' ' SG ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -48.33 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 10.0 110.556 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.699 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 31.1 ttt180 -178.59 161.58 1.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 10.0 110.29 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 69.24 -67.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.897 . . . . 10.0 110.219 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . 177.25 117.89 0.53 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . 64.79 -165.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 10.0 110.188 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 71' ' ' CYS . 78.9 m -150.09 77.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 10.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.67 -58.67 4.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 25.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -39.07 57.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 50.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 68' ' ' CYS . 20.3 t -66.53 96.89 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.922 . . . . 10.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -153.01 145.15 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.553 ' O ' HD13 ' A' ' 74' ' ' ILE . 3.7 m -141.05 -176.91 4.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 50.0 109.906 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG23 ' HB2' ' A' ' 97' ' ' ASP . 42.4 mm -143.8 88.07 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 50.0 109.984 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.4 p -58.64 120.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 50.0 110.509 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 74' ' ' ILE . 5.9 mmtt -88.19 -10.56 49.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 50.0 109.82 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER 175.75 167.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 25.0 109.988 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.15 -170.07 44.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.75 142.97 28.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -1.198 . . . . 50.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 HD11 ' A' ' 48' ' ' ILE . 9.7 mt -113.59 144.32 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 50.0 110.109 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 111.64 23.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 10.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.18 133.27 56.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 50.0 110.143 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.66 140.44 47.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 50.0 110.233 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.67 120.55 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 50.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.16 -56.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.895 . . . . 16.66 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.13 161.17 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 50.0 110.175 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 87' ' ' ILE . 16.6 tt -80.68 130.87 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 50.0 110.427 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD21 HD23 ' A' ' 100' ' ' LEU . 89.5 mt -139.46 143.08 37.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 12.5 109.879 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.82 133.64 55.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 12.5 110.373 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -48.48 -39.54 23.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 10.0 110.193 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.45 -40.08 77.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 50.0 109.772 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.5 tt0 -54.41 -41.43 69.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 50.0 109.675 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.5 t -80.06 -23.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 10.0 110.104 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -87.18 -33.63 19.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 12.5 110.467 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 -33.28 7.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 50.0 110.821 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.557 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.4 mtmt -107.07 -14.42 14.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.145 -0.972 . . . . 25.0 110.642 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.731 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER 56.86 21.1 5.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.954 -1.091 . . . . 50.0 109.941 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' SER . 37.1 t -84.64 160.72 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 50.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -178.39 130.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 50.0 110.259 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 88' ' ' LEU . 2.6 mm? -58.6 115.3 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 10.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 99' ' ' ARG . 75.0 p -113.7 17.87 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 10.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 -41.08 39.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 10.0 110.182 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 47' ' ' TYR . 1.3 tt -128.39 39.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 50.0 110.361 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.28 151.08 17.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 10.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 158.78 34.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.162 -1.199 . . . . 10.0 110.212 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.92 119.01 5.65 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.049 1.552 . . . . 10.0 110.51 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.35 -21.18 31.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 50.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -112.98 140.39 47.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 50.0 110.04 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 2' ' ' THR . 11.4 m-20 -52.47 -64.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 50.0 110.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.87 124.64 34.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 50.0 110.138 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 3' ' ' VAL . 21.5 t -140.5 143.08 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 12.5 110.287 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 76' ' ' LYS . 20.4 mttm -118.45 136.44 53.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 25.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.0 tt -160.08 147.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 10.0 110.274 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -92.83 136.99 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 50.0 109.582 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.84 163.79 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 50.0 110.321 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.548 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER 67.52 45.04 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 10.0 110.25 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -65.11 -19.82 66.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 50.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 4.1 ptmt -49.18 -23.2 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 50.0 109.987 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 m-70 -63.77 -26.04 68.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 50.0 109.788 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -42.67 132.1 3.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 12.5 110.146 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.04 -31.92 73.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 50.0 110.275 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.526 ' HB3' HD23 ' A' ' 120' ' ' LEU . 12.8 t80 -65.55 -15.4 62.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 16.66 110.045 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -108.58 -25.26 10.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 50.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -67.21 -25.31 66.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 50.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.0 -24.05 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 50.0 110.145 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -83.66 -33.79 25.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.231 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.77 109.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 50.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 126' ' ' ARG . 36.2 pt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.047 -0.978 . . . . 50.0 110.138 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . 0.513 ' O ' ' ND2' ' A' ' 116' ' ' ASN . . . . . . . . 0 C--O 1.215 -0.712 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.554 ' S2 ' ' HA ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 26.9 m -109.46 127.24 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 3.73 110.132 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 111' ' ' VAL . 22.2 t -121.59 113.27 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 10.0 110.091 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -82.75 120.1 25.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 50.0 110.18 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.9 p90 -95.89 139.56 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 50.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -128.61 133.6 48.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.835 . . . . 50.0 110.263 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 64.7 t30 -65.16 120.65 13.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 12.5 110.549 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.9 t80 -55.21 -29.21 57.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 50.0 109.539 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -67.94 -38.47 82.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.47 -0.769 . . . . 50.0 109.656 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 39.7 m -56.55 -35.3 67.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 50.0 109.477 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.2 tp -72.13 -35.06 69.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.818 . . . . 50.0 109.873 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -80.06 -60.23 2.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.413 -0.804 . . . . 50.0 110.101 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -47.53 -50.28 23.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.182 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.52 -16.47 59.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 50.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.84 38.47 95.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.537 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -82.69 -176.17 6.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 50.0 110.212 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -92.61 174.59 7.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 50.0 110.102 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.476 ' HG3' ' HE3' ' A' ' 76' ' ' LYS . 38.1 ttm -77.91 -49.61 13.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 50.0 110.34 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.61 -4.09 4.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 50.0 110.527 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 6.0 t70 -75.15 -59.26 2.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -0.933 . . . . 50.0 110.317 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 38.4 m-20 -67.93 -13.92 62.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 50.0 110.038 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 50.27 51.86 15.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 50.0 110.22 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CB ' HD11 ' A' ' 6' ' ' LEU . 6.2 mt -41.84 -34.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.723 . . . . 50.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 27.6 m-85 -58.55 -17.34 20.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.073 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 -39.75 3.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 50.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.77 -23.93 55.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.2 -0.937 . . . . 50.0 110.147 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.81 -35.01 79.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 50.0 110.323 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.79 69.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 50.0 110.288 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.9 -28.91 16.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 50.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 50.0 110.236 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.76 65.33 1.35 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.438 -1.465 . . . . 50.0 109.438 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.62 174.51 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.181 . . . . 50.0 110.238 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 138.24 55.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 50.0 110.199 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -46.07 93.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.662 -1.375 . . . . 50.0 109.662 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -59.73 -16.08 24.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 50.0 110.234 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.556 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 24.0 m-20 -97.37 -53.56 3.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 50.0 110.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.6 t80 -122.97 145.52 48.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 50.0 110.249 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.59 166.39 21.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 10.0 109.58 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.586 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 6.6 m -87.82 119.29 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -1.139 . . . . 50.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.757 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -88.91 92.84 9.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 50.0 110.19 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.97 116.54 7.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 12.5 110.164 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' MET . 92.8 t -118.37 134.31 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 10.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.28 161.27 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.349 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -63.08 120.83 12.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.315 -0.866 . . . . 25.0 110.241 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.16 84.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 10.0 109.628 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 8.5 tt0 -89.02 128.64 35.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -1.103 . . . . 10.0 110.145 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 m-85 -62.51 134.24 56.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 10.0 110.038 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.52 -62.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 10.0 110.087 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 71' ' ' CYS . 24.1 tp -50.1 -24.98 3.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 10.0 110.342 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 2.1 tp10 -78.74 -50.2 11.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 50.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.98 67.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.951 . . . . 12.5 109.812 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.93 -25.77 40.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.441 -0.787 . . . . 10.0 110.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.36 -38.88 92.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 10.0 110.093 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.54 63.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 50.0 109.972 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -97.96 -3.49 38.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.37 38.05 11.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.226 -1.549 . . . . 10.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 6.1 m-30 -90.97 163.82 14.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 12.5 109.905 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -135.4 133.83 39.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 110.292 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 18.7 m95 -128.6 138.6 33.45 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 50.0 110.598 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' LYS . 50.5 Cg_endo -76.72 -179.72 5.64 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.124 1.592 . . . . 10.0 110.339 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.73 172.5 7.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.355 -0.841 . . . . 10.0 109.972 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.8 -35.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 10.0 110.397 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 174.05 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -0.974 . . . . 10.0 110.122 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -127.88 20.1 6.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 10.0 110.316 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.06 132.5 54.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -0.871 . . . . 10.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.76 -177.9 49.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 79.39 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -1.19 . . . . 10.0 110.15 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.567 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 3.4 t -57.87 117.92 4.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 10.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.76 -58.46 1.67 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 25.0 110.288 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' TRP . 2.8 p30 -159.0 103.69 1.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 50.0 110.148 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.525 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER 175.41 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 10.0 110.188 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.37 108.42 2.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 10.0 109.937 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 74' ' ' ILE . 3.1 m -129.01 -175.84 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.957 . . . . 50.0 110.859 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 74' ' ' ILE . 1.4 mp -124.48 88.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.785 -0.821 . . . . 50.0 108.785 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.6 p -54.11 109.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 50.0 110.412 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HE3' ' HG3' ' A' ' 18' ' ' MET . 4.3 tptt -83.9 -11.64 56.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.252 -0.905 . . . . 50.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' N ' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -179.29 173.92 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 25.0 110.121 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 88.44 -146.75 19.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 10.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -175.02 147.82 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -1.158 . . . . 50.0 110.26 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 mt -125.08 154.98 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.292 -0.88 . . . . 50.0 110.091 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.06 127.62 47.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 10.0 110.091 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 ptp -138.54 -167.22 2.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.905 . . . . 50.0 110.359 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.21 176.93 4.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 50.0 110.359 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.454 ' O ' ' OE1' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -74.3 157.89 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 50.0 110.27 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -164.07 173.61 12.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 16.66 110.211 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 -4.51 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 50.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 87' ' ' ILE . 4.0 tp -94.6 14.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 50.0 110.305 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.47 142.04 32.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 12.5 109.972 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -135.89 123.36 22.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 12.5 110.379 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -46.07 -51.28 14.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 10.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -54.31 -27.52 36.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 50.0 109.645 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 89' ' ' SER . 3.8 tt0 -62.42 -48.14 80.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 50.0 109.792 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 93.1 t -79.96 -35.13 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 10.0 109.964 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.08 -24.8 59.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.808 . . . . 12.5 110.39 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 3.3 tt0 -108.09 -35.7 6.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 50.0 110.671 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.78 -13.16 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 25.0 110.68 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.868 ' O ' HG12 ' A' ' 75' ' ' VAL . 8.7 m-20 59.13 14.68 3.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.119 -0.988 . . . . 50.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' VAL . 9.0 p -82.69 123.67 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 50.0 110.438 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.77 -143.36 0.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 50.0 109.93 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.44 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -119.48 -53.52 2.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 10.0 110.077 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.6 p 49.79 24.93 1.38 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 10.0 110.275 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -88.52 -50.4 6.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 10.0 109.76 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 103' ' ' ILE . 59.0 mt -148.45 39.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -0.847 . . . . 50.0 110.055 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -119.68 169.32 13.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.36 153.84 45.5 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.33 -1.1 . . . . 10.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 154.23 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.047 1.551 . . . . 10.0 110.435 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.03 -73.79 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 50.0 110.333 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.7 156.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 50.0 110.178 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -63.39 -56.37 16.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 50.0 110.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -103.88 115.18 29.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.865 . . . . 50.0 109.899 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.8 t -113.73 132.17 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.0 . . . . 12.5 110.48 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HD2' ' CD2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -100.46 135.94 41.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 25.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.751 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -159.99 154.01 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 10.0 110.282 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -113.83 125.99 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.474 -0.766 . . . . 50.0 109.817 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.21 167.48 13.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 50.0 110.064 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 m-20 68.68 47.0 0.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 10.0 110.246 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -67.41 -11.42 57.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 50.0 110.237 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 60' ' ' PRO . 4.0 ptmt -57.34 -16.8 9.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 50.0 110.017 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 57.9 m-70 -72.52 -22.85 60.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 50.0 110.054 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -41.69 113.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 12.5 110.359 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 0.9 OUTLIER -61.83 -30.2 70.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 50.0 110.015 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.99 -21.2 28.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 16.66 109.917 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.38 -20.68 12.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -0.819 . . . . 50.0 110.158 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -57.78 -33.18 68.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 50.0 110.305 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.0 -18.49 65.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 50.0 110.104 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -85.4 -14.68 45.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 50.0 110.324 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 124' ' ' GLN . 8.5 p -54.53 -23.0 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 50.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 128' ' ' ILE . 9.7 pt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.064 -0.969 . . . . 50.0 110.278 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.567 ' S2 ' ' HA ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.36 -0.669 . . . . 4.9900000000000002 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 4.7 m -104.82 135.93 45.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 3.73 110.147 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 21.8 t -130.81 111.79 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 10.0 110.02 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.49 113.94 19.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 50.0 110.512 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 51.2 p90 -92.11 140.4 29.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 50.0 110.05 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.589 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -133.18 129.01 37.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 50.0 110.415 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 44.1 t30 -64.67 106.62 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 12.5 110.003 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 6.0 t80 -56.16 -32.46 64.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 50.0 109.715 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -41.3 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 50.0 109.792 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 52.6 m -60.5 -34.02 73.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 50.0 109.73 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' C ' ' A' ' 16' ' ' TRP . 16.2 tp -65.82 -41.01 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 50.0 110.03 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.71 -34.68 45.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.16 -43.24 64.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.912 . . . . 50.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 10' ' ' THR . 5.1 tt0 -75.51 -13.9 60.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 50.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.13 71.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.374 -1.49 . . . . 50.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.839 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -86.26 -170.36 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.176 . . . . 50.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.494 ' CA ' HD11 ' A' ' 11' ' ' LEU . 8.5 m-20 -124.67 174.35 7.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 50.0 110.232 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.421 ' SD ' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -79.9 -48.47 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 50.0 110.23 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -124.54 -13.03 7.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 50.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -65.09 -64.82 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -0.957 . . . . 50.0 110.168 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -79.48 2.2 22.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 50.0 110.23 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.5 50.91 17.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 50.0 110.233 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD13 ' CD1' ' A' ' 16' ' ' TRP . 11.8 tp -49.54 -44.75 46.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 50.0 109.988 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 13.7 m-85 -53.4 -22.9 8.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 50.0 109.792 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -39.68 5.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.459 -0.776 . . . . 50.0 110.413 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.67 -29.28 59.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 50.0 110.144 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -63.71 -18.89 64.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 50.0 109.928 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.15 -24.64 57.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 50.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.45 -0.61 57.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 50.0 110.139 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.09 -69.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 50.0 110.123 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 46.56 0.56 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.641 -1.384 . . . . 50.0 109.641 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.59 173.74 2.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.116 -1.226 . . . . 50.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.28 163.28 3.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 50.0 110.28 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.565 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -83.25 -22.98 55.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 1.2 tt0 -77.81 -0.29 26.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -1.139 . . . . 50.0 110.121 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 -122.51 -49.65 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 50.0 110.123 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 21.1 t80 -132.73 143.84 49.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 50.0 110.321 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 157.99 162.44 11.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.555 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 21.7 m -84.09 122.12 28.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -1.156 . . . . 50.0 109.972 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 ttm -88.63 113.09 23.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 50.0 110.51 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 105.97 14.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 12.5 109.878 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 51' ' ' ALA . 5.0 t -109.62 113.1 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 10.0 110.366 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -56.49 160.14 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 50.0 109.988 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.68 117.62 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 25.0 110.25 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.2 66.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.525 -1.43 . . . . 10.0 109.525 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' CD ' ' A' ' 50' ' ' GLU . 1.6 tt0 -83.22 146.66 28.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.191 -1.182 . . . . 10.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -73.12 135.54 44.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 10.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 104' ' ' GLY . 25.4 mm -50.58 -54.56 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 10.0 110.347 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 102' ' ' CYS . 2.8 pp -54.68 -27.35 39.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.158 -0.963 . . . . 10.0 110.295 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 49' ' ' LEU . 21.5 tt0 -73.33 -48.12 36.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 50.0 110.313 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.28 -38.43 86.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 12.5 110.469 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.99 -40.3 28.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 10.0 109.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -63.76 -25.03 68.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.794 . . . . 10.0 109.929 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.04 -14.37 59.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 50.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 1.8 mt-30 -98.16 -19.59 17.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 10.0 109.982 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.53 32.6 2.9 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.3 m-30 -95.74 144.43 26.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -1.132 . . . . 12.5 110.433 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 4.8 p-10 -106.4 151.13 25.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 10.0 109.807 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 61.2 m95 -141.51 128.76 11.69 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 50.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 45.5 Cg_endo -72.1 -172.54 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.059 1.557 . . . . 10.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 5.2 t80 67.97 147.43 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 10.0 110.383 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -178.44 122.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 10.0 110.043 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.6 65.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 10.0 110.415 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' SER . 31.2 ttm-85 62.32 14.75 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 10.0 110.364 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.63 -162.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 10.0 110.063 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.48 -89.33 1.0 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.93 8.62 18.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 10.0 110.396 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 148.03 38.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 10.0 110.174 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.73 -89.7 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 25.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.544 ' HA ' ' S2 ' ' A' ' 130' ' ' FES . 0.4 OUTLIER 179.53 156.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 50.0 110.218 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 2.5 p -167.38 131.5 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.97 . . . . 10.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . 176.68 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 10.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.78 -169.67 2.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.147 -0.971 . . . . 50.0 110.62 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 97' ' ' ASP . 43.4 mm -142.42 80.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.432 -0.792 . . . . 50.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 97' ' ' ASP . 5.6 p -43.85 119.83 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HD3' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -93.2 -12.39 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.152 -0.967 . . . . 50.0 110.452 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.72 117.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.105 -0.997 . . . . 25.0 110.439 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.684 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 139.61 -172.29 23.38 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.896 ' HG2' ' HB2' ' A' ' 108' ' ' ALA . 11.9 pt-20 -143.91 126.69 16.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 50.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.2 mt -110.94 156.24 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 50.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 107' ' ' ALA . 0.4 OUTLIER -97.36 122.64 40.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.878 . . . . 10.0 110.2 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 100' ' ' LEU . 2.0 ttp -127.47 94.99 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 50.0 110.276 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -46.08 162.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 50.0 109.973 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 1.3 mmt -64.09 145.14 56.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 50.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.7 mt-30 -178.19 -36.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 16.66 110.172 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.1 129.65 34.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 50.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -46.58 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 50.0 110.329 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.62 178.87 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 12.5 110.026 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.0 t -155.45 163.17 40.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 12.5 110.324 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.7 p-10 -66.41 -31.97 73.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 10.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.52 -24.8 61.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 50.0 110.156 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 mt-10 -78.36 -34.68 48.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 50.0 110.317 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.0 p -79.21 -19.38 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -0.927 . . . . 10.0 109.973 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.79 -38.71 8.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 12.5 109.537 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -91.67 -28.3 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 50.0 109.97 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -110.45 -19.28 13.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 25.0 110.116 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.6 m-20 58.53 16.69 4.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 50.0 110.437 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 96' ' ' LYS . 10.1 p -87.16 159.58 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 50.0 110.349 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.74 138.51 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 50.0 110.265 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 82' ' ' MET . 7.7 tp -58.36 107.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 10.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.45 HG23 ' CG2' ' A' ' 48' ' ' ILE . 6.7 m -78.55 -10.53 59.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 10.0 110.152 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.887 ' HA ' HD23 ' A' ' 49' ' ' LEU . 73.8 m -93.73 133.85 36.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 10.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.672 ' O ' HG22 ' A' ' 103' ' ' ILE . 2.8 mp 55.7 16.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.229 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -104.28 128.74 9.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.29 -1.524 . . . . 10.0 109.29 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 8.7 p -108.86 147.43 35.83 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.207 -1.173 . . . . 10.0 110.13 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.87 138.25 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.025 1.539 . . . . 10.0 110.489 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -114.63 -5.76 12.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 50.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . . . -118.64 144.82 45.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 50.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -53.37 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 50.0 110.118 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -96.63 117.13 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 50.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 69.0 t -125.39 127.06 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 12.5 110.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 77' ' ' GLU . 2.1 mmtp -86.93 143.63 27.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 25.0 110.045 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.5 tt -160.05 142.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.885 . . . . 10.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.6 t -111.19 121.41 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 50.0 109.495 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.33 -169.27 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.101 -0.999 . . . . 50.0 110.598 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 0.2 OUTLIER 74.25 20.89 2.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -0.788 . . . . 10.0 109.948 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.862 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -37.13 -27.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.683 -0.636 . . . . 50.0 111.444 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 7.2 ptmt -41.36 -25.62 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 50.0 110.753 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 12.6 p80 -66.17 -22.99 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 50.0 110.491 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.453 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -46.48 143.11 2.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 12.5 110.408 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -45.53 71.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 50.0 110.289 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.6 -25.68 18.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 16.66 109.582 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -92.61 -35.81 13.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.493 -0.754 . . . . 50.0 109.921 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -43.74 97.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 110.142 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -67.18 -9.86 44.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.493 -0.755 . . . . 50.0 110.09 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.14 8.01 38.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 50.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.04 136.51 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.234 -0.916 . . . . 50.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.963 -1.018 . . . . 50.0 110.152 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.544 ' S2 ' ' HA ' ' A' ' 70' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 N-CA-C 110.377 -0.663 . . . . 4.9900000000000002 110.377 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' CG2' ' A' ' 39' ' ' THR . 23.4 m -102.62 117.55 34.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.824 . . . . 3.73 110.155 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 111' ' ' VAL . 90.0 t -111.98 168.61 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 10.0 110.267 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' N ' HG12 ' A' ' 3' ' ' VAL . 12.3 tt0 -131.02 106.96 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 50.0 109.825 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 36.8 p90 -92.41 142.14 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 50.0 110.717 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -132.64 127.97 36.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.519 -0.738 . . . . 50.0 109.834 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' OD1' ' CE1' ' A' ' 115' ' ' TYR . 66.8 t30 -65.16 116.9 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 12.5 110.359 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 27.3 t80 -58.28 -30.25 66.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 50.0 109.582 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 4.1 tt0 -65.34 -39.78 92.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 50.0 109.824 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 3.2 m -56.31 -33.38 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 50.0 109.429 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.015 HD21 ' O ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -60.49 -43.0 97.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 50.0 109.326 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -79.88 -38.42 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 50.0 109.84 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' THR . 1.3 m-20 -56.95 -55.33 36.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 50.0 109.858 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' HD21 ' A' ' 32' ' ' LEU . 4.2 mm-40 -69.61 -30.32 68.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.898 . . . . 50.0 109.975 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 47.7 4.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.358 -1.497 . . . . 50.0 109.358 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.729 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.8 m0 -114.3 176.21 5.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -1.155 . . . . 50.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 1.015 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -86.17 -162.66 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.922 . . . . 50.0 109.961 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.596 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.29 -44.62 64.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 50.0 110.251 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.04 26.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 50.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 1.2 m-20 -68.0 -67.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 50.0 110.335 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' ASP . 49.2 t0 -79.11 49.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 50.0 110.515 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 25' ' ' GLU . 6.4 m-20 42.3 56.89 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 50.0 110.266 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.7 mm? -43.25 -62.58 1.01 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.217 -0.927 . . . . 50.0 110.904 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CD1' HD12 ' A' ' 6' ' ' LEU . 39.5 m-85 -53.2 -30.5 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 50.0 110.469 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -88.41 -56.86 3.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 50.0 110.384 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' ASP . 12.2 tptt -55.78 -25.39 40.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 50.0 109.851 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.79 86.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.845 . . . . 50.0 110.023 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 37' ' ' TYR . . . -73.46 -19.29 60.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 50.0 109.91 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.12 -25.44 31.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 50.0 110.131 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.23 -25.21 24.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 50.0 110.15 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.85 36.52 7.75 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.604 -1.398 . . . . 50.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD21 ' NE2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -53.88 147.58 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -1.199 . . . . 50.0 110.223 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.12 138.29 31.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 50.0 110.427 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -22.77 49.63 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.193 -1.563 . . . . 50.0 109.193 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -74.34 -0.73 18.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -1.138 . . . . 50.0 110.046 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 85.6 m-20 -120.29 -53.04 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 50.0 110.228 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 30.2 t80 -121.72 149.0 43.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 50.0 110.352 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.36 179.48 37.83 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 10.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.52 ' CG2' HG23 ' A' ' 2' ' ' THR . 31.0 m -99.5 123.28 43.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 50.0 110.136 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.918 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -91.61 87.97 6.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 50.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.76 111.13 22.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 12.5 109.958 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 3.0 m -125.4 170.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 10.0 110.538 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.7 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 50.0 110.051 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.75 117.35 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 25.0 110.395 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.3 4.6 37.9 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.496 -1.441 . . . . 10.0 109.496 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' ' OE2' ' A' ' 50' ' ' GLU . 4.5 tp10 -104.22 118.5 36.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -1.188 . . . . 10.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 21.8 m-85 -44.73 118.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 10.0 110.278 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.758 HG23 ' CE ' ' A' ' 40' ' ' MET . 89.7 mt -43.66 -61.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 10.0 110.399 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 10.0 tp -42.04 -48.49 4.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 10.0 110.184 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' OE2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -65.68 -43.93 87.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 50.0 110.101 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -65.37 -39.8 92.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 12.5 110.34 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.918 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.02 -37.34 34.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 10.0 110.319 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 9.5 tp10 -60.04 -30.45 69.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 10.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.4 57.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 50.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.21 -22.43 14.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 10.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.46 4.39 5.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 10.0 109.642 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 23.3 m-85 -84.58 132.3 34.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 12.5 110.389 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.0 m-20 -113.13 148.96 34.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 10.0 109.825 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 29.6 m95 -131.44 163.69 47.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 50.0 110.44 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 43.8 Cg_endo -70.61 101.22 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.048 1.551 . . . . 10.0 110.387 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -69.09 72.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.88 . . . . 10.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 p -85.98 5.56 32.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 10.0 110.118 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.92 104.74 16.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 10.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 77.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 10.0 110.252 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.77 -40.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 10.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.12 -14.12 6.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.321 -1.512 . . . . 10.0 109.321 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.6 109.08 4.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -1.106 . . . . 10.0 109.915 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.4 t -142.98 148.7 37.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 10.0 110.217 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.75 10.99 1.61 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 25.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -145.76 141.19 27.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 50.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 100' ' ' LEU . 15.3 m -116.2 -136.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 10.0 110.106 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -144.25 58.58 1.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 10.0 110.556 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.591 ' CB ' HD11 ' A' ' 113' ' ' ILE . 2.3 m -125.08 113.04 17.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.191 -0.943 . . . . 50.0 110.037 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 97' ' ' ASP . 16.5 mm -88.67 78.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 50.0 109.977 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.663 ' CA ' HD12 ' A' ' 113' ' ' ILE . 9.5 p -51.74 118.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 50.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 24' ' ' PHE . 9.8 tppt? -84.98 -15.07 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 50.0 110.16 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.36 155.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 25.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.48 -150.18 16.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.468 . . . . 10.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -169.16 137.59 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -1.148 . . . . 50.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 105' ' ' SER . 69.5 mt -112.86 140.55 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 50.0 110.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' SER . 4.1 m-20 -80.1 117.4 20.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 10.0 109.894 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.8 mtm -102.97 -174.82 2.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 50.0 110.538 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.43 175.58 0.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 50.0 110.542 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ttp -79.98 85.25 5.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 50.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -173.13 -153.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.957 . . . . 16.66 110.42 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -148.26 -87.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 50.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 19.5 mt 56.54 170.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 50.0 110.662 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 13.5 mt 61.16 177.68 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 12.5 110.423 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -133.19 156.74 46.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.361 -0.837 . . . . 12.5 110.0 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -63.16 -38.06 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 10.0 110.281 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -30.5 11.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 50.0 109.401 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.85 -46.58 44.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.748 . . . . 50.0 109.585 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 98' ' ' VAL . 86.7 t -80.11 -5.65 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 10.0 109.786 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 15.8 mt-10 -99.55 -41.87 7.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 12.5 110.003 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.65 -52.22 5.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 50.0 110.33 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -88.66 -25.82 22.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 25.0 110.144 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.631 ' HB2' HG23 ' A' ' 74' ' ' ILE . 1.6 m-20 67.29 26.92 8.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.266 -0.896 . . . . 50.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.7 p -86.08 157.31 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 50.0 110.364 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -162.32 -165.52 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 50.0 110.06 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 71' ' ' CYS . 6.1 mp -107.79 125.76 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 10.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.2 t -127.8 5.93 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.88 . . . . 10.0 110.153 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.1 m -79.72 -29.93 40.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 10.0 110.297 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 9.4 pt -145.86 27.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -109.18 161.98 12.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.423 -1.471 . . . . 10.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 80' ' ' ILE . 2.5 p -122.89 166.5 17.57 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 10.0 110.224 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 105' ' ' SER . 45.0 Cg_endo -71.48 125.71 11.49 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.015 1.534 . . . . 10.0 110.503 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.61 -18.48 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 50.0 110.188 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.606 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -113.61 134.66 54.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 50.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER -42.99 -56.52 3.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 50.0 110.133 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 2' ' ' THR . 2.1 pp20? -109.47 131.88 54.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 50.0 110.117 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' HG22 ' A' ' 3' ' ' VAL . 48.0 t -142.41 155.22 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 12.5 110.409 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -131.43 142.08 49.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 25.0 110.126 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.663 HD12 ' CA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.06 156.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 10.0 110.275 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.2 t -107.01 116.97 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 50.0 109.526 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' CE1' ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -80.0 154.54 28.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 50.0 110.26 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.2 t-20 74.85 47.34 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.469 -0.769 . . . . 10.0 110.524 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.594 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -69.63 -11.48 60.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -0.952 . . . . 50.0 109.776 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.639 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.35 -18.36 37.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 50.0 110.12 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.593 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 65.9 m-70 -68.84 -31.06 69.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 50.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' OH ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -43.56 141.1 1.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 12.5 110.25 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.75 -28.95 52.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 50.0 110.29 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -72.29 -10.93 60.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 16.66 110.004 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -113.43 -37.94 4.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 50.0 110.13 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -57.06 -31.13 64.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 50.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' ARG . 2.2 m-20 -45.27 -38.35 5.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 50.0 109.891 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.98 -37.95 3.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 50.0 110.033 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 128' ' ' ILE . 70.0 t -58.86 -73.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 50.0 110.234 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 127' ' ' VAL . 1.2 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 50.0 110.192 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.736 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.488 1.166 0 N-CA-C 110.465 -0.629 . . . . 4.9900000000000002 110.465 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 39' ' ' THR . 76.9 m -113.59 121.85 45.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 3.73 110.311 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 40' ' ' MET . 39.7 t -115.89 115.02 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.818 . . . . 10.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 24' ' ' PHE . 4.9 tt0 -82.1 114.67 20.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 50.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -91.73 139.93 30.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 50.0 110.173 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.703 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -131.04 124.62 31.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.883 . . . . 50.0 110.318 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 49.5 t30 -60.64 125.74 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 12.5 110.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 36.9 t80 -61.41 -33.65 74.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 50.0 109.612 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -64.02 -34.06 77.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 50.0 109.732 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 m -63.27 -28.26 69.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 50.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -71.4 -48.14 51.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 50.0 110.06 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -77.89 -46.24 21.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 50.0 110.063 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 25.2 t0 -54.46 -58.35 7.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 50.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -66.37 -10.13 40.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 50.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.41 39.33 96.83 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.586 -1.406 . . . . 50.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.484 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -99.55 178.85 4.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 50.0 110.174 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.4 m-20 -90.96 -178.98 5.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 50.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.1 mtt -76.1 -51.21 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 50.0 110.318 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.67 7.61 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.972 . . . . 50.0 110.245 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 t0 -67.94 -54.59 17.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 50.0 110.081 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 34.9 t0 -79.0 -3.56 45.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 50.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 1.4 m-20 49.84 51.44 16.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 50.0 110.039 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 21.2 mt -46.72 -41.27 14.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.501 -0.75 . . . . 50.0 110.074 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE2' HD12 ' A' ' 6' ' ' LEU . 53.9 m-85 -48.26 -23.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.314 -0.866 . . . . 50.0 109.782 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -111.4 -42.65 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.748 . . . . 50.0 110.102 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -34.52 38.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 23' ' ' LEU . . . -63.31 -16.94 61.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 50.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.81 67.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 110.051 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.92 -27.97 63.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 50.0 110.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.79 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 50.0 110.42 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 93.29 42.6 4.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.282 -1.527 . . . . 50.0 109.282 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -51.54 -177.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -1.186 . . . . 50.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.71 141.67 58.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 50.0 110.129 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.65 -29.44 73.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.394 -1.483 . . . . 50.0 109.394 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -72.58 -2.29 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -1.146 . . . . 50.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 14.7 m-20 -121.15 -51.43 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 50.0 110.467 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 t80 -128.86 145.98 51.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.116 -0.99 . . . . 50.0 110.314 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.63 160.71 10.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 2' ' ' THR . 6.5 m -82.12 120.52 25.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -1.184 . . . . 50.0 110.168 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.727 ' HE3' HG23 ' A' ' 48' ' ' ILE . 1.7 tmm? -91.29 167.42 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.03 122.44 17.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 12.5 110.283 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' CB ' ' A' ' 51' ' ' ALA . 49.5 t -138.15 113.97 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 10.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.92 34.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 50.0 110.151 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -49.17 116.01 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 25.0 110.089 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.71 1.15 13.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.17 131.02 53.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 10.0 110.183 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.0 m-85 -72.66 140.95 48.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 10.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.727 HG23 ' HE3' ' A' ' 40' ' ' MET . 6.3 mt -53.09 -65.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 10.0 110.576 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.83 HD13 ' SG ' ' A' ' 102' ' ' CYS . 1.3 tt -42.33 -27.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 10.0 110.451 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 47' ' ' TYR . 41.1 tt0 -75.11 -57.52 3.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 50.0 109.916 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -60.64 -31.59 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 12.5 109.742 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.14 -41.79 24.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.828 . . . . 10.0 109.856 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tp10 -63.12 -31.47 72.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 10.0 109.825 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.04 -12.15 60.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 50.0 109.892 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -98.38 -23.76 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 10.0 110.055 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.42 7.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.6 m-30 -69.6 134.5 48.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -1.199 . . . . 12.5 110.159 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 12.4 m-20 -108.41 145.51 34.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 10.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.604 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 21.7 m95 -134.24 143.11 45.63 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 50.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 47.1 Cg_endo -73.85 156.94 48.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.038 1.546 . . . . 10.0 110.522 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 27.5 p90 -134.26 106.25 7.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 10.0 109.988 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -94.08 1.91 56.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 10.0 110.443 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.8 m -68.61 -175.4 0.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 10.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 6.0 ttt180 -137.74 56.64 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 10.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 65.01 -173.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 10.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.87 -170.18 2.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.32 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 10.0 110.398 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 110.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.295 -0.878 . . . . 10.0 110.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.1 -91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 25.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.74 157.51 42.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 50.0 110.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -144.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 10.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -146.35 91.47 2.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 10.0 110.847 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 74' ' ' ILE . 81.5 p -141.17 -176.3 4.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 50.0 109.634 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 73' ' ' SER . 47.6 mm -147.3 88.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 50.0 110.049 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.9 p -57.23 124.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 50.0 110.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.11 -8.51 48.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 50.0 110.005 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER 178.52 172.3 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 25.0 110.219 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 72.43 -174.52 44.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -139.89 156.04 46.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -1.147 . . . . 50.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 4.7 mt -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 50.0 109.948 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.89 146.11 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 10.0 110.551 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.8 ptm -140.88 -178.46 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 50.0 109.849 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -74.9 152.67 38.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 50.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.43 98.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 50.0 110.267 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -157.08 163.6 38.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.868 . . . . 16.66 110.111 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.26 114.55 28.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 50.0 110.206 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -149.96 152.99 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 50.0 110.269 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' A' ' 98' ' ' VAL . 3.4 tp 53.09 -174.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 12.5 110.116 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 t -124.94 153.51 42.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 12.5 110.096 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.97 -40.21 72.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 10.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -34.23 67.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.406 -0.809 . . . . 50.0 110.06 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.06 -34.15 66.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 50.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 71.7 t -80.04 -27.55 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 10.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.68 -40.45 12.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 12.5 110.308 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.22 -49.16 6.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.892 . . . . 50.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.1 tptt -82.91 -22.89 33.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 25.0 110.114 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' HG23 ' A' ' 74' ' ' ILE . 5.3 m-20 64.99 19.41 11.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.204 -0.935 . . . . 50.0 110.48 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 96' ' ' LYS . 19.2 m -81.04 157.89 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 50.0 110.279 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -175.97 120.44 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 50.0 110.084 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -42.75 136.16 2.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 10.0 110.245 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 99' ' ' ARG . 20.3 p -123.55 -8.1 8.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 10.0 110.185 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.83 ' SG ' HD13 ' A' ' 49' ' ' LEU . 12.9 m -64.9 -45.85 84.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 10.0 110.272 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 103' ' ' ILE . 7.2 mt -122.49 47.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 50.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.98 144.04 13.32 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 10.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 p -116.46 155.87 48.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.184 . . . . 10.0 110.187 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.5 Cg_endo -72.08 151.05 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.957 1.504 . . . . 10.0 110.426 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.42 -20.1 9.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 50.0 110.375 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -97.23 163.88 12.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 50.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.69 -72.3 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 50.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.81 99.31 10.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 50.0 110.316 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -106.2 135.33 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 12.5 110.173 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' LYS . 25.1 mttt -103.57 142.16 34.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 25.0 110.375 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.6 tt -160.12 155.11 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 10.0 110.281 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.2 t -113.98 130.61 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 50.0 109.809 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -92.57 168.05 11.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 50.0 110.268 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER 67.69 44.96 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 10.0 110.236 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -64.69 -14.41 58.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 50.0 110.022 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 1.1 ptmt -52.98 -19.29 2.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 50.0 110.227 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 73.2 m-70 -73.51 -21.49 60.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 50.0 110.239 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -42.16 130.37 3.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 12.5 110.431 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -41.55 87.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 50.0 109.935 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 16.9 t80 -70.23 -6.29 33.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 16.66 110.0 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.42 -8.07 5.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.903 . . . . 50.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 1.008 ' O ' HG22 ' A' ' 127' ' ' VAL . 7.5 mt-30 -54.75 -23.38 17.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.179 -0.951 . . . . 50.0 110.376 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -42.04 -33.03 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 50.0 110.487 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.9 -38.19 7.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.947 . . . . 50.0 110.256 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 124' ' ' GLN . 34.4 m -60.99 161.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 50.0 110.205 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.966 -1.016 . . . . 50.0 110.117 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.749 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.488 1.194 0 N-CA-C 110.369 -0.666 . . . . 4.9900000000000002 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 50.0 m -105.02 111.66 24.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 3.73 110.136 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.4 t -98.36 167.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 10.0 110.168 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 3' ' ' VAL . 2.7 tp10 -134.32 113.89 12.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 50.0 110.302 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 50.5 p90 -99.02 129.32 45.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 50.0 110.335 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 23' ' ' LEU . 1.8 tp -125.48 113.6 17.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.425 -0.797 . . . . 50.0 109.761 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' OD1' ' CE2' ' A' ' 115' ' ' TYR . 39.0 t30 -44.51 120.55 2.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.384 -0.822 . . . . 12.5 110.826 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 7.4 t80 -60.45 -37.28 80.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 50.0 109.699 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -59.41 -35.38 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 50.0 109.746 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 4.1 m -59.51 -28.16 66.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 50.0 109.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.5 tt -68.11 -51.32 47.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 50.0 109.623 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.07 -41.32 42.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.86 . . . . 50.0 109.693 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 14.3 t70 -47.58 -63.75 0.97 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 50.0 109.775 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -8.98 57.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 50.0 109.912 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.93 36.63 82.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.429 . . . . 50.0 109.526 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.666 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -86.3 175.75 8.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -1.125 . . . . 50.0 110.009 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -88.16 178.26 6.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 50.0 110.291 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 11' ' ' LEU . 6.1 mtt -74.39 -45.49 46.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 50.0 110.203 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.01 8.11 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 50.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -77.55 -57.91 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.997 . . . . 50.0 110.083 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 1.5 m-20 -77.38 -8.39 57.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.96 . . . . 50.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 m-20 51.99 51.4 16.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 50.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.829 ' HB3' HD21 ' A' ' 6' ' ' LEU . 35.1 mt -39.67 -43.2 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.616 -0.677 . . . . 50.0 110.184 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 76' ' ' LYS . 18.6 m-85 -45.98 -28.34 1.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 50.0 109.569 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -101.28 -47.99 4.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.703 . . . . 50.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -62.19 -28.44 69.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 50.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -7.49 35.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 50.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.69 -28.38 16.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 50.0 110.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -95.66 -14.78 23.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 50.0 110.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -12.87 46.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 50.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.76 45.08 77.94 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 50.0 109.546 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 174.37 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -1.184 . . . . 50.0 110.26 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 18.5 t70 -65.22 120.36 12.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 50.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.62 -31.98 5.44 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.808 -1.317 . . . . 50.0 109.808 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 5.4 mm-40 -71.28 -10.45 59.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -1.129 . . . . 50.0 110.363 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 78.4 m-20 -101.89 -47.0 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 50.0 110.265 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.0 t80 -130.91 145.23 51.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 50.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 167.36 167.4 27.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.522 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 3.6 m -86.65 129.65 34.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 50.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 mtp -94.58 88.59 5.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 50.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.51 116.96 7.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 12.5 110.118 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG11 ' CD ' ' A' ' 106' ' ' PRO . 79.4 t -116.11 123.79 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 10.0 110.276 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -75.25 116.77 16.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 50.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -41.66 116.17 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 25.0 110.297 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.56 5.95 20.19 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.379 -1.489 . . . . 10.0 109.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.82 153.1 43.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 10.0 110.198 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.0 m-85 -77.04 143.56 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.928 . . . . 10.0 110.194 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.824 HD13 ' HB ' ' A' ' 101' ' ' THR . 3.2 mt -52.15 -66.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 10.0 110.507 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.637 HD22 ' S1 ' ' A' ' 130' ' ' FES . 29.7 tp -41.88 -30.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 10.0 110.537 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -75.24 -55.8 5.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 50.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . -57.02 -37.13 71.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 12.5 110.041 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -76.78 -23.08 52.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 10.0 110.011 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -40.29 82.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 10.0 109.854 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 -6.01 45.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 50.0 110.217 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 51' ' ' ALA . 1.4 mp0 -99.1 -26.02 14.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 10.0 110.229 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.06 24.61 5.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.462 -1.455 . . . . 10.0 109.462 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.634 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 19.0 m-85 -94.89 117.43 30.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -1.122 . . . . 12.5 110.204 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.41 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.161 -0.962 . . . . 10.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CH2' ' HB2' ' A' ' 115' ' ' TYR . 95.3 m95 -137.8 159.53 68.42 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 50.0 110.539 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HB3' ' CG ' ' A' ' 118' ' ' LYS . 44.9 Cg_endo -72.56 148.03 46.98 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.23 1.648 . . . . 10.0 110.823 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 62.84 171.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 10.0 110.237 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 0.6 OUTLIER -143.57 -166.73 2.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.214 -0.928 . . . . 10.0 110.295 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 62' ' ' SER . 27.7 m -154.51 64.36 0.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 10.0 110.402 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -108.11 -21.31 12.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 10.0 110.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.78 -31.88 3.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 10.0 110.146 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.13 159.48 17.2 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -179.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -1.144 . . . . 10.0 110.429 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -89.47 81.43 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 10.0 110.289 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.17 32.35 1.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.91 . . . . 25.0 110.084 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 81.0 m-20 -120.72 -126.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 50.0 110.074 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 70' ' ' ASN . 29.1 m 57.0 173.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 10.0 110.417 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -168.81 117.18 0.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 10.0 109.983 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HD13 ' A' ' 74' ' ' ILE . 77.6 p -140.48 175.22 9.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 50.0 110.41 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 73' ' ' SER . 19.2 mm -139.29 84.39 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 50.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.4 p -51.36 115.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 50.0 110.313 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.29 -16.42 46.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 50.0 110.21 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.33 155.04 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 25.0 110.054 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 107.12 -157.05 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.36 -1.496 . . . . 10.0 109.36 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.5 153.67 17.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 50.0 110.244 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.26 141.39 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 50.0 110.18 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.9 146.23 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 10.0 110.26 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.2 ptm -157.23 -172.91 4.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 50.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.28 156.78 27.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 50.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.68 126.09 30.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 50.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.78 128.1 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 16.66 110.041 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -100.5 67.33 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 50.0 110.317 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -111.61 -17.75 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 50.0 110.139 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 93' ' ' VAL . 1.2 pp -111.02 174.58 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 12.5 110.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -111.03 121.54 45.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 12.5 109.817 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 15.7 p-10 -42.26 -43.04 3.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 10.0 110.279 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -29.89 63.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 50.0 109.938 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' SER . 11.2 tt0 -71.01 -38.54 72.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.834 . . . . 50.0 109.885 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 88' ' ' LEU . 39.5 t -74.17 -26.7 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 10.0 109.863 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 6.1 mt-10 -87.44 -44.13 11.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 12.5 110.119 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.08 -47.5 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 50.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -82.69 -15.26 52.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 25.0 110.405 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.9 m-20 60.03 15.05 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 50.0 110.415 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' SER . 64.4 t -80.76 151.48 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.034 -1.041 . . . . 50.0 110.388 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 100' ' ' LEU . 14.8 ttm-85 -167.08 159.58 13.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 50.0 110.324 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 3.2 mp -94.52 103.12 15.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 10.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.824 ' HB ' HD13 ' A' ' 48' ' ' ILE . 81.8 p -108.44 61.65 0.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 10.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -126.06 -29.59 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 10.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.36 13.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -0.963 . . . . 50.0 110.282 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' ILE . . . -128.64 171.79 19.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.09 43.67 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.377 -1.072 . . . . 10.0 110.103 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.696 ' CD ' HG11 ' A' ' 42' ' ' VAL . 45.8 Cg_endo -73.36 143.27 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.937 1.493 . . . . 10.0 110.331 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -112.01 -19.97 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 50.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -95.08 150.47 20.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 50.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -59.38 -60.13 4.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 50.0 110.122 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.43 119.14 38.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 50.0 110.135 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 108' ' ' ALA . 49.0 t -132.01 118.8 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 12.5 110.114 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 14.2 mttp -97.79 146.77 25.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 25.0 110.39 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 7.5 tt -160.1 141.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.83 . . . . 10.0 110.242 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 24.5 t -85.22 130.7 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 50.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.574 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -99.15 151.63 20.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 50.0 110.0 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.51 43.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 10.0 109.916 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -66.38 -21.83 66.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 50.0 110.351 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 2.8 ptmt -47.6 -23.43 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 50.0 110.047 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.533 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 77.9 m-70 -67.73 -24.03 65.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 50.0 109.994 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 123' ' ' LEU . 55.9 tp -49.71 116.17 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 12.5 110.276 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -45.51 -35.63 3.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 50.0 110.195 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -30.73 69.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 16.66 110.164 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.74 HD12 HD23 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -97.93 -26.32 14.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 50.0 110.165 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 mt-30 -70.11 -23.16 62.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 50.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.98 -5.42 17.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 50.0 110.646 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -82.73 4.98 22.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 50.0 110.376 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 124' ' ' GLN . 24.9 m -79.83 170.94 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 50.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.99 -1.005 . . . . 50.0 110.211 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.637 ' S1 ' HD22 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.556 -0.594 . . . . 4.9900000000000002 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 109' ' ' ASP . 16.3 m -102.02 141.19 35.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 3.73 110.09 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.1 t -135.21 106.81 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 10.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 29.8 tt0 -83.58 116.09 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.893 . . . . 50.0 110.215 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 34.3 p90 -92.35 146.15 23.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.925 . . . . 50.0 110.559 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.864 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.32 129.06 26.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.839 . . . . 50.0 109.984 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.584 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.9 t30 -63.07 124.59 21.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.025 -1.047 . . . . 12.5 110.365 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 4.6 t80 -61.48 -34.44 75.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 50.0 109.751 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' OE2' ' ND1' ' A' ' 119' ' ' HIS . 3.3 tp10 -62.89 -33.13 74.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 50.0 110.036 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 26.6 m -60.56 -39.34 87.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.917 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.04 -35.43 80.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 50.0 109.765 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.8 -40.48 28.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 50.0 109.784 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.35 -54.1 45.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 109.961 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -14.69 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 50.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.31 35.59 91.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.383 -1.487 . . . . 50.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -91.62 175.72 6.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -1.091 . . . . 50.0 110.34 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' ' 23' ' ' LEU . 17.5 m-20 -83.57 179.22 7.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 50.0 110.33 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 ttm -76.08 -46.53 28.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.352 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -135.2 3.66 3.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 50.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -74.32 -51.98 13.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 50.0 110.274 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 2.1 m-20 -79.9 -2.21 42.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 50.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.0 OUTLIER 48.47 51.95 14.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 50.0 109.985 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.5 mp -41.62 -47.41 3.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 50.0 110.347 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.4 m-85 -49.52 -23.48 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 50.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.66 -46.82 4.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.525 -0.735 . . . . 50.0 110.231 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -22.18 64.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 50.0 110.105 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.11 85.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 50.0 110.275 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.13 -26.08 65.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 50.0 110.089 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -81.82 -37.21 27.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 50.0 109.991 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.85 -13.58 60.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 50.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 59.0 38.55 93.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.194 -1.562 . . . . 50.0 109.194 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 31' ' ' GLY . 9.3 mt -50.53 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -1.121 . . . . 50.0 110.494 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.46 164.19 27.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.25 -0.906 . . . . 50.0 110.386 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.56 -23.26 40.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.396 -1.481 . . . . 50.0 109.396 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.28 5.17 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.136 . . . . 50.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.584 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 87.1 m-20 -128.7 -46.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.833 . . . . 50.0 109.971 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 14.4 t80 -127.93 145.21 51.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 50.0 109.946 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.89 159.32 10.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.38 -1.488 . . . . 10.0 109.38 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -87.3 113.54 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 50.0 110.114 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.811 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -89.61 71.0 7.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 50.0 110.151 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 45.2 mt-10 -75.48 115.64 15.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 12.5 110.161 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 46' ' ' GLU . 33.3 m -132.57 150.09 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 10.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -63.61 155.82 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 50.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.71 114.11 2.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.867 . . . . 25.0 110.172 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.75 5.13 24.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.252 -1.539 . . . . 10.0 109.252 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -87.9 109.16 19.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 10.0 110.147 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ILE . 35.7 m-85 -50.88 112.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.87 . . . . 10.0 109.999 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' THR . 23.7 mm -41.85 -74.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.87 . . . . 10.0 110.718 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -41.61 -27.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 10.0 110.278 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -79.63 -54.7 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 50.0 109.97 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -39.96 64.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.947 . . . . 12.5 110.083 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.811 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.7 -26.13 44.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 10.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.4 mm-40 -63.73 -31.44 72.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 10.0 109.87 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.52 -7.54 52.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.436 -0.79 . . . . 50.0 110.166 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -106.31 -20.24 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 10.0 110.198 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.99 14.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.288 -1.525 . . . . 10.0 109.288 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 57' ' ' TYR . 8.7 m-30 -73.19 139.08 46.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -1.118 . . . . 12.5 110.116 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 32.8 t0 -97.1 143.67 27.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 10.0 110.214 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 79.6 m95 -137.09 164.85 39.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 50.0 109.916 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HG3' ' HB3' ' A' ' 72' ' ' ALA . 42.2 Cg_endo -69.36 124.2 11.01 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.877 1.462 . . . . 10.0 110.814 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.644 ' HB3' ' S2 ' ' A' ' 130' ' ' FES . 12.1 m-85 52.45 174.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 10.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -145.46 65.07 1.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 10.0 110.201 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 3.7 m -42.62 137.49 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 10.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 -69.81 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 10.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.0 -2.21 21.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 10.0 110.573 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.03 149.39 21.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.586 -1.406 . . . . 10.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . . . -86.04 159.87 19.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -1.154 . . . . 10.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 28.1 p -108.09 40.06 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 10.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 67.77 71.76 0.33 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 25.0 110.238 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 88' ' ' LEU . 1.2 m-20 66.01 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.249 -0.907 . . . . 50.0 110.458 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 10.0 109.996 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -145.39 80.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.103 -0.998 . . . . 10.0 110.424 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 74' ' ' ILE . 3.7 t -139.13 -173.24 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 50.0 110.208 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 26.5 mm -149.11 86.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 50.0 110.301 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.4 p -59.26 120.47 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 50.0 110.005 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -83.08 -13.34 55.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 50.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 175.76 151.56 0.13 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.89 . . . . 25.0 110.001 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.06 -164.01 15.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.338 -1.505 . . . . 10.0 109.338 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -155.56 140.57 17.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -1.205 . . . . 50.0 110.368 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 81' ' ' ASP . 17.0 mt -102.23 170.75 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 50.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 12.7 t70 -124.46 152.17 43.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.86 . . . . 10.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 178.86 7.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 50.0 110.298 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 84' ' ' MET . 27.0 t0 -71.64 167.44 19.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 50.0 110.24 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.435 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -43.78 134.67 4.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 50.0 109.892 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.74 HE22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -155.39 151.03 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 16.66 110.375 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.14 60.74 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 50.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.57 -61.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.846 . . . . 50.0 110.219 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.74 HD21 HE22 ' A' ' 85' ' ' GLN . 0.5 OUTLIER -58.95 157.2 10.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 12.5 110.063 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.48 140.97 29.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 12.5 110.267 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -49.09 -47.94 44.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 10.0 109.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 62.1 mt-10 -55.8 -21.85 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.427 -0.796 . . . . 50.0 109.782 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 5.6 tt0 -73.49 -43.98 58.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 50.0 109.955 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.31 -23.18 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 10.0 109.914 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 -42.73 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 12.5 110.029 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -88.36 -34.59 17.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 50.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -100.29 -11.2 20.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 25.0 110.112 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.4 m-20 55.03 17.7 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.284 -0.885 . . . . 50.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 99' ' ' ARG . 12.1 p -83.85 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 50.0 110.651 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 178.15 -173.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.469 -0.77 . . . . 50.0 109.735 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.04 128.89 46.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 10.0 110.148 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -117.02 -18.81 10.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 10.0 110.545 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.0 m -62.76 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 10.0 110.323 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.7 74.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 50.0 110.063 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.93 148.58 15.47 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 81' ' ' ASP . 5.1 p -115.7 148.58 41.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.099 . . . . 10.0 110.065 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 45.4 Cg_endo -71.48 133.56 22.69 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.967 1.509 . . . . 10.0 110.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -97.55 -65.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 50.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.12 152.65 1.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 50.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -61.67 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 50.0 110.35 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -88.08 118.01 27.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 50.0 110.401 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.8 t -130.16 119.67 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 12.5 110.234 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.0 mttt -94.51 144.38 25.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 25.0 110.26 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.5 tt -160.1 164.41 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 10.0 110.399 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.864 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.8 t -122.78 125.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 50.0 109.959 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -89.09 163.42 15.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 50.0 110.346 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t-20 76.7 62.44 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.563 -0.711 . . . . 10.0 110.043 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -81.73 3.64 24.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 50.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 123' ' ' LEU . 45.6 mtpt -73.17 -17.92 61.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 50.0 110.021 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.5 m-70 -85.09 -7.62 59.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -0.837 . . . . 50.0 110.272 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -52.32 154.27 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 12.5 110.088 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 122' ' ' TYR . 7.2 p30 -61.77 -12.43 16.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 50.0 110.382 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 27.2 t80 -71.02 -26.4 63.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 16.66 110.308 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 118' ' ' LYS . 3.0 mt -110.34 -33.46 6.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 50.0 110.305 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 50.0 110.193 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -6.59 35.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 50.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 123' ' ' LEU . 2.3 ttt180 -82.88 -19.5 37.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 50.0 110.204 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.5 t -71.72 156.85 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 50.0 110.285 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 128' ' ' ILE . 18.9 mm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 50.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.644 ' S2 ' ' HB3' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 46.7 Cg_endo . . . . . 0 N--CA 1.488 1.181 0 N-CA-C 110.441 -0.638 . . . . 4.9900000000000002 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.521 HG23 ' CG2' ' A' ' 39' ' ' THR . 5.3 m -104.72 117.92 35.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.341 -0.849 . . . . 3.73 110.078 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.92 HG22 ' HB ' ' A' ' 111' ' ' VAL . 25.6 t -104.66 166.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 10.0 110.169 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.4 tt0 -134.17 114.43 13.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.954 . . . . 50.0 110.214 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 37.9 p90 -94.46 137.73 33.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 50.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.02 118.11 17.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.515 -0.741 . . . . 50.0 110.21 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' ND2' ' OD2' ' A' ' 36' ' ' ASP . 36.1 p-10 -56.46 122.45 11.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 12.5 109.791 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.538 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 13.4 t80 -56.21 -18.81 11.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 50.0 109.926 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 13' ' ' ASP . 32.6 tt0 -64.36 -42.34 96.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 50.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 HD21 ' A' ' 23' ' ' LEU . 4.1 m -57.36 -33.3 67.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 50.0 109.683 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -70.97 -48.05 55.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 50.0 109.94 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.2 -55.36 5.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 50.0 109.958 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . 15.2 t0 -51.12 -49.61 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 50.0 109.969 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -80.4 -25.11 39.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 50.0 110.199 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.82 46.74 51.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CB ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -99.47 -179.55 4.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -1.192 . . . . 50.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -103.57 -177.82 3.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -0.92 . . . . 50.0 110.277 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -80.02 -51.62 8.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 50.0 110.637 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 36.3 p-10 -123.0 -16.81 6.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.96 . . . . 50.0 110.553 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 54.8 t0 -59.63 -71.2 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 50.0 110.228 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.543 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 54.7 m-20 -79.73 6.44 10.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 50.0 110.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' GLU . 1.0 OUTLIER 47.65 51.51 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' A' ' 16' ' ' TRP . 16.9 tp -42.56 -51.5 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 50.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.2 m-85 -47.97 -24.29 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.369 -0.832 . . . . 50.0 109.535 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -97.35 -48.83 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.474 -0.766 . . . . 50.0 110.438 -179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -17.55 13.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 50.0 110.084 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -67.62 -44.2 78.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 50.0 110.012 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.65 -23.36 64.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 50.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -85.09 -25.3 27.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.909 . . . . 50.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.99 -45.98 22.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 50.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.72 47.84 2.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.547 -1.421 . . . . 50.0 109.547 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.67 165.12 24.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -1.181 . . . . 50.0 110.114 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.42 156.45 19.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 50.0 110.35 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -67.25 -24.02 73.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.19 -0.31 16.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 50.0 110.283 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -116.42 -52.18 2.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 50.0 110.473 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.0 t80 -132.88 141.98 48.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 50.0 110.515 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.84 176.26 37.05 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.598 -1.401 . . . . 10.0 109.598 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 2' ' ' THR . 88.9 m -94.65 128.96 41.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -1.139 . . . . 50.0 110.285 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.6 mtp -97.25 75.77 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 50.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -59.61 103.62 0.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 12.5 110.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 51' ' ' ALA . 46.9 t -104.59 131.07 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 10.0 110.294 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.27 131.35 39.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 50.0 110.151 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -49.68 116.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 25.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 5.14 34.23 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.449 . . . . 10.0 109.479 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -116.33 114.92 24.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -1.196 . . . . 10.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 17.6 m-85 -44.76 148.32 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 10.0 110.168 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.621 HG21 ' HG ' ' A' ' 100' ' ' LEU . 2.7 mp -58.26 -57.7 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 10.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 101' ' ' THR . 2.5 pp -51.33 -21.04 1.95 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 10.0 109.921 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -80.0 -56.44 4.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 50.0 110.608 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.726 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -63.06 -31.08 72.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 12.5 110.479 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -42.82 22.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 10.0 110.382 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -59.41 -31.22 69.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.36 -0.837 . . . . 10.0 109.91 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.39 -6.23 54.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 50.0 109.991 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.1 mt-30 -104.76 -15.3 15.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 10.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.68 6.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.701 -1.359 . . . . 10.0 109.701 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 55' ' ' GLN . 14.2 m-30 -95.17 151.91 18.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 12.5 110.235 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 17.4 t0 -126.72 136.86 53.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 10.0 109.53 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 18.8 m95 -131.4 163.88 46.43 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.016 . . . . 50.0 110.775 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.765 ' CG ' ' HB3' ' A' ' 72' ' ' ALA . 45.5 Cg_endo -75.14 71.64 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.137 1.598 . . . . 10.0 110.357 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 35.3 p90 -107.94 -163.18 0.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 10.0 110.15 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER 68.63 18.98 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 10.0 110.559 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 19.0 p -70.65 64.74 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 10.0 110.195 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 62' ' ' SER . 1.9 mmp_? -72.12 -15.11 61.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.85 . . . . 10.0 110.038 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.82 -179.72 8.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 10.0 110.221 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 67' ' ' ALA . . . 95.4 -94.09 1.67 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . 177.15 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 10.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 51.8 t -133.17 -91.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 10.0 109.923 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 58.18 13.23 2.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.042 . . . . 25.0 110.759 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.48 ' O ' ' CG1' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -154.49 17.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 50.0 110.438 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.606 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 5.5 m 42.51 -139.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.32 -0.863 . . . . 10.0 110.065 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.765 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . -167.8 72.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.01 -1.056 . . . . 10.0 110.565 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.948 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -146.62 112.67 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.25 -0.907 . . . . 50.0 109.811 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 43.3 mm -83.24 95.44 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 50.0 110.083 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -61.65 115.81 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.863 . . . . 50.0 110.3 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -85.31 -9.73 57.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.016 -1.052 . . . . 50.0 110.527 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -179.47 153.53 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 25.0 110.437 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.83 -172.47 23.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 10.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.1 mm-40 -138.63 168.98 18.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 50.0 110.124 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.447 HD13 HD12 ' A' ' 100' ' ' LEU . 23.4 mt -135.15 138.9 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 50.0 110.285 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.45 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 10.0 110.023 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -133.99 -175.38 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 50.0 110.217 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -117.21 177.57 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 50.0 109.933 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.3 ttp -61.22 108.59 0.93 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.12 -0.988 . . . . 50.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -177.75 131.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 16.66 110.292 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.1 tp60 66.05 -149.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 50.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ILE . 6.3 tp -139.47 131.72 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 50.0 110.287 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.95 142.75 18.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 12.5 109.945 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.7 p -130.17 153.59 48.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 12.5 110.326 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.61 ' O ' HG12 ' A' ' 93' ' ' VAL . 30.9 t0 -65.57 -43.6 89.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -0.89 . . . . 10.0 110.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 6.6 pt-20 -51.34 -23.74 3.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 50.0 109.296 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -76.2 -43.27 43.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.755 . . . . 50.0 109.666 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 90' ' ' ASP . 3.8 p -79.96 -14.75 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 10.0 110.061 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -93.39 -41.47 9.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 12.5 110.062 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 3.1 tt0 -92.32 -40.92 10.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 50.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 13.9 mttm -105.27 -20.3 13.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 25.0 110.22 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 4.2 m-20 57.25 24.41 9.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.3 -0.875 . . . . 50.0 110.696 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' SER . 39.4 t -89.96 125.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.016 -1.052 . . . . 50.0 110.597 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER 171.21 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 50.0 110.139 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 48' ' ' ILE . 3.0 tp 67.48 -153.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.922 . . . . 10.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.77 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.4 m 57.08 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 10.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.558 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.2 m -44.0 168.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.86 . . . . 10.0 110.597 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' CYS . 22.2 mt -41.67 152.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 50.0 110.466 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . 138.9 152.94 6.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 p -117.13 160.88 35.54 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.239 -1.154 . . . . 10.0 110.228 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.04 141.87 37.31 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.017 1.535 . . . . 10.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 79' ' ' GLU . . . -101.7 -24.62 14.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 50.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.76 145.22 44.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 50.0 110.303 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -47.82 -75.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 50.0 110.057 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -80.36 131.09 35.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 50.0 110.079 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.92 ' HB ' HG22 ' A' ' 3' ' ' VAL . 10.5 t -141.66 103.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 12.5 110.471 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.2 mmtp -82.59 143.97 30.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 25.0 109.806 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 73' ' ' SER . 0.0 OUTLIER -160.15 157.06 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.018 . . . . 10.0 110.401 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.766 ' N ' HD13 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -108.74 115.27 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 50.0 109.204 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -85.44 157.07 20.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.422 -0.799 . . . . 50.0 109.833 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.2 t-20 72.18 39.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 10.0 109.826 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -64.53 -11.12 30.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 50.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -13.27 12.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 50.0 110.181 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 83.7 m-70 -75.54 -26.84 58.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 50.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -40.81 138.15 1.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.435 -0.79 . . . . 12.5 110.345 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.76 42.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 50.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.79 -30.49 68.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 16.66 109.799 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.9 mm? -84.59 -35.06 23.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 50.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -63.65 -23.72 67.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 50.0 110.133 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.59 -25.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -0.893 . . . . 50.0 110.283 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' VAL . 52.2 mtt180 -129.5 56.49 1.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 50.0 110.259 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 127' ' ' VAL . 2.3 m -44.48 153.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 50.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.98 -1.01 . . . . 50.0 110.283 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.765 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.606 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.263 0 N-CA-C 110.346 -0.675 . . . . 4.9900000000000002 110.346 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.4 m -101.63 133.93 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 3.73 110.373 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HB ' ' A' ' 111' ' ' VAL . 56.1 t -128.1 120.15 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 10.0 109.784 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 27.4 tt0 -86.63 116.13 24.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 50.0 110.609 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 31.1 p90 -96.46 133.96 40.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 50.0 110.054 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -130.29 109.3 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 50.0 109.724 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 6' ' ' LEU . 23.9 p-10 -47.34 120.46 3.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 12.5 110.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 1.6 t80 -58.54 -22.06 54.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 50.0 109.164 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.491 ' OE1' ' CE1' ' A' ' 119' ' ' HIS . 6.9 tp10 -57.36 -40.09 77.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 50.0 109.233 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.44 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 2.5 m -64.27 -27.77 69.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.576 -0.702 . . . . 50.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HG ' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -68.79 -46.88 67.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 50.0 109.752 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -77.47 -41.52 39.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 50.0 109.918 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -51.65 -63.0 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 50.0 109.992 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -68.94 -27.22 65.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 50.0 109.917 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.35 6.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 50.0 109.371 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -104.34 177.97 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 50.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.766 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.3 173.24 12.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 50.0 110.611 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -71.64 -50.84 26.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 50.0 110.086 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -131.57 3.16 4.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 50.0 110.151 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.8 t0 -79.97 -50.67 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 50.0 110.555 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 22' ' ' ASP . 34.3 t70 -76.94 3.39 12.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 50.0 110.574 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER 43.43 54.26 5.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.118 -0.989 . . . . 50.0 110.017 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 6' ' ' LEU . 1.8 mp -41.55 -48.04 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 50.0 110.334 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 55.3 m-85 -45.36 -29.69 1.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 50.0 109.393 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -83.86 -50.04 8.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.635 -0.666 . . . . 50.0 110.009 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -27.22 65.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 50.0 110.083 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.98 -4.31 40.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 50.0 110.086 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.41 -20.5 19.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 50.0 110.29 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -19.77 16.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 50.0 110.145 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 32' ' ' LEU . . . -78.44 -14.8 59.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 50.0 109.99 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.72 29.95 75.41 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -55.64 168.61 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -1.176 . . . . 50.0 110.185 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.86 144.18 11.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 50.0 110.362 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.96 -32.45 66.18 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.219 -1.552 . . . . 50.0 109.219 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.41 -13.86 34.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -1.054 . . . . 50.0 109.917 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 50.4 m-20 -100.6 -61.33 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.787 . . . . 50.0 110.009 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 24' ' ' PHE . 39.2 t80 -117.17 131.73 56.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 50.0 110.119 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 178.98 154.34 12.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.49 . . . . 10.0 109.376 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.0 m -79.95 117.2 20.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.18 . . . . 50.0 110.111 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.618 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -86.53 147.34 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 50.0 110.154 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.05 107.36 9.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 12.5 110.023 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' CB ' ' A' ' 51' ' ' ALA . 3.0 m -119.02 147.2 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 10.0 110.147 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -65.83 165.15 13.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.869 . . . . 50.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -66.04 121.23 14.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -0.847 . . . . 25.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.89 7.72 83.55 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.604 -1.398 . . . . 10.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 1.4 tp10 -87.31 129.53 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -1.185 . . . . 10.0 110.126 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 10.7 m-85 -57.26 121.26 9.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 10.0 110.383 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.2 mm -49.27 -70.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -0.891 . . . . 10.0 110.688 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 101' ' ' THR . 3.0 tp -40.6 -34.52 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.309 -0.869 . . . . 10.0 110.552 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 21.7 tt0 -71.69 -51.55 22.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 50.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -56.43 -41.93 77.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 12.5 110.558 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.618 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -80.09 -23.59 41.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 10.0 110.383 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.3 mm-40 -63.4 -41.35 98.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 10.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -6.14 29.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.805 . . . . 50.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -100.91 -30.15 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.15 7.76 6.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 10.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 51.0 m-85 -78.39 99.39 6.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -1.214 . . . . 12.5 110.05 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -83.17 128.52 34.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 10.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 64.9 m95 -104.72 164.03 16.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 50.0 110.286 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 44.0 Cg_endo -70.36 89.89 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.948 1.499 . . . . 10.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.85 72.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 10.0 110.399 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 60' ' ' PRO . 9.4 t -79.47 -0.29 32.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.186 -0.946 . . . . 10.0 110.069 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 151.48 13.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 10.0 110.28 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -117.35 -48.55 2.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 10.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.76 88.55 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.958 . . . . 10.0 110.299 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' ALA . . . 64.47 113.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.476 -1.45 . . . . 10.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HB1' HE22 ' A' ' 86' ' ' GLN . . . 55.03 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -1.095 . . . . 10.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.8 p -170.93 33.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 10.0 110.223 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . 55.33 96.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 25.0 109.983 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.499 HD21 HD21 ' A' ' 88' ' ' LEU . 0.6 OUTLIER 57.95 159.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 50.0 109.86 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 56.9 m -106.83 -78.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 10.0 110.566 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' CYS . . . 174.28 88.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.018 . . . . 10.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 88.8 p -163.1 173.01 14.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 50.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 73' ' ' SER . 39.0 mm -140.43 84.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 50.0 110.228 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 97' ' ' ASP . 8.9 p -52.72 117.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 50.0 110.267 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mmtp -94.43 -8.33 38.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.176 -0.952 . . . . 50.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.28 158.98 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.975 . . . . 25.0 110.315 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.98 -146.23 19.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.53 -1.428 . . . . 10.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -167.42 157.49 10.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 50.0 110.203 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.5 mt -125.92 150.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 50.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.2 OUTLIER -112.93 136.92 52.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 10.0 110.27 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 81' ' ' ASP . 2.3 mtp -137.9 156.94 47.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.885 . . . . 50.0 110.128 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 84' ' ' MET . 4.4 m-20 -93.54 166.69 12.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 50.0 110.165 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.475 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.5 ptt? -43.41 119.87 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 50.0 110.23 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -153.99 -61.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 16.66 110.278 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.571 HE22 ' HB1' ' A' ' 67' ' ' ALA . 1.3 mt-30 -148.22 149.38 31.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 50.0 110.292 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 mm -70.73 146.95 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 50.0 110.422 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 70' ' ' ASN . 0.0 OUTLIER -133.12 146.07 51.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 12.5 109.674 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.19 128.41 53.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 12.5 110.395 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.635 ' O ' HG12 ' A' ' 93' ' ' VAL . 9.7 t70 -45.66 -42.89 12.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 10.0 110.027 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -54.21 -23.21 13.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 50.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 98' ' ' VAL . 25.8 tt0 -79.17 -39.5 33.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 50.0 109.724 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.9 p -79.97 -8.86 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 10.0 110.398 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 -51.69 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 12.5 110.03 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.84 -28.54 30.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.003 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -116.17 -13.26 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 25.0 110.21 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.623 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.8 m-20 41.56 30.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.913 . . . . 50.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 92' ' ' GLU . 8.5 p -87.76 161.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 50.0 110.196 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' CA ' ' OD1' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -171.04 168.61 6.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 50.0 110.463 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.87 123.07 28.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 10.0 110.059 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 35.8 p -117.56 9.83 13.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 10.0 110.325 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.62 -72.04 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 10.0 110.123 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 103' ' ' ILE . 8.2 tt -110.67 17.74 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 50.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.97 160.79 28.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.693 -1.363 . . . . 10.0 109.693 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -126.66 154.17 75.59 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.123 . . . . 10.0 110.124 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -73.56 154.78 50.14 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.043 1.549 . . . . 10.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.78 -38.31 2.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 50.0 110.296 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -84.95 143.44 28.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.873 . . . . 50.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.49 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 50.0 110.014 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -86.0 113.1 21.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 50.0 110.038 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.801 ' HB ' HG22 ' A' ' 3' ' ' VAL . 12.2 t -113.88 129.51 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 12.5 110.375 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.3 mttt -104.67 137.0 43.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 25.0 110.088 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 4.7 tt -160.19 149.4 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 10.0 110.061 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -87.36 129.16 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 50.0 109.753 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.28 148.16 22.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 50.0 109.547 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t30 72.42 54.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.293 -0.88 . . . . 10.0 110.011 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -68.48 -14.05 62.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 50.0 110.488 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 60' ' ' PRO . 10.8 ptmt -54.23 -17.75 3.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 50.0 110.327 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.0 m-70 -76.25 -21.27 56.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 50.0 110.68 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -48.61 123.01 6.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 12.5 110.18 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.51 -27.61 65.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 50.0 110.451 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.717 ' HB3' HD23 ' A' ' 120' ' ' LEU . 33.6 t80 -64.34 -12.14 39.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 16.66 110.06 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.6 -40.58 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 50.0 110.173 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.28 -12.59 42.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 50.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -56.34 -25.55 49.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 50.0 110.338 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 128' ' ' ILE . 6.2 ttp180 -100.75 32.99 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 50.0 110.219 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 p -47.24 153.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 50.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 126' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.11 -0.947 . . . . 50.0 110.109 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . 0.409 ' O ' ' HD3' ' A' ' 118' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.333 -0.68 . . . . 4.9900000000000002 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -120.92 139.62 52.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 3.73 110.26 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG23 ' HB ' ' A' ' 111' ' ' VAL . 7.8 p -125.49 125.83 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 10.0 110.004 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -83.4 113.76 20.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.278 -0.889 . . . . 50.0 111.169 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 43.1 p90 -92.89 139.56 30.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.872 . . . . 50.0 109.432 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.03 118.51 20.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.083 -1.01 . . . . 50.0 110.548 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.829 ' N ' HD12 ' A' ' 6' ' ' LEU . 67.1 t30 -49.64 115.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 12.5 110.454 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CA ' HG22 ' A' ' 114' ' ' VAL . 28.5 t80 -62.31 -28.16 69.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.905 . . . . 50.0 109.645 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 1.4 mm-40 -62.69 -36.27 82.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 50.0 109.74 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 43.6 m -60.62 -28.55 68.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 50.0 109.635 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -66.7 -47.72 71.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 50.0 109.726 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.63 -43.96 36.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 50.0 110.013 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.71 -62.71 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 50.0 109.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -65.26 -10.66 34.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 50.0 110.094 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.64 76.45 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 50.0 109.622 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -82.75 177.07 8.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -1.161 . . . . 50.0 110.325 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.33 -177.59 5.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 50.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.463 ' HA ' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.48 -53.07 8.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.877 . . . . 50.0 110.323 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -128.12 -7.08 5.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.168 -0.958 . . . . 50.0 110.491 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -45.48 34.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 50.0 110.375 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.05 -8.4 53.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.947 . . . . 50.0 110.359 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER 43.49 53.33 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 50.0 110.063 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.731 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.8 mt -49.65 -48.96 49.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 50.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 28.4 m-85 -43.84 -27.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 50.0 109.458 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.22 -51.21 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.536 -0.728 . . . . 50.0 110.479 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -37.04 85.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 50.0 110.506 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -62.19 -15.11 44.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 50.0 110.043 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -89.36 -17.41 28.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 50.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -97.65 -28.78 13.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 50.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -79.83 -20.81 45.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 50.0 110.18 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 49.75 3.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.493 -1.443 . . . . 50.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.9 mm? -68.22 142.84 55.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -1.175 . . . . 50.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.44 139.51 8.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 50.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.71 -25.42 67.41 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.685 -1.366 . . . . 50.0 109.685 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.24 -15.54 63.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -1.181 . . . . 50.0 110.463 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 38.7 m-20 -106.81 -52.91 2.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.188 -0.945 . . . . 50.0 110.356 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.9 t80 -124.31 147.17 48.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 50.0 110.148 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 158.77 163.98 13.71 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.426 -1.47 . . . . 10.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -80.08 126.98 31.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -1.147 . . . . 50.0 110.072 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.693 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.4 mtp -96.95 84.88 3.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -0.972 . . . . 50.0 110.107 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.93 108.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 12.5 110.283 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.695 HG11 ' HD3' ' A' ' 106' ' ' PRO . 84.9 t -114.1 121.83 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 10.0 109.991 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -57.11 148.13 22.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 50.0 110.273 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.23 116.36 8.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 25.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.06 10.26 42.97 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 47.6 tt0 -115.93 141.6 47.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -1.119 . . . . 10.0 110.17 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 16.2 m-85 -60.51 135.19 57.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 10.0 110.192 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 80' ' ' ILE . 25.6 mt -59.49 -61.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 10.0 109.998 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' CD1' ' A' ' 59' ' ' TRP . 5.0 tp -43.63 -26.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 10.0 109.919 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 2.1 tp10 -73.43 -51.95 15.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 50.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.657 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -66.43 -34.78 78.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 12.5 109.969 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.693 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.57 -39.03 67.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 10.0 109.805 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.3 -29.45 70.53 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.415 -0.803 . . . . 10.0 109.552 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.93 -22.13 65.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 50.0 109.714 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 57' ' ' TYR . 6.9 mm-40 -93.52 -13.22 28.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 10.0 109.971 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.74 25.59 8.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.356 -1.497 . . . . 10.0 109.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 55' ' ' GLN . 10.4 m-30 -86.25 130.13 34.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 12.5 110.23 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 59' ' ' TRP . 6.1 p-10 -89.01 166.98 13.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 10.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 97.9 m95 -152.1 151.96 28.76 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 50.0 110.221 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.56 141.39 31.17 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.013 1.533 . . . . 10.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.63 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER 47.54 79.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 10.0 110.493 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 2.3 p -59.19 -178.19 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 10.0 110.232 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.68 40.09 3.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 10.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -88.66 -41.89 12.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 10.0 110.319 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.22 90.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 10.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 179.15 33.16 0.06 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 10.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' GLY . . . 43.42 37.36 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 10.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 41.3 t -59.22 -84.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 10.0 110.282 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 49.41 36.29 9.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 25.0 110.109 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -172.95 109.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 50.0 110.199 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -177.07 3.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 10.0 110.279 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -131.57 111.0 11.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 10.0 110.301 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.3 m -147.37 173.15 12.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 50.0 110.02 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 97' ' ' ASP . 41.3 mm -138.7 82.6 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 50.0 109.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 97' ' ' ASP . 13.3 p -49.33 117.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.411 -0.806 . . . . 50.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -89.26 -7.33 55.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 50.0 110.355 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.18 -174.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 25.0 110.308 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 60.59 -156.47 31.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 10.0 109.52 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 24.5 pt-20 -160.5 135.93 8.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 50.0 110.176 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HD11 ' A' ' 48' ' ' ILE . 35.0 mt -107.68 143.88 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 50.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 36.0 t0 -87.95 159.43 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 10.0 109.884 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.35 162.6 40.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 50.0 110.43 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.32 153.34 31.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 50.0 110.139 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 17.8 mtp -56.5 125.06 20.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 50.0 110.309 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.464 ' HG2' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -162.84 130.8 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 16.66 110.102 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 66.03 4.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 50.0 110.369 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.464 HG12 ' HG2' ' A' ' 85' ' ' GLN . 1.4 pp -136.05 32.17 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 50.0 110.002 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 172.88 16.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 12.5 110.034 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.08 135.23 35.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 12.5 110.225 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -51.35 -42.43 61.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 10.0 110.058 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -28.71 40.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.33 -0.856 . . . . 50.0 109.416 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ASP . 2.6 tp10 -71.04 -39.68 72.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 50.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 98' ' ' VAL . 90.7 t -79.97 -20.08 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.422 -0.798 . . . . 10.0 109.849 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -94.47 -35.86 12.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 12.5 110.007 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -24.31 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 50.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.632 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -118.4 -4.31 10.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 25.0 110.295 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.706 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.2 m-20 48.31 28.55 1.65 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.19 -0.944 . . . . 50.0 110.375 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.712 ' O ' HG22 ' A' ' 93' ' ' VAL . 23.6 t -76.42 146.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.068 -1.02 . . . . 50.0 110.221 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 80' ' ' ILE . 8.3 mtt-85 -155.66 162.33 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 50.0 110.375 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.811 HD22 HG22 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -85.42 130.24 34.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 10.0 109.971 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.12 43.24 3.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 10.0 110.34 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 62.9 m -145.72 -51.51 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 10.0 110.164 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.811 HG22 HD22 ' A' ' 100' ' ' LEU . 18.0 tt -97.73 5.83 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 109.911 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -118.81 174.31 15.27 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 10.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 0.7 OUTLIER -131.37 -179.91 1.18 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.135 -1.215 . . . . 10.0 110.34 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.695 ' HD3' HG11 ' A' ' 42' ' ' VAL . 46.6 Cg_endo -73.15 145.36 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.007 1.53 . . . . 10.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.824 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -130.95 8.22 4.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 50.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -143.47 136.67 27.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 50.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 108' ' ' ALA . 6.7 t70 -42.47 -49.27 5.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 50.0 110.21 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -126.21 119.22 26.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 50.0 110.222 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' A' ' 108' ' ' ALA . 25.8 t -128.09 153.61 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 12.5 110.093 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 81.1 mttt -129.13 140.61 51.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 25.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.5 tt -160.14 150.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.402 -0.811 . . . . 10.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -90.52 126.39 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 50.0 109.727 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.607 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -93.24 158.99 15.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 50.0 109.995 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.607 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 61.07 38.03 17.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.321 -0.862 . . . . 10.0 110.074 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . -63.3 -12.45 29.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 50.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -49.85 -21.54 1.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.973 . . . . 50.0 110.114 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 50.5 m-70 -70.61 -19.98 62.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 50.0 110.366 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.43 135.37 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.972 . . . . 12.5 110.313 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 23.7 p-10 -67.37 -10.25 49.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 50.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -79.9 -42.49 24.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.912 . . . . 16.66 110.369 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -19.33 32.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.322 -0.861 . . . . 50.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -67.52 -29.89 69.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 50.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -55.35 -19.84 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 50.0 109.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.37 -16.99 62.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 50.0 110.164 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.08 168.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 50.0 110.313 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.016 -0.992 . . . . 50.0 110.152 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.66 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.63 ' S1 ' ' O ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.279 -0.7 . . . . 4.9900000000000002 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 46.0 m -133.43 151.91 51.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.959 . . . . 3.73 110.51 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG22 ' HB ' ' A' ' 111' ' ' VAL . 43.0 t -140.65 172.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 10.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 tt0 -137.7 116.39 12.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 50.0 110.772 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 51.9 p90 -98.83 131.85 44.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 50.0 110.137 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -123.66 115.13 20.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 50.0 110.161 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.7 t30 -47.43 112.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 12.5 110.311 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 5.2 t80 -55.95 -25.35 43.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 50.0 109.773 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 1.1 tm-20 -63.45 -42.39 98.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 50.0 109.783 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -58.35 -34.3 70.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 50.0 109.835 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.3 tp -65.61 -44.43 86.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 50.0 109.791 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -79.6 -45.02 19.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 50.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -55.26 13.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 50.0 110.136 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -5.75 51.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 50.0 110.39 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.1 99.42 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.254 -1.538 . . . . 50.0 109.254 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -85.93 -177.78 6.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 50.0 110.471 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -92.46 -179.32 5.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 50.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -54.03 6.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 50.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.29 -1.4 3.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 50.0 110.403 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -71.16 -54.67 10.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 50.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.03 -4.01 32.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 50.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.6 t0 44.06 54.28 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 50.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 16' ' ' TRP . 1.8 mp -40.9 -42.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.47 -0.768 . . . . 50.0 110.653 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 34.0 m-85 -54.35 -19.03 4.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.142 -0.974 . . . . 50.0 110.004 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.51 -49.7 3.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 50.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -30.83 69.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 50.0 110.282 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -60.56 -35.24 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 50.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.18 63.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.862 . . . . 50.0 109.982 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.95 -19.24 52.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 50.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.28 -63.21 1.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 50.0 110.166 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.08 74.49 0.67 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.556 -1.418 . . . . 50.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.24 178.12 6.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -1.108 . . . . 50.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.51 133.88 51.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 50.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -55.53 -21.75 29.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 50.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.75 -5.22 54.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -1.183 . . . . 50.0 110.28 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.31 -44.72 2.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 50.0 110.27 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.9 t80 -133.47 117.88 17.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 50.0 110.206 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -166.87 161.21 35.03 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 122.33 28.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -1.157 . . . . 50.0 110.262 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 48' ' ' ILE . 2.8 ttt -85.35 107.38 17.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 50.0 110.296 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' VAL . 69.5 tt0 -91.08 113.08 25.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 12.5 109.974 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 48' ' ' ILE . 60.0 t -145.76 127.33 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 10.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 1' ' ' PRO . . . -57.29 156.87 6.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 50.0 110.1 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.81 114.56 11.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 25.0 109.984 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.35 13.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.944 -1.662 . . . . 10.0 108.944 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' TYR . 2.7 tt0 -92.15 112.41 24.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -1.102 . . . . 10.0 109.83 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' GLU . 24.3 m-85 -42.23 123.49 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.407 -0.808 . . . . 10.0 110.239 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.669 HG23 ' SD ' ' A' ' 40' ' ' MET . 16.0 mm -60.28 -58.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.388 -0.82 . . . . 10.0 110.754 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.917 HD23 ' HB ' ' A' ' 101' ' ' THR . 4.1 pp -41.91 -27.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.057 -1.027 . . . . 10.0 110.218 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.677 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.5 tt0 -80.02 -48.18 13.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 50.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -62.92 -46.42 87.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 12.5 110.433 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.15 -40.47 78.18 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -0.84 . . . . 10.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 14.6 tp10 -60.21 -35.75 76.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.459 -0.776 . . . . 10.0 109.825 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.97 0.83 29.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.425 -0.797 . . . . 50.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -106.87 -31.46 8.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 10.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.12 23.46 1.77 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.96 124.44 39.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.249 . . . . 12.5 110.182 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -94.61 156.51 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 10.0 109.681 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.661 ' HB3' ' S1 ' ' A' ' 130' ' ' FES . 93.4 m95 -136.88 162.63 54.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 50.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 46.3 Cg_endo -73.33 176.39 9.28 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.269 1.668 . . . . 10.0 110.851 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 2.8 t80 66.93 165.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.816 . . . . 10.0 110.419 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 m -74.22 54.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 10.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -168.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 10.0 110.169 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.1 148.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.31 -0.869 . . . . 10.0 110.445 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 44.64 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 10.0 110.443 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.1 -157.98 14.84 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.455 -1.458 . . . . 10.0 109.455 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.64 163.6 25.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 10.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.74 128.18 36.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 10.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.39 -16.91 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 25.0 109.919 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -161.5 63.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 50.0 110.139 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' ARG . 44.7 t -44.8 165.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.241 -0.912 . . . . 10.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.711 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -124.41 90.46 3.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 10.0 110.76 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.616 ' O ' HD13 ' A' ' 74' ' ' ILE . 10.1 p -142.39 171.7 13.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 50.0 109.399 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 97' ' ' ASP . 43.2 mm -146.09 87.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.04 -1.037 . . . . 50.0 110.593 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.2 p -53.09 118.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.036 -1.04 . . . . 50.0 109.574 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 112' ' ' LYS . 6.0 ttmt -89.02 -11.81 43.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 50.0 110.422 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -178.36 145.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.945 . . . . 25.0 110.11 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.81 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 108.51 166.95 21.04 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.134 -1.587 . . . . 10.0 109.134 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.98 127.73 55.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -1.186 . . . . 50.0 110.216 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.756 HG21 ' HG2' ' A' ' 99' ' ' ARG . 70.4 mt -105.5 160.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 50.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -130.97 135.28 47.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 10.0 110.22 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 83' ' ' ASP . 5.9 tmm? -143.84 142.1 30.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 50.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' O ' ' SD ' ' A' ' 82' ' ' MET . 2.6 m-20 -61.84 165.43 5.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 50.0 110.151 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.49 144.9 55.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.144 -0.972 . . . . 50.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 86' ' ' GLN . 38.5 tt0 -174.94 141.27 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 16.66 110.31 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 85' ' ' GLN . 3.3 tt0 44.09 -168.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 50.0 110.468 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 88' ' ' LEU . 4.4 mt -69.11 -83.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 50.0 110.059 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.666 ' N ' HG22 ' A' ' 87' ' ' ILE . 0.5 OUTLIER 65.06 167.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.185 -0.947 . . . . 12.5 110.22 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 145.03 2.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 12.5 110.239 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -52.13 -40.86 61.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 10.0 110.26 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.56 -22.05 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 50.0 109.738 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.31 -45.42 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -0.782 . . . . 50.0 110.108 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.653 HG21 ' NH2' ' A' ' 99' ' ' ARG . 21.6 t -78.28 -20.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 10.0 109.83 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -38.91 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.83 . . . . 12.5 110.123 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -96.17 -38.97 9.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 50.0 110.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.65 -23.55 15.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.945 . . . . 25.0 110.48 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.696 ' HB2' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER 63.3 16.24 9.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.14 -0.975 . . . . 50.0 109.988 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 73' ' ' SER . 40.7 t -86.9 159.57 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 50.0 110.72 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.756 ' HG2' HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -145.31 -173.71 4.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 50.0 110.23 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 101' ' ' THR . 0.3 OUTLIER -117.18 172.42 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 10.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.917 ' HB ' HD23 ' A' ' 49' ' ' LEU . 3.7 p 42.66 32.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 10.0 109.805 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 59' ' ' TRP . 2.7 m 48.9 68.91 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 10.0 109.077 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.887 HG12 HD13 ' A' ' 113' ' ' ILE . 1.6 mp 65.61 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 50.0 109.548 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' ILE . . . -35.83 -93.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 p -117.17 130.86 24.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.139 -1.212 . . . . 10.0 110.454 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.56 124.76 8.49 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.902 1.475 . . . . 10.0 110.476 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.23 -36.88 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.928 . . . . 50.0 110.112 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.65 155.86 18.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.391 -0.818 . . . . 50.0 110.044 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -70.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 50.0 110.331 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 3.4 pt-20 -97.89 137.37 36.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 50.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.836 ' HB ' HG22 ' A' ' 3' ' ' VAL . 5.9 t -143.62 142.37 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 12.5 110.261 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 77' ' ' GLU . 3.3 mtpm? -113.18 145.6 40.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 25.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.887 HD13 HG12 ' A' ' 103' ' ' ILE . 3.5 tt -160.05 153.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.407 -0.808 . . . . 10.0 110.143 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -96.03 129.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 50.0 109.995 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -101.03 151.79 21.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.424 -0.797 . . . . 50.0 109.384 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.566 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.4 t30 73.7 47.8 0.16 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.42 -0.8 . . . . 10.0 109.884 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -71.0 -12.16 61.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.137 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -19.35 16.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 50.0 110.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 90.8 m-70 -70.48 -29.84 66.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 50.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.561 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 1.2 mt -46.89 120.61 3.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.918 . . . . 12.5 110.059 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -65.46 -19.81 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 50.0 110.372 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 122' ' ' TYR . 29.1 t80 -79.52 -12.52 59.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 16.66 110.276 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.28 -32.78 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 50.0 110.415 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -51.03 -25.28 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 50.0 110.121 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 126' ' ' ARG . 29.7 p-10 -68.71 -28.39 66.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 50.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 6.9 tpt180 -60.06 -20.02 55.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 50.0 110.123 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 75.5 t -68.63 -40.33 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 50.0 110.131 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 11.5 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.992 -1.004 . . . . 50.0 110.19 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.661 ' S1 ' ' HB3' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 N-CA-C 110.407 -0.651 . . . . 4.9900000000000002 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 39' ' ' THR . 3.2 m -110.3 141.3 43.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 3.73 110.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 111' ' ' VAL . 93.5 t -122.93 166.79 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 10.0 110.039 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -138.72 106.15 5.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 50.0 110.149 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.5 p90 -91.91 137.24 32.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 50.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.919 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -132.04 114.29 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 50.0 110.462 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 35.1 p-10 -52.1 113.89 1.16 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.129 -0.982 . . . . 12.5 109.549 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.727 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -57.04 -20.82 26.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 50.0 110.159 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.28 94.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.045 . . . . 50.0 109.616 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 7' ' ' ASN . 1.5 m -63.27 -35.05 79.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.838 . . . . 50.0 109.41 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -62.59 -43.95 97.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.817 . . . . 50.0 109.656 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.12 -50.15 10.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 50.0 110.016 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -49.17 -46.02 44.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 50.0 110.153 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -88.64 -15.34 35.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.35 -0.844 . . . . 50.0 110.069 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 39.46 94.64 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.364 -1.494 . . . . 50.0 109.364 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.652 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -84.88 -170.07 2.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -1.104 . . . . 50.0 110.305 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' O ' HD21 ' A' ' 11' ' ' LEU . 4.7 m-20 -102.8 179.99 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 50.0 110.444 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.8 mtm -80.08 -53.99 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.863 . . . . 50.0 110.446 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -131.48 -1.75 3.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 50.0 110.729 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.49 -50.99 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.005 -1.06 . . . . 50.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' CG ' ' CD1' ' A' ' 16' ' ' TRP . 25.7 t70 -73.09 -2.03 19.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 50.0 110.095 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . 16.0 m-20 50.14 50.32 18.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 50.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD2' ' A' ' 16' ' ' TRP . 69.5 mt -52.21 -39.39 60.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 50.0 109.741 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.1 m-85 -58.51 -16.22 14.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.4 -0.812 . . . . 50.0 110.099 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 1.3 mt-10 -112.64 -38.66 4.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 50.0 110.115 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -29.07 60.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 50.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -64.46 -12.16 40.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 50.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.23 -18.0 40.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 50.0 110.187 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -91.98 -10.76 38.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 50.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.7 -34.44 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 50.0 110.333 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.27 57.63 2.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 50.0 109.534 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.71 176.15 9.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 50.0 110.053 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.3 133.36 41.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 50.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -54.59 -23.56 28.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.86 -7.43 34.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.25 . . . . 50.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 11.8 m-20 -118.66 -43.81 2.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 50.0 110.77 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.506 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 11.2 t80 -133.9 142.41 47.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.041 . . . . 50.0 110.531 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 168.14 161.17 17.38 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 2' ' ' THR . 5.4 m -88.03 116.48 26.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -1.142 . . . . 50.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.792 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -81.23 72.37 8.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 50.0 110.093 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -72.77 115.74 12.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 12.5 110.33 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 40' ' ' MET . 3.6 m -133.91 160.24 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 10.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.82 134.7 36.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 50.0 110.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -43.72 114.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 25.0 109.972 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.84 22.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.231 -1.548 . . . . 10.0 109.231 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -95.22 131.29 41.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 10.0 110.217 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 103' ' ' ILE . 3.4 m-30 -64.79 118.5 9.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 10.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 101' ' ' THR . 35.8 mm -42.14 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 10.0 110.578 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -41.74 -35.14 0.73 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -0.913 . . . . 10.0 110.235 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -68.56 -50.06 54.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 50.0 109.831 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -70.68 -33.91 71.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 12.5 109.83 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.792 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.09 -28.34 48.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 10.0 109.871 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.6 tt0 -70.17 -35.32 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 10.0 109.568 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 -9.73 58.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.456 -0.778 . . . . 50.0 109.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 8.2 mm100 -100.41 -30.17 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.349 -0.845 . . . . 10.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.07 29.0 1.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 10.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' A' ' 59' ' ' TRP . 13.0 m-30 -100.97 102.36 13.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -1.173 . . . . 12.5 110.244 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 10.0 t70 -82.67 157.3 23.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 10.0 110.323 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.581 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 56.9 m95 -138.16 153.81 73.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 50.0 109.948 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 47.3 Cg_endo -80.14 172.66 13.56 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.11 1.584 . . . . 10.0 111.061 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.488 ' O ' ' S1 ' ' A' ' 130' ' ' FES . 0.1 OUTLIER 45.57 69.49 0.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 10.0 110.165 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 63' ' ' CYS . 15.1 m -72.13 -15.06 61.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 10.0 110.116 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' C ' ' O ' ' A' ' 62' ' ' SER . 20.1 p 33.09 -147.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.231 0.538 . . . . 10.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -166.5 52.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 10.0 110.255 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ARG . . . 54.83 52.56 11.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.917 . . . . 10.0 110.135 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' CYS . . . -148.19 -121.83 1.23 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.408 -1.477 . . . . 10.0 109.408 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.59 82.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 10.0 110.143 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -150.99 111.83 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 10.0 110.655 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.46 -21.53 13.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 25.0 109.568 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.909 ' HB2' HG11 ' A' ' 98' ' ' VAL . 1.8 p30 -141.84 130.6 22.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.492 -0.755 . . . . 50.0 109.74 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 100' ' ' LEU . 96.2 m -75.3 -96.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.063 -1.023 . . . . 10.0 110.164 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -178.75 36.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.979 -1.076 . . . . 10.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' HD11 ' A' ' 113' ' ' ILE . 30.2 m -116.35 124.1 49.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 50.0 109.987 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 28.1 mm -91.07 91.54 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 50.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.3 p -57.74 122.54 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 50.0 110.627 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -91.85 -11.44 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 50.0 109.878 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 15.4 tt0 177.49 159.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 25.0 109.914 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.12 -164.06 38.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.327 -1.509 . . . . 10.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -161.48 153.09 19.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 50.0 110.43 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.836 HG23 ' C ' ' A' ' 105' ' ' SER . 87.1 mt -118.18 132.13 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 50.0 109.942 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' SER . 11.1 t70 -81.29 144.73 31.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 10.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -117.14 -170.64 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 50.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.92 -177.88 5.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 50.0 110.184 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tpt -65.68 92.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 50.0 110.104 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -160.24 178.19 9.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 16.66 110.352 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.87 94.83 1.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 50.0 110.013 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' HG2' ' A' ' 85' ' ' GLN . 3.0 mt -129.14 -69.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 50.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.14 155.52 17.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 12.5 110.436 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 t -106.75 140.91 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 12.5 110.014 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -46.76 -33.62 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 10.0 110.656 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.42 -35.53 72.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 50.0 110.191 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -70.09 -33.25 71.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 50.0 110.109 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 56.5 t -80.02 -27.31 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.178 -0.951 . . . . 10.0 110.284 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -92.5 -37.42 12.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 12.5 110.379 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.89 -46.8 7.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 50.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HB3' HG23 ' A' ' 98' ' ' VAL . 5.4 mmtp -91.1 -13.06 33.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 25.0 110.28 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 2.3 m-20 59.27 17.87 6.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.31 -0.869 . . . . 50.0 110.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.909 HG11 ' HB2' ' A' ' 70' ' ' ASN . 75.1 t -77.83 154.48 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.094 -1.004 . . . . 50.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' HG2' HD12 ' A' ' 80' ' ' ILE . 5.4 tpt180 -156.31 162.38 40.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 50.0 110.881 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.647 HD13 ' SG ' ' A' ' 71' ' ' CYS . 0.2 OUTLIER -82.3 127.35 33.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.429 -0.795 . . . . 10.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.794 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -123.51 -18.83 6.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 10.0 110.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 77.3 m -67.84 -42.87 80.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.928 . . . . 10.0 110.125 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.591 ' HA ' ' CD2' ' A' ' 47' ' ' TYR . 12.0 pt -135.92 33.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 50.0 110.312 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.6 170.65 14.11 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.404 -1.478 . . . . 10.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.836 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -141.62 142.42 25.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.166 . . . . 10.0 110.127 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.9 133.54 20.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.915 1.481 . . . . 10.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.81 -36.91 6.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 50.0 110.165 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.84 143.38 37.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.36 -0.838 . . . . 50.0 110.145 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.27 -54.37 17.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.354 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.62 119.59 39.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 50.0 110.249 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.8 t -127.12 115.22 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 12.5 110.028 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.5 mmtp -101.49 142.49 32.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 25.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.641 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.21 153.41 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 10.0 110.129 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -105.1 155.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 50.0 109.234 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -117.67 -179.58 3.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 50.0 110.23 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.585 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.4 m-20 70.74 24.75 4.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.561 -0.712 . . . . 10.0 110.07 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.741 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -40.19 -26.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.896 . . . . 50.0 110.829 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 116' ' ' ASN . 39.2 pttt -42.98 -25.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.96 . . . . 50.0 110.503 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.727 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.6 p80 -64.05 -24.34 67.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.033 -1.042 . . . . 50.0 110.064 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -60.13 121.96 13.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 12.5 110.379 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.74 -26.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 50.0 110.173 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.67 -38.18 80.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 16.66 110.182 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.84 -36.31 31.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 50.0 110.087 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -61.41 -28.08 69.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.925 . . . . 50.0 110.041 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -56.69 -18.58 12.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.351 -0.843 . . . . 50.0 110.386 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -27.1 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 50.0 110.3 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.21 144.03 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 50.0 109.921 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.513 ' OXT' HG22 ' A' ' 128' ' ' ILE . 20.9 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.037 -0.983 . . . . 50.0 110.244 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.509 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.405 ' CG ' ' HG2' ' A' ' 106' ' ' PRO . 48.2 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 110.357 -0.67 . . . . 4.9900000000000002 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 84.2 m -117.36 135.41 53.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 3.73 110.069 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 40' ' ' MET . 13.7 t -118.39 171.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 10.0 110.131 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -132.65 119.55 20.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.935 . . . . 50.0 110.269 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 49.9 p90 -102.89 137.43 41.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 50.0 110.079 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.993 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -132.47 120.12 21.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 50.0 110.277 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.4 t-20 -57.26 113.27 1.67 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 12.5 110.538 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -59.57 -33.33 71.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.086 -1.009 . . . . 50.0 109.57 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.73 -36.67 83.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 50.0 110.086 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 53.7 m -62.66 -30.83 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 50.0 109.881 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 16' ' ' TRP . 1.6 tp -67.81 -49.45 62.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 50.0 109.538 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.73 -38.44 80.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 50.0 109.593 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.34 -47.46 73.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 50.0 109.795 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' THR . 9.6 mm100 -65.97 -31.71 72.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.793 . . . . 50.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.2 29.71 12.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.657 -1.377 . . . . 50.0 109.657 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.844 ' O ' HD11 ' A' ' 11' ' ' LEU . 26.5 m0 -99.64 173.62 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -1.165 . . . . 50.0 110.402 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 m-20 -93.18 -173.06 3.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 50.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 ttp -77.66 -53.72 7.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 50.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -120.06 -9.0 9.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 50.0 110.275 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -70.06 -49.29 52.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 50.0 110.406 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -78.84 -7.61 58.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 50.0 110.581 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.06 52.49 14.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 50.0 109.959 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.993 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -49.29 -49.04 45.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.463 -0.773 . . . . 50.0 110.684 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.4 m-85 -53.66 -20.45 5.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 50.0 110.06 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -107.12 -53.28 2.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 50.0 110.513 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -64.31 -35.27 80.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 50.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -60.32 -34.0 73.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 50.0 110.054 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.84 -26.97 67.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 50.0 110.063 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.2 14.64 30.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 50.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.39 -33.27 6.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 50.0 110.34 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 67.8 0.97 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.524 -1.43 . . . . 50.0 109.524 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' LEU . 1.8 mm? -96.4 170.75 9.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -1.146 . . . . 50.0 110.206 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 164.27 26.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 50.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -85.09 -32.77 19.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.455 -1.458 . . . . 50.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.09 -4.73 26.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -1.189 . . . . 50.0 109.993 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 92.1 m-20 -119.3 -51.58 2.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 50.0 110.401 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 39.8 t80 -132.09 152.26 51.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 50.0 110.584 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 151.64 165.17 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.283 -1.527 . . . . 10.0 109.283 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.38 131.03 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.183 . . . . 50.0 109.871 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.752 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 1.4 ttm -99.24 110.9 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 50.0 110.388 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.06 113.97 20.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 12.5 109.976 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 51' ' ' ALA . 53.7 t -120.74 105.06 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 10.0 110.368 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.17 145.57 55.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 50.0 110.061 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.3 118.28 3.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 25.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.16 -2.43 26.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.549 -1.421 . . . . 10.0 109.549 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -109.62 131.21 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -1.169 . . . . 10.0 110.194 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.9 m-30 -71.08 139.43 50.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 10.0 110.089 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.554 HG23 ' CE ' ' A' ' 40' ' ' MET . 5.8 mt -43.91 -67.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 10.0 110.329 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -46.01 -24.85 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 10.0 110.133 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tp10 -72.96 -54.47 8.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 50.0 109.827 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -69.38 -28.85 66.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 12.5 109.925 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.752 ' HB2' ' HE1' ' A' ' 40' ' ' MET . . . -80.07 -40.69 27.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.883 . . . . 10.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.0 tt0 -58.9 -43.76 91.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 10.0 109.957 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.99 -21.22 60.99 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.534 -0.729 . . . . 50.0 109.791 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 2.3 mp0 -87.84 -20.9 25.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 10.0 110.024 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.48 1.17 27.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 10.0 109.384 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 9.0 m-30 -63.71 108.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 12.5 109.965 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 133.81 36.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 10.0 110.285 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.607 ' HZ3' ' HG ' ' A' ' 73' ' ' SER . 89.5 m95 -119.08 125.91 27.37 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 50.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 118' ' ' LYS . 46.8 Cg_endo -71.46 167.7 25.63 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.046 1.551 . . . . 10.0 111.079 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 65.24 86.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.514 -0.741 . . . . 10.0 110.597 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.31 169.56 15.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 10.0 109.914 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 m -90.05 84.29 6.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 10.0 109.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -37.75 18.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 10.0 110.506 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.21 151.52 29.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 10.0 110.414 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.69 -33.14 62.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.346 -1.502 . . . . 10.0 109.346 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.42 77.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -1.13 . . . . 10.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.4 t -77.22 -81.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 10.0 110.353 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.26 25.46 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 25.0 109.915 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 1.3 m-20 -94.19 -68.11 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 50.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.578 ' HA ' ' S1 ' ' A' ' 130' ' ' FES . 4.5 m 67.16 172.59 0.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.303 -0.873 . . . . 10.0 109.543 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -151.54 70.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.006 -1.059 . . . . 10.0 111.146 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.607 ' HG ' ' HZ3' ' A' ' 59' ' ' TRP . 71.9 m -126.38 167.85 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 50.0 109.948 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.689 HG23 ' HB2' ' A' ' 97' ' ' ASP . 37.4 mm -134.48 81.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 50.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.2 p -48.13 119.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.38 -0.825 . . . . 50.0 110.833 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 4.6 tmtm? -89.43 -8.99 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.936 -1.103 . . . . 50.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.73 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 25.0 110.074 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 127.08 -164.36 20.66 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -154.67 139.28 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 50.0 110.148 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 mt -115.38 146.97 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 50.0 110.48 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -100.59 132.34 46.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 10.0 110.099 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -144.53 177.65 8.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 50.0 110.411 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 150.59 37.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 50.0 110.055 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 mtp -68.35 128.56 37.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 50.0 110.198 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -159.86 161.91 34.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 16.66 110.102 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -69.61 -163.09 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 50.0 110.39 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 86' ' ' GLN . 2.4 mp 59.58 168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 50.0 110.359 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' N ' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER 61.97 106.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 12.5 110.227 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.52 154.81 22.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 12.5 110.264 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -48.59 -50.85 30.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.886 . . . . 10.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 4.5 tt0 -56.09 -21.76 23.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 50.0 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 97' ' ' ASP . 1.2 tt0 -75.0 -41.23 59.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 50.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 3.2 t -76.93 -20.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 10.0 110.034 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -95.92 -35.54 11.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 12.5 109.866 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 1.2 tp10 -95.8 -33.16 12.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 50.0 110.103 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -108.82 -24.15 11.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 25.0 110.122 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.863 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m-20 66.64 16.37 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 50.0 110.281 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.6 t -83.41 164.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.241 -0.912 . . . . 50.0 110.218 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER 175.42 160.4 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.955 . . . . 50.0 110.481 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.04 117.71 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 10.0 110.45 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -101.46 -11.72 19.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 10.0 110.048 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 49' ' ' LEU . 3.8 m -100.0 157.85 16.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.86 . . . . 10.0 109.899 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 47' ' ' TYR . 2.3 mt 44.15 25.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 50.0 110.15 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' TYR . . . -125.97 149.18 17.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 t -123.62 147.36 52.88 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 10.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 46.6 Cg_endo -72.83 117.65 5.22 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.016 1.535 . . . . 10.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.85 -16.45 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -0.869 . . . . 50.0 110.185 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.07 154.18 18.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.915 . . . . 50.0 110.263 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 50.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -92.32 113.16 25.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 50.0 109.928 179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.592 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 84.6 t -115.15 137.84 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 12.5 110.466 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HD2' ' CG ' ' A' ' 24' ' ' PHE . 6.1 mtmt -103.39 139.91 38.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 25.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 73' ' ' SER . 1.2 tt -160.07 140.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 10.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 6' ' ' LEU . 3.3 t -96.78 147.19 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 50.0 109.69 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.46 173.04 6.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.044 -1.035 . . . . 50.0 110.441 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.616 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.2 t30 77.69 22.86 0.85 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.925 -0.485 . . . . 10.0 110.268 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -39.31 -25.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.239 -0.913 . . . . 50.0 111.117 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 4.5 ptmt -41.94 -26.28 0.08 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.087 -1.008 . . . . 50.0 110.326 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 11.9 p80 -67.97 -21.26 65.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 50.0 110.229 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -40.47 128.72 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.443 -0.786 . . . . 12.5 110.629 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.36 -10.16 30.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 50.0 109.798 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.95 -24.83 48.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 16.66 110.237 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.61 -22.45 12.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 50.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -55.67 -23.62 29.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 50.0 110.473 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.41 -16.91 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.1 14.86 5.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 50.0 110.225 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 124' ' ' GLN . 7.2 p -75.99 -26.12 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 50.0 110.143 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.006 -0.997 . . . . 50.0 110.259 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.578 ' S1 ' ' HA ' ' A' ' 71' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.392 -0.657 . . . . 4.9900000000000002 110.392 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.414 HG23 HG22 ' A' ' 39' ' ' THR . 88.7 m -107.13 96.35 6.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 3.73 110.115 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' MET . 14.3 t -96.41 116.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.154 -0.966 . . . . 10.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.85 118.09 27.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 50.0 110.609 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 44.1 p90 -94.76 133.51 38.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.09 -1.006 . . . . 50.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.83 HD21 ' HB3' ' A' ' 23' ' ' LEU . 5.3 tp -130.16 121.99 27.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 50.0 110.338 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.8 t30 -58.65 117.42 4.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 12.5 110.534 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -58.54 -24.81 61.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.965 . . . . 50.0 109.607 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -40.95 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 50.0 110.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 4.6 m -57.04 -28.86 62.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 50.0 109.752 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 23' ' ' LEU . 4.0 tp -67.18 -43.6 81.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.435 -0.791 . . . . 50.0 109.737 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.59 -47.87 14.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 50.0 110.345 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -52.45 -47.97 66.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 50.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -79.34 -13.79 59.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.898 . . . . 50.0 110.39 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.24 30.94 69.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.186 -1.566 . . . . 50.0 109.186 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 35.5 m0 -94.61 -166.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.116 . . . . 50.0 110.337 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 59.1 t0 -137.08 155.95 49.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 50.0 110.074 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.46 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 mmt -75.79 -14.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 50.0 110.334 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.85 -35.28 3.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 50.0 110.418 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -78.62 -73.1 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 50.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 1.2 t70 -67.84 -13.39 62.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 50.0 110.763 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER 47.8 54.13 10.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 50.0 109.944 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.83 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -38.51 -49.92 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.512 -0.743 . . . . 50.0 110.576 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 21.6 m-85 -48.19 -30.35 4.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 50.0 109.832 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -100.0 -48.1 4.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.583 -0.698 . . . . 50.0 110.797 -179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -62.81 -26.6 68.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 50.0 110.49 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.38 -15.92 62.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 50.0 109.901 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -22.24 52.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 50.0 110.073 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.01 10.48 39.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 50.0 110.503 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.81 4.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 50.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.93 34.39 8.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.91 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.319 -1.107 . . . . 50.0 110.331 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -73.29 148.26 43.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 50.0 109.995 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.07 -23.08 78.45 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 59.3 tt0 -76.38 1.48 16.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -1.171 . . . . 50.0 110.364 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -125.42 -50.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 50.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 50.5 t80 -129.27 136.35 49.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 50.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 169.2 175.9 38.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 10.0 109.343 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.414 HG22 HG23 ' A' ' 2' ' ' THR . 0.2 OUTLIER -89.76 135.02 33.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -1.176 . . . . 50.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -109.35 80.53 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 50.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -70.55 115.63 9.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.285 -0.884 . . . . 12.5 110.611 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 5.0 t -114.41 107.41 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 10.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -43.22 152.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 50.0 110.288 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.59 120.53 13.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 25.0 110.212 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.58 -6.15 65.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.342 -1.503 . . . . 10.0 109.342 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -94.06 136.99 33.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -1.178 . . . . 10.0 110.133 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 8.1 m-85 -65.14 140.16 58.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 10.0 110.235 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.463 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 8.0 mt -54.08 -64.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 10.0 110.461 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 17.0 tp -42.8 -31.26 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 10.0 110.269 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tt0 -66.36 -49.94 65.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.005 . . . . 50.0 109.578 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.2 72.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 12.5 109.764 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.17 -43.8 32.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 10.0 109.747 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 3.0 tt0 -60.77 -27.36 67.92 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.431 -0.793 . . . . 10.0 109.507 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.65 -5.46 55.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 50.0 109.93 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 3.0 mm-40 -109.47 -38.02 5.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 10.0 110.062 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.5 30.02 0.74 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.843 -1.303 . . . . 10.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 7.1 m-30 -99.02 101.58 13.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.038 -1.272 . . . . 12.5 110.125 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.5 135.71 34.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.941 . . . . 10.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CE3' HG21 ' A' ' 101' ' ' THR . 54.2 m95 -118.41 146.8 40.42 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 50.0 110.481 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.21 131.03 18.47 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.242 1.654 . . . . 10.0 110.56 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.16 121.99 32.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -160.74 80.92 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 10.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 61.0 m -134.6 44.41 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 10.0 110.256 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 8.9 mtt-85 47.5 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -177.99 153.85 0.84 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.083 -1.011 . . . . 10.0 110.134 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.74 -103.62 3.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.395 -1.482 . . . . 10.0 109.395 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.25 167.22 16.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 10.0 110.118 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.0 OUTLIER -125.47 54.8 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 10.0 110.347 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.17 39.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 25.0 110.297 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.15 94.06 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 50.0 110.144 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -85.53 -145.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.343 -0.848 . . . . 10.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 117' ' ' ALA . . . -145.02 68.27 1.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 10.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' HD13 ' A' ' 74' ' ' ILE . 74.9 m -136.77 -176.59 4.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 50.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 73' ' ' SER . 39.9 mm -143.19 65.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 50.0 109.647 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -38.92 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.626 -0.672 . . . . 50.0 110.948 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -90.68 -9.7 45.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 50.0 110.135 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -179.19 148.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 25.0 110.286 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 102.22 -148.02 17.47 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.69 -1.364 . . . . 10.0 109.69 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.48 149.42 0.8 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -1.075 . . . . 50.0 109.978 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 48' ' ' ILE . 42.5 mt -115.96 151.01 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 50.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.7 147.47 24.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 10.0 110.095 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 tpt -158.99 137.03 10.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.897 . . . . 50.0 110.015 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 2.8 p30 -46.91 143.88 2.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 50.0 110.169 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -52.47 144.77 12.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 50.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 84' ' ' MET . 1.2 mt-30 -167.18 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 16.66 110.381 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -102.51 150.64 23.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 50.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 mt -91.12 86.18 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 50.0 110.048 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 170.01 5.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 12.5 110.247 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -119.13 141.34 48.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.867 . . . . 12.5 110.007 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' O ' HG12 ' A' ' 93' ' ' VAL . 18.1 m-20 -54.85 -36.91 65.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 10.0 110.165 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -55.57 -30.93 61.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 50.0 109.758 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -71.23 -40.13 71.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 50.0 109.875 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -79.91 -6.18 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.91 . . . . 10.0 109.898 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -44.16 4.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 12.5 109.278 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.25 -28.51 25.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 50.0 109.639 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CB ' HG23 ' A' ' 98' ' ' VAL . 7.0 mmtt -120.82 -20.53 6.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 25.0 109.91 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.6 m-20 48.97 28.33 1.96 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 50.0 110.341 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' CB ' ' A' ' 96' ' ' LYS . 13.2 t -75.66 158.36 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 50.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.29 -150.96 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 50.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 71' ' ' CYS . 0.3 OUTLIER -127.03 114.55 17.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 10.0 110.752 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.61 HG21 ' CE3' ' A' ' 59' ' ' TRP . 5.9 t -99.32 3.46 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 10.0 109.879 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' GLY . 24.5 p -105.65 -125.58 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 10.0 109.903 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.14 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.869 -1.145 . . . . 50.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -178.01 152.61 11.88 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -115.48 152.07 46.69 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.25 -1.147 . . . . 10.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.454 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo -73.42 143.11 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.046 1.55 . . . . 10.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.51 -14.61 9.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 50.0 110.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -115.85 153.98 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 50.0 110.231 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.45 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 50.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.38 106.87 17.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 50.0 110.374 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 108' ' ' ALA . 53.4 t -116.06 120.06 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 12.5 109.991 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 77' ' ' GLU . 13.2 mttt -97.99 145.74 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 25.0 110.541 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.9 tt -160.17 137.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 10.0 110.334 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 6' ' ' LEU . 2.5 t -93.17 124.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.334 -0.854 . . . . 50.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -90.03 -178.58 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 50.0 110.837 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.573 ' ND2' ' CZ ' ' A' ' 115' ' ' TYR . 5.4 m-20 68.44 32.67 4.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.962 0.41 . . . . 10.0 110.898 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -47.47 -22.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.956 -1.09 . . . . 50.0 110.275 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.38 -24.78 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.129 -0.982 . . . . 50.0 110.031 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.7 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.7 p80 -61.36 -27.04 68.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.131 -0.98 . . . . 50.0 109.877 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -46.38 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 12.5 110.072 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.2 -14.41 60.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 50.0 110.248 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -65.25 -22.12 66.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.975 . . . . 16.66 110.386 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -20.94 6.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 50.0 110.208 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 127' ' ' VAL . 4.8 tp60 -62.41 -14.73 43.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 50.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -49.53 -23.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 50.0 110.406 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -114.3 50.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 50.0 110.386 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 124' ' ' GLN . 18.7 m -46.76 172.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.952 . . . . 50.0 110.122 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.938 -1.029 . . . . 50.0 110.216 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.497 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.195 0 N-CA-C 110.215 -0.725 . . . . 4.9900000000000002 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -113.29 137.25 51.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 3.73 110.331 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' MET . 61.8 t -124.39 167.05 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.897 . . . . 10.0 109.92 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.3 tt0 -136.42 110.87 8.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 50.0 110.242 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 53.8 p90 -98.29 131.17 44.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 50.0 110.187 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -122.82 119.51 30.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 50.0 110.003 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 6' ' ' LEU . 65.7 t30 -45.98 110.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.831 . . . . 12.5 110.815 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.813 ' HB2' HG12 ' A' ' 114' ' ' VAL . 6.4 t80 -57.38 -30.94 65.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 50.0 109.745 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 119' ' ' HIS . 7.5 tt0 -61.62 -42.87 99.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.878 . . . . 50.0 109.68 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.7 m -61.96 -26.25 68.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 50.0 109.333 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -66.85 -47.88 70.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.415 -0.803 . . . . 50.0 109.82 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.66 -49.75 12.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 50.0 109.929 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -51.8 -44.36 63.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 50.0 110.004 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -78.56 -28.83 46.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.107 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.99 47.89 5.65 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.307 -1.517 . . . . 50.0 109.307 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.855 ' CE3' HD22 ' A' ' 23' ' ' LEU . 77.7 t90 -101.51 146.06 28.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 50.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.584 ' O ' ' CD2' ' A' ' 16' ' ' TRP . 3.4 t0 -90.14 165.57 13.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 50.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -19.4 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.037 -1.039 . . . . 50.0 110.082 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.11 38.72 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 50.0 110.444 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 15.1 t70 -79.66 -97.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 50.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 31.1 t0 -80.07 -105.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 50.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 25' ' ' GLU . 27.7 m-20 -155.37 44.39 0.47 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.115 -0.991 . . . . 50.0 108.999 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.855 HD22 ' CE3' ' A' ' 16' ' ' TRP . 6.0 tp -33.29 -67.55 0.12 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.195 0.522 . . . . 50.0 111.402 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HA ' HD22 ' A' ' 6' ' ' LEU . 3.9 m-85 -50.59 -24.88 3.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.178 -0.951 . . . . 50.0 110.378 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -98.15 -50.06 4.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.325 -0.859 . . . . 50.0 110.61 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -59.83 -29.01 67.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.124 -0.985 . . . . 50.0 110.443 -179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.08 -23.75 55.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 50.0 110.084 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -86.53 -2.87 58.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 50.0 110.21 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.13 8.5 3.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 50.0 110.16 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -98.18 -23.45 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 50.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 35.48 5.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.51 -1.436 . . . . 50.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -83.98 161.23 20.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.201 . . . . 50.0 110.189 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.23 138.03 55.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 110.224 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.7 -32.4 69.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.584 -1.406 . . . . 50.0 109.584 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.83 -14.25 43.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.133 . . . . 50.0 109.962 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.3 m-20 -101.15 -58.85 1.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 50.0 109.845 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.664 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 36.5 t80 -114.72 141.43 47.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 50.0 110.006 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 168.31 164.85 24.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.679 -1.368 . . . . 10.0 109.679 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -88.15 123.4 32.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -1.125 . . . . 50.0 110.01 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' VAL . 3.6 mtp -88.74 116.88 27.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 50.0 110.28 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 8.3 pt-20 -90.64 119.19 30.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 12.5 109.968 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.7 94.55 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 10.0 110.4 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -58.46 133.18 55.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 50.0 110.085 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 43' ' ' ALA . 2.3 mt-10 -42.55 116.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 25.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.26 7.04 25.18 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.82 109.86 15.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -1.14 . . . . 10.0 110.391 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 20.7 m-85 -49.88 155.06 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 10.0 109.903 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 80' ' ' ILE . 3.1 mt -56.12 -67.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 10.0 110.659 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.1 tt -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.006 . . . . 10.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -77.37 -50.47 12.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 50.0 109.873 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.16 -30.69 67.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 12.5 109.849 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.18 -41.42 41.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.409 -0.807 . . . . 10.0 109.964 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.78 -35.78 77.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 10.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 -20.85 66.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.477 -0.764 . . . . 50.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 71.2 mm-40 -93.36 -24.95 17.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 10.0 110.205 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.33 24.33 4.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 10.0 109.588 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 5.0 m-30 -90.94 107.84 19.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 12.5 110.268 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.01 138.41 31.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 10.0 109.935 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 29.6 m95 -119.63 153.53 54.31 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 50.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 44.8 Cg_endo -71.81 173.57 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.206 1.635 . . . . 10.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 8.2 m-85 -91.76 139.42 30.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.379 -0.826 . . . . 10.0 110.456 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 2.5 t -160.26 70.33 0.42 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 10.0 109.923 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.06 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 10.0 110.003 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -138.94 -152.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 10.0 110.081 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.58 20.49 4.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 10.0 110.327 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.59 -38.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 68' ' ' CYS . . . -139.19 156.67 46.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 10.0 110.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER 69.31 83.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 10.0 110.279 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.535 ' O ' ' S1 ' ' A' ' 130' ' ' FES . . . -126.26 -169.36 2.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 25.0 109.995 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 7.5 m120 55.05 88.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 50.0 110.154 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.676 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -162.0 -151.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 10.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.676 ' HB3' ' O ' ' A' ' 71' ' ' CYS . . . 67.89 98.76 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 10.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.544 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -148.3 170.18 18.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 50.0 110.091 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 73' ' ' SER . 44.6 mm -133.18 82.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.126 -0.984 . . . . 50.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 97' ' ' ASP . 12.2 p -45.35 118.23 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.422 -0.799 . . . . 50.0 110.296 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 3.0 tptp -87.0 -8.42 57.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.984 . . . . 50.0 110.037 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER 175.14 140.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 25.0 110.18 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.86 -162.85 12.38 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.535 -1.426 . . . . 10.0 109.535 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -164.25 148.8 9.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 48' ' ' ILE . 34.3 mt -118.68 161.7 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 50.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.23 125.78 44.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 10.0 110.13 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -179.47 3.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 50.0 110.278 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -101.83 -173.27 2.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 50.0 110.251 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.22 86.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 50.0 109.985 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -153.91 117.18 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 16.66 110.299 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 55.18 177.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 50.0 110.445 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.65 160.05 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.41 -0.806 . . . . 50.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 tt -139.39 144.59 38.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 12.5 110.334 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 4.0 m -96.26 146.95 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 12.5 110.239 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.7 t70 -62.22 -48.75 78.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 10.0 110.437 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 3.1 tt0 -55.29 -23.69 24.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 50.0 109.744 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -73.98 -42.93 59.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 50.0 109.785 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.769 HG21 HH21 ' A' ' 99' ' ' ARG . 1.1 p -75.66 -19.67 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 10.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.17 -32.32 12.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 12.5 110.211 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 3.1 tt0 -95.15 -26.86 15.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 50.0 110.397 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.4 mttm -118.74 -15.34 9.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 25.0 110.664 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.5 m-20 56.59 23.63 7.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 50.0 110.013 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 99' ' ' ARG . 8.9 p -85.52 161.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 50.0 110.329 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.769 HH21 HG21 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -176.62 123.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 50.0 110.285 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.083 HD23 ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -49.71 122.34 6.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 10.0 110.18 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.466 ' HA ' HD13 ' A' ' 48' ' ' ILE . 41.8 p -101.58 29.43 4.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 10.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 86.3 m -116.7 149.68 39.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 10.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 102' ' ' CYS . 40.8 pt 37.46 33.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.611 -0.68 . . . . 50.0 110.481 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 102' ' ' CYS . . . -130.91 146.88 18.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 p -116.76 144.44 33.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.298 -1.119 . . . . 10.0 110.314 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 46.6 Cg_endo -73.8 151.3 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.053 1.554 . . . . 10.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.98 -58.86 2.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 50.0 110.486 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -51.79 134.43 30.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 50.0 110.354 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 110' ' ' GLU . 12.7 t0 -44.03 -68.52 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 50.0 109.954 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.42 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 1.1 mp0 -100.73 129.13 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 50.0 109.947 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 108' ' ' ALA . 59.3 t -131.85 135.53 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 12.5 110.5 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 15.2 mttt -107.44 144.23 34.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 25.0 110.057 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.03 146.98 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 10.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.813 HG12 ' HB2' ' A' ' 8' ' ' TYR . 4.5 t -94.24 128.07 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 50.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -94.54 155.22 17.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 50.0 110.133 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 70.9 51.36 0.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 10.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.671 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . . . -62.69 -21.19 65.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 50.0 110.145 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -44.08 -26.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 50.0 109.836 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 62.7 m-70 -64.99 -18.45 65.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 50.0 110.055 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -40.31 121.57 1.41 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.491 -0.755 . . . . 12.5 110.476 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -49.53 -28.6 5.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 50.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.48 -31.73 72.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 16.66 109.961 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.5 mt -103.37 -22.33 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.465 -0.772 . . . . 50.0 110.1 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.635 ' O ' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -48.44 -32.14 7.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 50.0 110.215 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -57.42 -27.9 62.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 50.0 110.274 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -51.93 -42.49 62.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 50.0 110.364 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 124' ' ' GLN . 6.4 p -49.78 164.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 50.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.884 -1.055 . . . . 50.0 110.176 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.701 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 1.083 ' S2 ' HD23 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.272 -0.703 . . . . 4.9900000000000002 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 m -106.96 135.95 47.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.862 . . . . 3.73 110.278 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 111' ' ' VAL . 36.6 t -128.48 132.78 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 10.0 109.847 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -90.76 124.81 35.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.078 -1.014 . . . . 50.0 110.601 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 16.6 p90 -103.82 142.41 34.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 50.0 110.239 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.869 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.69 124.75 21.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 50.0 110.096 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 58.8 t30 -59.53 118.35 5.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 12.5 110.525 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.715 ' CD1' ' CG ' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -58.06 -26.86 63.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 50.0 109.92 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 26.6 tt0 -68.14 -39.6 82.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 50.0 110.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -59.8 -32.54 70.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 50.0 110.09 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 tp -68.55 -43.6 76.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 50.0 109.653 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.34 -52.08 13.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 50.0 110.274 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.4 -61.52 1.87 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -0.897 . . . . 50.0 110.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -65.93 -14.5 61.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 50.0 110.228 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.37 46.3 71.78 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.549 -1.42 . . . . 50.0 109.549 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -90.59 -177.19 4.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 50.0 110.202 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.1 m-20 -95.0 177.27 5.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 50.0 110.211 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.3 mmm -69.61 -47.35 63.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -147.53 13.64 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 50.0 110.285 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' ASP . 29.0 t0 -74.12 -53.22 10.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 50.0 110.165 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.1 m-20 -79.95 8.58 6.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 50.0 110.549 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.0 t0 43.19 55.69 4.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 50.0 109.964 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.7 mp -38.15 -57.16 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.526 -0.734 . . . . 50.0 111.034 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 33.6 m-85 -46.54 -25.84 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.028 . . . . 50.0 109.582 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ASP . 29.3 tt0 -97.81 -54.59 3.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 50.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -66.47 -28.4 68.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 50.0 110.177 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -57.72 -27.85 63.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 50.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.09 62.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 50.0 110.15 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -81.06 -23.51 38.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 50.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.31 -51.9 6.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 50.0 110.218 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 60.2 0.87 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 50.0 109.457 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.88 171.31 15.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -1.124 . . . . 50.0 110.377 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.04 150.84 40.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 50.0 110.09 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.16 -28.24 73.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.765 -1.334 . . . . 50.0 109.765 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.14 -10.02 27.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 50.0 110.275 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 31.5 m-20 -122.46 -51.07 1.97 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 50.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t80 -124.72 138.5 54.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 50.0 110.08 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.11 162.57 14.11 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 10.0 109.568 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -83.21 124.36 30.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 50.0 110.167 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.1 ttp -94.52 127.84 40.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 50.0 109.978 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.23 110.77 21.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 12.5 110.334 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 51' ' ' ALA . 60.1 t -118.37 113.99 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 10.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.51 151.9 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.94 115.97 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 25.0 109.995 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.76 -7.77 23.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.277 -1.529 . . . . 10.0 109.277 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.57 122.56 46.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -1.13 . . . . 10.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 31.7 m-85 -47.45 124.09 6.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 10.0 110.224 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HA ' HG11 ' A' ' 42' ' ' VAL . 7.1 mt -46.54 -69.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.399 -0.813 . . . . 10.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 102' ' ' CYS . 24.2 tp -42.44 -37.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 10.0 110.736 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -66.49 -46.63 75.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 50.0 109.965 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -70.18 -33.72 72.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 12.5 110.002 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.04 -47.65 17.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 10.0 110.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.26 -29.47 68.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.416 -0.803 . . . . 10.0 109.747 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -20.09 64.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 50.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -95.74 -32.46 12.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 10.0 110.225 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.22 -11.27 2.04 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.823 -1.311 . . . . 10.0 109.823 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 57' ' ' TYR . 4.1 m-30 -66.61 111.81 3.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.095 -1.238 . . . . 12.5 110.19 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.9 t0 -92.12 147.58 22.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 10.0 110.172 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 52.1 m95 -137.97 133.99 17.8 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.227 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.67 82.52 1.91 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.946 1.498 . . . . 10.0 110.535 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' HB2' ' S2 ' ' A' ' 130' ' ' FES . 13.8 p90 -121.12 149.05 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 10.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -127.08 16.68 7.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 10.0 109.987 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.95 113.44 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 10.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -134.06 -36.19 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 10.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.07 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 10.0 110.158 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.04 154.69 52.87 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.566 -1.414 . . . . 10.0 109.566 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.74 161.68 7.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 10.0 110.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 2.5 t -119.09 117.64 29.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 10.0 110.502 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.59 -23.57 15.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 25.0 109.674 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -153.4 106.75 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.413 -0.804 . . . . 50.0 109.817 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 101' ' ' THR . 45.9 t -67.04 -102.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 10.0 110.494 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . -169.68 24.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 10.0 111.124 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.724 ' OG ' HD11 ' A' ' 113' ' ' ILE . 59.5 p -117.5 122.95 45.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.26 -0.9 . . . . 50.0 110.234 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 97' ' ' ASP . 10.4 mm -88.27 79.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 50.0 110.239 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.71 ' CA ' HD12 ' A' ' 113' ' ' ILE . 7.6 p -50.6 118.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 50.0 110.217 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -89.83 -6.89 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 50.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.11 157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -0.978 . . . . 25.0 110.186 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.49 -146.44 18.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 10.0 109.363 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -171.38 132.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 50.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 ' HD3' ' A' ' 99' ' ' ARG . 43.0 mt -107.89 149.81 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 50.0 109.903 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.15 171.67 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 10.0 110.35 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ptp -165.17 -169.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 50.0 110.116 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.0 127.48 35.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 50.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.2 85.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 50.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -167.5 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 16.66 110.231 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -152.61 170.64 19.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 50.0 110.322 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 133.03 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.77 139.43 45.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 12.5 110.288 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 2.4 p -116.75 127.53 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 12.5 110.14 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 p-10 -53.21 -43.77 67.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 10.0 109.992 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 7.8 tt0 -54.71 -26.82 36.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.233 -0.917 . . . . 50.0 109.319 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 1.4 tt0 -72.9 -43.12 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 50.0 109.821 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -79.98 -6.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 10.0 110.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -104.18 -48.14 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 12.5 110.327 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.4 mt-10 -82.79 -37.27 24.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 50.0 110.079 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.619 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.74 -21.04 12.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 25.0 109.851 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.595 ' HB2' HG23 ' A' ' 74' ' ' ILE . 4.4 m-20 61.26 23.5 13.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 50.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 96' ' ' LYS . 98.8 t -71.09 158.81 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.056 -1.028 . . . . 50.0 110.042 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.613 ' HD3' HD12 ' A' ' 80' ' ' ILE . 18.6 mtt-85 -162.79 150.53 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 50.0 110.389 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD21 ' C ' ' A' ' 103' ' ' ILE . 6.0 tt -68.14 124.72 24.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 10.0 110.26 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.746 HG22 ' SG ' ' A' ' 71' ' ' CYS . 12.8 t -125.9 -10.9 6.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 10.0 110.461 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 79.0 m -75.03 -57.78 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 10.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' C ' HD21 ' A' ' 100' ' ' LEU . 2.6 mt -118.87 59.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 50.0 110.273 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.78 160.72 28.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.522 -1.431 . . . . 10.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.66 157.11 57.74 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.254 -1.145 . . . . 10.0 110.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' A' ' 48' ' ' ILE . 44.9 Cg_endo -72.18 144.68 42.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.931 1.49 . . . . 10.0 110.312 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -114.33 -28.11 7.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.123 -0.985 . . . . 50.0 110.609 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.58 149.86 23.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 50.0 110.382 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -47.81 -79.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 50.0 110.019 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 2' ' ' THR . 1.5 mp0 -98.19 121.64 40.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 50.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 3' ' ' VAL . 40.8 t -119.94 146.26 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.927 . . . . 12.5 110.181 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.3 mttt -112.8 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 25.0 110.306 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.724 HD11 ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -160.09 153.03 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 10.0 110.133 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.869 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -109.16 145.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.282 -0.887 . . . . 50.0 109.298 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -108.3 179.71 4.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.087 -1.008 . . . . 50.0 110.407 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER 76.84 21.41 1.2 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.934 -0.479 . . . . 10.0 110.354 -179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 72' ' ' ALA . . . -38.61 -27.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 50.0 110.819 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -43.92 -24.47 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.981 . . . . 50.0 110.368 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.715 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 13.5 p80 -63.86 -25.44 68.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.114 -0.991 . . . . 50.0 110.14 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.491 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 3.0 mt -47.22 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.153 -0.967 . . . . 12.5 110.279 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.18 -15.3 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 50.0 110.073 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -79.04 -13.1 59.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 16.66 110.173 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -11.81 6.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 50.0 110.335 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -45.77 -30.87 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 50.0 110.231 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -45.9 -25.07 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.905 . . . . 50.0 110.001 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -25.31 67.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 50.0 110.144 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.77 111.68 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 50.0 110.185 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 128' ' ' ILE . 3.0 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.947 -1.025 . . . . 50.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.733 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.577 ' S2 ' ' HB2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.49 1.289 0 N-CA-C 110.444 -0.637 . . . . 4.9900000000000002 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 17.0 m -125.34 136.58 53.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 3.73 110.218 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.901 HG22 ' HB ' ' A' ' 111' ' ' VAL . 87.1 t -132.42 173.51 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 10.0 110.221 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.5 tt0 -141.65 120.43 12.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 50.0 110.001 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 21.4 p90 -92.92 137.28 32.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 50.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -126.84 129.34 48.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.814 . . . . 50.0 109.981 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.562 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.1 t30 -64.63 121.9 15.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 12.5 110.781 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 114' ' ' VAL . 73.3 t80 -64.34 -36.12 83.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.852 . . . . 50.0 109.719 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 50.0 109.805 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -71.31 -38.49 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 50.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -65.88 -40.47 91.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 50.0 109.687 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.5 m-20 -79.86 -50.58 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 50.0 109.774 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.7 t0 -48.25 -51.5 25.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 50.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -17.51 61.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 50.0 110.008 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.16 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.379 -1.488 . . . . 50.0 109.379 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -87.71 -171.6 3.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 50.0 110.149 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 13.6 t0 -99.31 -173.09 2.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 50.0 110.221 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.65 -50.16 39.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 50.0 110.148 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.19 14.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 50.0 110.435 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 1.6 m-20 -77.24 -44.99 27.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 50.0 109.963 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.6 ' CB ' ' CD1' ' A' ' 16' ' ' TRP . 45.3 m-20 -76.66 1.98 15.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 50.0 110.04 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 56.82 48.51 15.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 50.0 110.152 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.9 mp -49.83 -55.91 12.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.487 -0.758 . . . . 50.0 110.283 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 24.1 m-85 -53.91 -20.5 6.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 50.0 109.743 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.78 -56.88 2.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 50.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -63.61 -24.87 67.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 50.0 110.231 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -59.17 -18.89 40.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 50.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.38 -24.7 46.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.857 . . . . 50.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.51 -5.4 49.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 50.0 110.146 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.37 -13.8 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 50.0 110.192 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.86 36.44 90.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.324 -1.51 . . . . 50.0 109.324 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.72 169.33 5.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 50.0 110.27 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.86 154.85 6.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.64 -23.69 66.79 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.698 -1.361 . . . . 50.0 109.698 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 59' ' ' TRP . 6.2 tt0 -78.71 -13.51 59.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -1.22 . . . . 50.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 77.8 m-20 -97.84 -46.53 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 110.105 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 26.3 t80 -133.33 130.49 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 50.0 110.084 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 179.77 -177.88 48.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.319 -1.512 . . . . 10.0 109.319 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.57 122.87 45.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -1.136 . . . . 50.0 110.214 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -96.93 112.57 24.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 50.0 110.197 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.93 114.15 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 12.5 109.896 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HD3' ' A' ' 106' ' ' PRO . 57.7 t -124.98 112.46 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 10.0 110.42 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.24 147.99 50.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 50.0 110.132 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.47 117.59 5.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 25.0 110.029 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.84 5.42 38.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' OG ' ' A' ' 105' ' ' SER . 0.4 OUTLIER -116.34 106.91 14.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -1.2 . . . . 10.0 110.05 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 11.9 m-30 -41.57 126.35 2.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.322 -0.861 . . . . 10.0 110.244 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' LEU . 22.9 mt -45.39 -61.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 10.0 110.596 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 69' ' ' ALA . 8.1 tt -41.95 -32.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 10.0 110.392 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -69.68 -46.17 66.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 50.0 110.26 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 55' ' ' GLN . . . -64.53 -29.25 70.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 12.5 110.3 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . . . -73.95 -42.44 60.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 10.0 110.269 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -31.8 72.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 10.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.96 -12.91 60.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 50.0 109.831 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -98.2 -34.55 10.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.892 . . . . 10.0 109.755 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.17 19.36 1.76 Allowed Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.737 -1.221 . . . . 10.0 110.415 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 2.8 m-30 -91.11 94.29 9.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.776 -1.426 . . . . 12.5 110.212 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.0 64.87 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 10.0 109.49 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.729 ' CE3' ' CD2' ' A' ' 115' ' ' TYR . 5.4 m95 -51.52 164.85 0.47 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.492 -0.755 . . . . 50.0 111.14 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 59' ' ' TRP . 44.3 Cg_endo -70.64 121.85 8.32 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.311 1.69 . . . . 10.0 110.372 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -66.8 156.24 36.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.933 . . . . 10.0 110.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.94 59.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 10.0 110.086 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.2 OUTLIER -159.89 175.97 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 10.0 110.228 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -79.3 178.2 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 10.0 110.097 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.66 152.18 37.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 10.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.21 59.89 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.471 -1.451 . . . . 10.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 51.75 20.36 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -1.198 . . . . 10.0 110.24 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' CYS . 0.0 OUTLIER -97.44 120.42 37.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 10.0 110.085 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 49' ' ' LEU . . . -105.5 -148.74 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 25.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -56.88 167.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 50.0 110.382 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -171.49 76.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 10.0 110.157 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -176.37 88.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 10.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.644 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -130.32 141.78 50.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 50.0 110.287 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.811 HG23 ' HB2' ' A' ' 97' ' ' ASP . 1.2 mp -101.59 91.47 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 50.0 109.756 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 97' ' ' ASP . 7.7 p -51.86 122.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 50.0 110.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -88.77 -8.49 54.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 50.0 109.881 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 179.34 169.08 1.04 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 25.0 110.316 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.56 -148.39 23.8 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' HG3' ' HB3' ' A' ' 107' ' ' ALA . 5.0 pt-20 -171.44 136.26 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 50.0 110.076 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 20.5 mt -110.21 144.88 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 50.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 105' ' ' SER . 2.6 t70 -105.83 162.91 13.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 10.0 109.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -143.67 150.58 38.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 50.0 110.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -64.99 178.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.873 . . . . 50.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -49.08 105.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 50.0 110.231 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 84' ' ' MET . 2.5 tt0 -177.35 32.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 16.66 110.016 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -46.74 120.34 2.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 50.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -155.42 -39.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 50.0 110.026 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' N ' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -66.48 167.01 11.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 12.5 110.203 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.26 141.61 37.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 12.5 110.28 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -56.89 -50.13 73.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 10.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.1 pp20? -55.43 -25.51 36.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.344 -0.847 . . . . 50.0 109.753 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.41 -43.83 80.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 50.0 110.177 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 13.0 t -71.75 -30.33 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 10.0 110.297 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -91.58 -28.41 17.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 12.5 110.232 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 9.2 tm-20 -100.86 -26.8 13.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 50.0 110.402 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -117.15 -19.95 9.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 25.0 110.38 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.811 ' HB2' HG23 ' A' ' 74' ' ' ILE . 3.7 m-20 67.88 15.08 9.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 50.0 110.18 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 74' ' ' ILE . 42.9 t -91.53 142.64 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.161 -0.962 . . . . 50.0 110.633 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' O ' ' A' ' 80' ' ' ILE . 6.8 ttt180 -162.51 146.19 11.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.012 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.607 HD22 ' CG2' ' A' ' 103' ' ' ILE . 25.9 mt -41.94 135.91 2.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 10.0 110.398 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 m -121.92 -18.29 7.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 10.0 110.058 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 27.3 p -98.19 -3.45 37.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 10.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.607 ' CG2' HD22 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -146.65 42.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 50.0 110.135 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.21 144.41 11.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.688 -1.365 . . . . 10.0 109.688 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -109.41 160.76 26.53 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.334 -1.098 . . . . 10.0 110.054 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD3' HG11 ' A' ' 42' ' ' VAL . 47.9 Cg_endo -73.75 114.3 4.0 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.927 1.488 . . . . 10.0 110.57 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.792 ' HB3' ' HG3' ' A' ' 79' ' ' GLU . . . -84.54 9.14 14.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 50.0 110.098 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -134.64 146.29 49.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 50.0 110.179 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.3 -80.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 50.0 110.335 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -89.77 120.05 30.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 50.0 110.113 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.901 ' HB ' HG22 ' A' ' 3' ' ' VAL . 46.2 t -123.4 153.53 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 12.5 110.338 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HE2' ' CG ' ' A' ' 24' ' ' PHE . 20.5 mtpt -126.76 143.53 51.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 25.0 110.053 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.715 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.08 148.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 10.0 110.635 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 6' ' ' LEU . 77.1 t -99.75 125.01 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 109.459 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.729 ' CD2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.7 179.02 6.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 50.0 110.14 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' OD1' ' CZ ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 61.76 28.3 17.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.083 -1.011 . . . . 10.0 110.311 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -63.09 -14.35 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 50.0 110.011 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -57.73 -18.04 18.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.164 -0.96 . . . . 50.0 109.442 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 56.3 m-70 -63.08 -36.39 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.408 -0.808 . . . . 50.0 109.946 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -42.14 152.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.875 . . . . 12.5 110.277 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 -38.08 67.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 50.0 110.224 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -70.28 -4.89 24.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 16.66 110.183 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -39.59 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 50.0 110.36 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 5.2 tt0 -62.52 -25.66 68.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 50.0 110.443 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -53.78 -23.7 12.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 50.0 110.143 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.99 -33.22 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 50.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.05 136.09 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 50.0 110.369 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.944 -1.027 . . . . 50.0 110.237 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.772 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.611 ' S2 ' ' O ' ' A' ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_